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Abstract 
JRC has developed a quantitative methodology to detect very early signs of emerging technologies, so called "weak 
signals of technology development". Using text mining and scientometric indicators, 256 of these weak signals have been 
identified on the basis of scientific literature and have been reported earlier this year in a JRC technical report. The 
purpose of this follow-up report is to provide a European perspective and to provide recommendations for policy makers. 
Europe shows vulnerabilities in 179 of these weak signals, further analysed in the present report.  
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Executive summary 
 
This report presents the results of an analysis performed on 256 weak signals in technology development detected 
through applying text mining techniques to a dataset of scientific publications. The aim of the present analysis is to 
identify points of focus for policy-makers, the research community, and stakeholders of technological development.  
 
The main conclusions from the analysis are: 
 There is a risk of technology dependency of Europe in 98 of the weak signals. 
 There is no or little R&D activities in Europe for ¼ of the weak signals (64). 
 Research in Europe should be reinforced for ¼ of the weak signals (66). 
 Research ecosystems in Europe are fragmented in more than a third of the weak signals (97). 
 Patenting incentives should be put in place for more than half (136) of the weak signals. 
 42 research ecosystems might be impacted by the Brexit.  
 There are knowledge monopolies or duopolies in 8 weak signals. 
 
It also appears that Europe is strong in weak signals related to social sciences, health, and environment, but shows some 
vulnerabilities in Physics & Engineering, Biology, ICT, Viruses, Energy, and Materials. Looking at sub-topics, Europe is 
strong in weak signals related to biomaterials, microbiology, neurosciences, new medicines, and digital social sciences but 
vulnerable in weak signals related to the 27 other sub-topics, including perovskite, solar cells, 5G, Internet of Things, 3D 
printing, Neural Networks, Viruses, new materials (2D materials, nanomaterials, metasurfaces, new catalysts).  
 
Organisations leading R&D are most often from China and the US. Overall, a reasonable proportion of European 
companies are taking part in research and development efforts in the various weak signals. There are as many small 
industrial players in Europe than in the other main territories, but fewer large size companies. Organisations from China 
and the US are the most frequent in the ranking of the top 10 organisations for each weak signals. Except for the weak 
signals related to Environment, European organisations do not appear often in these top 10. 
 
Finally, Europe suffers from a low capacity of transformation of knowledge into patents compared to the US, China, 
Japan, or South Korea. This is observed for many weak signals, even when European companies are very active. Chinese 
organisations are very active in patenting but only a small number of the patents filed in China (6.22%) are extended to 
another patent jurisdiction. This proportion of patents extended is much higher for South Korea, the US, Japan, and for the 
EU (up to 80%). 
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1 Introduction 
 
For an organisation like the Joint Research Centre acting at the interface between science, policy making and society, the 
early identification of emerging technologies is key to support the design and implementation of European policies, which 
need to take into account the potential of these new technologies to create opportunities or disruptions. To complement 
its current foresight capacity, which is mostly based on qualitative technology monitoring and assessment, JRC is 
developing new analytic techniques based on text mining applied to large datasets.  
 
The present report analyses the 256 weak signals in technology development identified with the new quantitative 
methodology developed by JRC and presented in the report “Weak signals in Science and Technologies - 2019 Report”1. 
This quantitative methodology relies on text mining algorithms and was conceived to identify early signals of new 
technological developments, as well as new applications of existing technologies. The weak signals of the 2019 exercise 
(see figures 1 and 2) were detected by applying this new text mining methodology on a corpus of scientific publications 
covering the period 01/01/1996 to 31/12/2018.  
 
 
The 256 weak signals can be examined in detail here:  
https://www.timanalytics.eu/TimTechPublic/main.jsp?dataset=s_1231 
 
The aim of the analysis is to better understand the positioning of Europe for each of the weak signals and to make 
recommendations. The following types of questions are considered: Does Europe produce knowledge? Are European 
organisations active in innovation and patenting? Is there a risk for future technology dependency? Will Brexit have an 
impact on the research environment? The weak signals can be sorted in one of the four following categories: 1) Europe is 
weak in producing knowledge, 2) Europe is weak in patenting, 3) Europe is strong in producing knowledge, and 4) Europe 
is strong in patenting. In particular, the analysis will focus on the weak signals where Europe is producing little knowledge 
or patents (categories 1 and 2) and those which could be impacted by Brexit. 
 
In a next step, the results of the present exercise will be submitted to experts in Europe and more widely in other regions 
of the world. Through an iterative and structured process, the significance and future impacts of the identified weak 
signals on the European economy and society will be evaluated. The objective is to combine the results of the new JRC 
quantitative methodology to detect weak signals with expert consultations to reach an assessment of the European 
positioning and competitiveness in these technologies, their possible widespread development, including needs for further 
research and investments, and their social and ethical acceptance. The ultimate aim is to identify a set of key policy 
recommendations and legislative opportunities for European stakeholders and policymakers to act upon.  
 
The detection of weak signals using text mining techniques on large data corpuses will be integrated to existing foresight 
and anticipation mechanisms in JRC to support services and policy Directorate Generals of the European Commission in 
designing European policies.  
 
  
                                           
1 JRC 2019.5552, EUR 29900 EN, ISBN 978-92-76-12386-6, ISSN 1018-5593, doi: 10.2760/858426 
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2 List of weak signals as identified in JRC report “Weak signals in 
Science and Technologies - 2019 Report”  
 
 
Figure 1: wheel of weak signals, per topic. 
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Figure 2: List of weak signals per topic. 
 
 
 
 
 
 
 
 
 
 
 
 
 
BIOLOGY MATERIALS ICT ENERGY
BIOMATERIALS ENGINEERING 2D MATERIALS 5G Communication MISC
Melt Electrowriting Graphene-like 5G Security Accident tolerant nuclear fuel
Brain organoids      Antimonene Drone base stations Electrolyte free fuel-cell
Retinal organoids      Arsenene Heterogeneous ultra-dense networks Energy justice
Spytag spycatcher protein ligase      Bismuthene Network slicing Energy trilemma
     Borophane Non-Orthogonal Multiple Access Garnet electrolyte
GENETICS      Borophene Ultra-reliable low latency communication
Assay for transposase-accessible chromatin sequencing      Phagraphene SOLAR CELL
Double digest RAD Sequencing      Phosphorene BLOCKCHAIN Flexible solar cell
Single cell RNA sequencing      Stanene Consortium blockchain Inverted solar cell
Cr2ge2te6 Private blockchain Non fullerene organic solar cell
MICROBIOLOGY MoTe2 Public blockchain Ternary polymer solar cells
Bacillus velezensis ReS2
In silico DNA-DNA hybridization Titanium carbides BATTERIES
Parageobacillus thermoglucosidasius INTERNET OF THINGS Al-Air batteries
Seed microbiome WEARABLES Internet of battlefield things Aqueous organic redox flow batteries
Spray-induced gene silencing Wearable flexible electronics Internet of drones Dual-carbon batteries
Wearable energy storage Internet of vehicles Li and Mn rich layered oxides
MOLECULAR BIOLOGY Wearable IoT Low power wide area network Li-CO2 batteries
Biomolecular condensates Massive machine type communication Lithium-Metal batteries
Circular RNA NANO MATERIALS Narrowband internet of things Magnesium-sulfur batteries
Diagnostics based on circular RNA Biomimetic nanoparticle Smart village Potassium-ion batteries
Synthetic Notch Renal clearable nanoparticles Sodium-metal anodes
Nanocinnamon NEURAL NETWORKS Sodium-metal batteries
MOLECULAR BIOLOGY - CRISPR Molybdenum disulfide quantum dots 3D convolutional neural networks Zinc-ion batteries
Anti-CRISPR Convolutional autoencoders
CRISPR/CPF1 CATALYSIS Deep Q learning MICROGRID
CRISPR interference Alkaline hydrogen evolution reaction Dilated convolutional neural network Home microgrid
Platinum free catalysts Generative adversarial networks Hybrid microgrid
BIOLOGY MISC. Single atom catalysis Hierarchical recurrent neural network Mobile maritime microgrid
Acute hepatopancreatic necrosis disease Surface heterojunction photocatalytics High resolution image recognition by NN Peer-to-peer energy trading
De-extinction Long Short-Term Memory  neural network
Dynamic in vitro digestion POLYMERS Quaternion valued neural network SOCIAL SCIENCES
Thanatomicrobiome Gelatin methacrylate hydrogel Residual neural network
Transcriptome metabolome wide association Microplastic ingestion DIGITAL
Microplastics sampling COMPUTING Algorithmic fairness
HEALTH PET hydrolytic enzymes Edge computing Algorithmic journalism
Pet-Raft polymerisation Fog computing Civic technologies
NEUROSCIENCE Twisted and coiled polymer muscles Mobile edge caching Digital consitutionalism
Chronnectomics Vitrimers Mobile edge computing Digital humanitarianism
Fluorescence lifetime imaging ophthalmoscopy Drug cryptomarkets
Glymphatic system METASURFACES MISC Immersive journalism
Network neuroscience Acoustic metasurface Ambient backscatter Small private online course
Precision psychiatry Adaptative metasurface Crypto supersingular isogeny Take over request in self driving
SC79 Hologram metasurface Digital twin in industry
Targeted memory reactivation Metasurface lens Drone detection VARIOUS
Tau PET Nonlinear metasurface Micro-service architecture Biophilic cities
Online multiple object tracking Circular bioeconomy
NEW MEDICINES/DISEASES PEROVSKITE Ransomware detection Crowd shipping
Activated phosphoinositide 3-kinase (PI3K) δ syndrome Cesium lead halide perovskites Smartphone spectrometry Sociology of quantification
Adenosine deaminase 2 deficiency FAPbI3 perovskite Software-defined vehicular networks
Anti-CGRP antibodies Lead free perovskite YOLO ENVIRONMENT
Christensenellaceae FASnI3 perovskite
New gout therapies MASnI3 perovskite PHYSICS AND ENGINEERING CLIMATE CHANGE
Nlrp3 inhibitors Triple cation perovskites Climate clubs
Nusinersen Perovskite LEDs LIGTH-RELATED Coastal blue carbon
Octapeptins Perovskite quantum dots Photoelectrochemical aptasensors Deep decarbonization
PCSK9 inhibitors Perovskite nanocrystals Photoelectrochemical immunosensors Marine heatwave
Pegvaliase Perovskite nanowires Photoinduced force microscopy Land degradation neutrality
Semaglutide Perovskite photodetectors Remote photoplethysmography
Senolityc drugs Planar perovskites Structure-from-Motion photogrammetry POLLUTANTS MITIGATION AND DEGRADATION
Siderophore cephalosporin Topological photonics Comammox
MATERIALS MISC. Visible light positioning Electro-fermentation
CANCER 0d 2d heterostructures Functionalised Biochar
Androgen receptors inhibition Bimetallic organic frameworks DETECTION Nitrite-oxidizing bacterium suppression
Anti-CD38 antibodies CaKFe4As4 superconductor Ratiometric nano-thermometers Organophosphorus flame retardant
Anti-PDGFR monoclonal antibodies CrMnFeCoNi high entropy alloys Spatial heterodyne raman spectrometer Peroxymonosulfate activation
CAR T cells immunotherapy Cs2HfCl6 Stretchable strain sensors
Cyclin-dependent kinase (CDK) 4/6 inhibitors Dihydrolevoglucosenone Ultra-Fast Silicon Detectors ENVIRONMENT MISC.
Ferroptosis Eutectic high entropy alloys Black soldier fly larvae biodiesel
Gasdermin Natural deep eutectic solvents 3D PRINTING Cargo bikes
Programmed death-ligand 1 (PD-L1) inhibitors PbTaSe2 superconductor 3D Bioprinting Ecoacoustic
Radiomics machine learning Tin selenide crystals 3D Concrete printing Environmental DNA metabarcoding
Radiotheranostics 3D printed of tablets Flex crops
Rovalpituzumab tesirine VIRUSES 4D printing Octane on demand
Tyrosine Kinases (TK) inhibitor Robocasting Ultra-low-temperature district heating
Taurine-upregulated gene 1 (TUG1) VIRUSES IN AGRICULTURE Wire arc additive printing
Tumor mutational burden Atypical porcine pestivirus
X-inactive specific transcript (Xist) Grapevine red blotch virus WIRELESS POWER TRANSFER
Orthotospovirus Capacitive wireless power transfer
HEALTH MISC. Porcine circovirus 3 Dynamic wireless power transfer
Heat-not-burn Tobacco Product Tomato mottle mosaic virus Underwater wireless power transfer
Flash Glucose Monitoring Wireless powered communication networks
New synthetic opioids VACCINES AND ANTIVIRAL TREATMENT
Ebola vaccine MISC
Glecaprevir/Pibrentasvir Air-Filled Substrate Integrated Waveguide
Herpes zoster vaccine Cold sintering process
MK-8591 Hybrid modular multilevel converter
Nonavalent human papillomavirus vaccine Levitated optomechanics
Quantitative viral outgrowth assay for HIV Out-of-time-ordered correlators
Staphyloccocal kayviruses Quantum machine learning
Zika virus vaccine Supraharmonics
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3 Methodology for the analysis 
The 256 weak signals detected have been reconstructed in TIM Technology, a technology monitoring system developed 
and operated by JRC, using semantic searches. As a result, each weak signal in TIM Technology is composed of a group of 
documents retrieved by the search query in a patent database (Patstat), a scientific literature database (Scopus), and a 
database containing R&D grants funded by the Framework Programme for Research of the European Commission 
(Cordis). Bibliometric indicators are then calculated on the basis of the documents retrieved to analyse and classify the 
weak signals.  
3.1 Indicators 
The following indicators are used in the analysis of the weak signals: 
 Total number of scientific publications worldwide; 
 Number of scientific publications by European organisations (including UK); 
 Number of publications for organisations in Europe (all Member States except UK); 
 Total number of patents families worldwide; 
 Number of patent families by organisations in Europe; 
 The fragmentation of the research environment in Europe, calculated by dividing the number of organisations 
from Europe active in research (i.e. publishing scientific publications) by the number of co-publications between 
these organisations. A fragmented research landscape is a research environment where research organisations 
do not collaborate together (few or no co-publications), while a collaborative landscape is characterised by a lot 
of co-publications between the organisations active in research. 
It should be noted that the indicators for patents are considering only the number of patent families (a set of patents 
applied in various countries to protect a single invention) and do not use proxies related to their importance, such as the 
essential patents or the triadic patents (a series of corresponding patents for the same invention filed at the European 
Patent Office, the US Patent Office, and the Japan Patent Office). 
3.2 Entity disambiguation 
A common issue in scientometrics is the disambiguation of entity names i.e. merging all the name variants of an 
organisation from different documents and/or sources into one unique name. Algorithms that automatically compare the 
entities names with a list of known organisations are used to ensure a reasonable level of disambiguation of organisation 
name variants. This process is complemented by manual cleaning when necessary. Although this allows reaching high 
levels of disambiguation of the data related to organisations, it must be noted that the accuracy of the entity matching 
process in TIM never reaches 100%. 
To estimate the accuracy of the entity matching process, 10 randomized samples of 100 name variants have been 
extracted from the raw metadata in our system (patents in Patstat, scientific publications in Scopus, EU grants in Cordis), 
and compared manually to their unique name as resolved by the TIM entity matcher. The average accuracy of the process 
as measured by this sampling technique reaches 93.8% with a standard deviation of 2.15. Although the disambiguation 
of entities names is not error-free, the result is accurate enough to allow the observation of trends in science and 
technologies. 
3.3 Categories of weak signals 
The focus of the present analysis is made on weak signals that are problematic from a European perspective. The 
following vulnerabilities have been considered: 
 
 Low knowledge production (Europe representing less than 25% of the scientific publications for the weak 
signal). The number of publications from European organisations is used as a proxy to knowledge production. 
There are of course other types of knowledge produced that are not considered in this study (number of PhD 
thesis, informal knowledge within organisations …). The assumption is: the higher the number of scientific 
publications for a country/territory, the higher the knowledge production for that country/territory. 
 
 Low transformation of knowledge into innovation (less than 25% of the patents belong to organisations in 
Europe). The number of patents is used as a proxy to the capacity to innovate. The following assumption is 
made: the higher the number of patents, the higher the capacity of a country/territory to transform academic 
knowledge into patents (technological products or services). Innovation is a complex mechanism and patents 
only reflect the capacity for technological innovations. In addition, patenting strategies can vary from one 
country to another (some countries have strong incentives in place to promote patenting), from one culture to 
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another, or from one technological field to another. The number of patents should therefore be taken as an 
indication of the capacity to innovate, and not as a definitive and accurate measure of innovation. 
 
 A significant proportion of knowledge and/or patents originating from the UK. This is considered as a 
vulnerability in view of Brexit, which might isolate UK institutions and companies from their counterpart in 
Europe. It is likely that collaboration at a scientific level will continue, but research environments might be 
disturbed by the transition towards Brexit. In addition, Brexit could represent a loss of knowledge from the 
European perspective. We consider here that the weak signals that could be impacted by Brexit are those for 
which more than 40% of the scientific publications or of the patents from Europe involve at least one 
organisation from the UK (author or applicant). These vulnerabilities could potentially lead to technology 
dependency of Europe in various new emerging technological areas.  
 
 In addition, two characteristics of the research ecosystem in Europe are considered as vulnerabilities:  
o A low level of collaboration in knowledge production (i.e. number of co-publications). This level is 
calculated by the fragmentation of the network graph of publishing organisations. The network is 
considered as fragmented when the fragmentation indicator is above 1. 
o Imbalances in strength for the different actors in Europe (e.g. monopolistic situation when one 
organisation dominates) 
 
The analysis is designed to investigate the above mentioned vulnerabilities. In a first step, the indicators described at 
point 3.1 are calculated for each weak signal, which allows for their classification into the four categories described in 
figure 3: 1) EU is weak in knowledge production (and in patenting), 2) EU is weak in patenting, 3) EU is strong in 
knowledge production, 4) EU is strong in knowledge production and in patenting. In a second step, weak signals belonging 
to the categories “EU weak in KW” and “EU weak in IP” are analysed further in order for recommendations to be made 
(see chapter 4), while the weak signals of the categories “EU strong in KW” and “EU strong in KW and IP” are only 
analysed further if a possible impact from Brexit is detected. The report also contains an additional analysis of some of 
the so-called “persistent” weak signals (for which documents have been retrieved over many different years), which may 
seem counterintuitive for technologies that are supposed to emerge. In total, 190 weak signals are looked at in this 
report. 
Figure 3: Categories chosen for the analysis of weak signals 
 
 
 
3.4 Recommendations 
The Joint Research Centre acts at the interface between science, policy making and society, and supports the design and 
implementation of European policies. Within the context of that mission, early identification of emerging technologies is 
an important step to ensure economic opportunities for Europe or mitigate technological disruptions. Recommendations 
are therefore made to stakeholders of the European science and innovation ecosystem to support adequate decision-
making regarding for example funding of research, support mechanisms to innovative industry, or investment 
opportunities. 
 
5 types of recommendations have been made for the weak signals for which Europe shows some vulnerabilities: 
 
- Measures should be put in place to create R&D activities: For weak signals where Europe lags behind in 
knowledge production. 
 
- Measure to further reinforce R&D activities should be considered for weak signals where there is production 
of knowledge in Europe but for which there is fierce competition with other countries/territories. 
 
- Measures to develop the network of research organisations and increase scientific collaboration should be 
put in place. For weak signals where actors from European are not collaborating. 
 
% scientific 
publications 
from Europe
Number 
patents 
worldwide
% patents 
from 
Europe
< 25 % < 5 -
< 25 % > 5 < 25 % 
EU weak in IP
Contains  weak signals for which there is knowledge produced but little/no 
patents from Europe while patents are detected for other countries 
> 25 % > 5 < 25 %
EU strong in KW
Contains weak signals for which there is little/no patents worldwide and 
for which EU organisations produce scientific publications
> 25 % < 5 -
EU strong in KW and IP
Contains the weak signals for which there is knowledge and patents in 
Europe
> 25 % > 5 > 25 %
Category
Includes weak signals that have 
Contains the weak signals for which there is little knowledge production in 
Europe 
EU weak in KW
Description
Full 
Analysis 
Brexit 
risk 
only 
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- Measures to foster innovation and encourage innovation and patenting should be put in place for weak 
signals where Europe lags behind in patenting. Patenting of innovations developed in Europe are essential if 
Europe wants to remain technologically independent in strategic technologies. 
 
- Measures to support the R&D ecosystem in Europe during Brexit: for weak signals for which the research 
ecosystem in Europe might be disturbed by the departure of UK organisations from the European Union. 
 
In addition, two risks are flagged: 
- Risk of technological dependency when there is very little knowledge developed in Europe, or very few patents 
owned by European organisations, or very few organisations from Europe active in R&D compared to other 
countries.  
- Risk related to “Knowledge imbalance” when knowledge in Europe is concentrated in one or two organisations. 
 
3.5 Considerations on the patent data 
A steep increase in the number of patents from China is observed for many of the weak signals detected. Without 
negating the reality of Chinese innovation capacity in the various weak signals that have been detected, some 
particularities related to patent data call for considering the number of patents for the last 24 months with some caution.  
First, and for most of the patent authorities, a systematic decrease in the number of patents for years 2017 and 2018 
can be observed. This is inherent to the patent system and related to the 18 month delay between the first filing of a 
patent and its publication. An extra delay can be caused by the frequency at which national patent offices send their 
patent data to the European Patent Office (EPO) for integration in the Patstat database. Figure 4 shows the effect of 
these two factors on the database of patents used for the analysis.  
 
Figure 4: number of patents families per year and related relative proportions for the 5 biggest territories  
(EU = patents filed in the 28 Member States). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The higher proportion of patents from China observed for the years 2017 and 2018 is the exception to the above-
mentioned decrease. This is confirmed by figures 5 and 6, using data compiled by the EPO2 for the present report and 
shown below.  
 
Figure 5: total number of patents applications for the year 2018 contained in PATSTAT Global - 2019 Spring Edition.  
Figures for the Korean, Japanese, US, Chinese, and European patent offices 
 
 
 
 
 
 
 
 
 
                                           
2 Courtesy of Geert Boedt, European Patent Office. 
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Figure 5 shows that the numbers of patents filed at the Chinese patent office in 2018 is at least ten times higher than in 
the four other territories considered here. This might be a direct result of the National Patent Development Strategy of 
the Chinese National Intellectual Property Administration which has incentives in place to increase the number of patents 
filed in China3. This results in numerous patents being awarded for small design improvements and incremental changes, 
protected by utility models and design patents. Contrary to patents for inventions, utility models and design patents are 
delivered faster (less than 1 year) and are not subject to rigorous examination. 77% of the patents filed in China in 2017 
are utility models or design patents and about 60% of them are abandoned within five years of their filing4. This could 
partly explain both the increase in patenting observed in China and the skewing of data towards China in 2017-2018 
observed in figure 4. This trend to multiply design patents and utility models is not observed in other economies like 
Japan, the EU, or the US, where patents are still mostly granted for entirely new inventions ("patents for inventions").  
 
Figure 6 clearly shows that China applies an early publication strategy for invention patents as well. Around 80% of 
invention patents are already published 6 months after their filing at the Chinese patent office. Early publications are also 
observed for the other territories, but later and to a lesser extent. For example, for patents registered at month 6, while 
80% of Chinese patents are already published, only 10% of the patents have been through early publication in Japan and 
South Korea and around 40% in Europe and the US.  
 
 
 
 
Figure 6: proportion of invention patents published as a function of the number of months after filing for South Korea, 
Japan, US, China, and Europe (courtesy of the EPO). Data from August 2019, excluding PCT applications. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Considering the three elements explained above, i) incentives in China to patent, ii) design patents and utility models 
included in the numbers of patent filed, and iii) the trend for Chinese organisation to request early publication of their 
patent, it is not surprising to observe more Chinese patents over the last years for many of the weak signals detected 
(see details in annex 1). The steep increase in patenting from Chinese organisations over the last 2-3 years should 
therefore be nuanced, considering further elements explained below.  
 
 
                                           
3 “International Patenting Strategies of Chinese Residents: An Analysis of Foreign-Oriented Patent Families”, Mila Kashcheeva, 
Sacha Wunsch-Vincent, Hao Zhou, Economic Research Working Paper No. 20, WIPO, 2014. 
4 Source: National Intellectual Property Administration of China. 
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4 Analysis of the weak signals in technology and science 
4.1 Overview 
In total, 60193 scientific publications and 6922 patents have been retrieved for the 256 weak signals detected. From the 
distribution of publications and patents into the 9 topics of weak signals (figure 7), one can see that more than half of 
the scientific publications have been retrieved for three topics: ICT, Materials, and Health. Half of the patents have been 
retrieved for the topic ICT.  
 
Figure 7: number of patents and publications per topic of weak signals  
(number of WS per category on top of each column). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
According to the categories of weak signals defined at point 3.2 above, Europe lacks knowledge and patents in 45% (114) 
of the weak signals detected. This means that European organisations are involved in less than 25% of the publications 
and of patents worldwide. There are 44 weak signals for which European organisations are strong in producing 
knowledge but fail to transform this knowledge into patents. For these weak signals, European organisations are involved 
in more than 25% of the scientific publications worldwide but applied to less than 25% of the patents. In addition, Brexit 
could impact 10 of these weak signals. Finally, Europe is strong in 80 weak signals (72 EU strong in KW, 8 EU strong in 
patents). In total, Europe leads in 98 of the weak signals detected but Europe’s strength resides in UK organisations for 
18 of them (more than 40% of the publications and/or 40% of the patents involve UK organisations). There are therefore 
only 80 weak signals (72 EU strong in KW, 8 EU strong in patents) out of 256 for which Europe is strong. 
 
 
 
 
Figure 8: proportion of weak 
signals per categories. 
 
 
 
The proportion of weak signals for which Europe is vulnerable or strong varies with the technical topic of the weak signal 
(figure 9). For example, Europe leads in all the weak signals related to Social Sciences but underperforms for those 
related to Materials.  
Figure 9: proportion of weak signals per categories and by topics. 
 
 
 
 
 
 
 
 
Figure 10 shows the sub-topics of weak signals where: 
 Europe leads: European organisations lead in terms of patenting and or scientific publications in a majority of the 
weak signals (the majority of weak signals in the sub-topics belong to the categories “EU strong in KW” and “EU 
strong in KW and IP”);  
 Europe follows: European organisations lead in some weak signals and follows in others (a high proportion of weak 
signals in the sub-topics belonging to the categories “EU weak in KW” and “EU weak in KW and IP”); 
EU weak in KW EU weak in IP EU strong in KW EU strong in IP
SOCIAL SCIENCES 0.0% 0.0% 92.3% 7.7%
HEALTH 20.5% 17.9% 56.4% 5.1%
ENVIRONMENT 38.9% 0.0% 61.1% 0.0%
PHYSICS AND ENGINEERING 39.3% 25.0% 32.1% 3.6%
BIOLOGY 41.7% 12.5% 45.8% 0.0%
ICT 45.0% 42.5% 10.0% 2.5%
VIRUSES 53.8% 7.7% 38.5% 0.0%
ENERGY 58.3% 12.5% 25.0% 4.2%
MATERIALS 70.2% 8.8% 15.8% 5.3%
 11 
 
 Europe lags behind: European organisations take a leading role in very few or none of the weak signals for the sub-
topics (the majority of weak signals in the sub-topics belong to the categories “EU weak in KW” and “EU weak in KW 
and IP”). 
 
Figure 10: Positioning of Europe in sub-topics of weak signals 
With [x, y, z] = [#WS in categories “EU strong in KW” and “EU strong in KW and IP”, 
#WS in category “EU weak in IP”, #WS in category “EU weak in KW and IP”] 
 
 
 
 
 
 
 
 
 
 
 
Although Europe is strong in 80 of the 256 weak signals detected (31%), it appears clearly from figure 10 that there are 
only few sub-topics of weak signals where Europe is the leader. While EU is a clear leader in weak signals related to e.g. 
neurosciences, medicines & diseases, and digital aspects of social sciences, Europe shows vulnerabilities in topics like 
batteries, perovskite, solar cells, 3D printing, or 2D materials, to name but a few. 
 
4.2 Risk of technology dependency 
Based on the analysis presented in the annex, the possibility of a future technology dependency has been identified for 
98 weak signals (figure 11). In the present report, we considered a risk of technology dependency when: 
 Modest research activities is ongoing in Europe while intense research is being performed elsewhere in the world,  
 Little patenting activity is detected in Europe while patents are being filed in the main competing countries. 
 
Figure 11: weak signals presenting a risk of technology dependency for Europe 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Biomaterials Genetics Light-related WS Molecular biology Perovskite Solar cells
3, 1, 0 1, 2, 0 3, 0, 4 1, 0, 4 1, 1, 10 0, 0, 4
Microbiology Cancer Detection CRISPR 5G Microgrids
4, 0, 1 6, 5, 4 2, 0, 2 1, 0, 2 1, 4, 1 1, 2, 1
Neuroscience Polymers Wireless power transfer 2D materials Blockchain Viruses 
7, 0, 1 4, 0, 3 2, 0, 2 1, 1, 10 0, 1, 2 0, 1, 4
Medicines/diseases Vaccines&antivirals Batteries Wearables Internet of things Catalysis
9, 1, 3 5, 0, 3 4, 0, 7 0, 1, 2 1, 4, 2 1, 0, 3
Digital social sciences Computing Climate change Nano materials 3D printing Metasurfaces
9, 0, 0 1, 3, 0 3, 0, 2 0, 0, 4 0, 5, 1 1, 1, 3
Pollutants Neural Networks
3, 0, 3 1, 1, 8
EU leads in EU follows in EU lags behind in
Topic Weak signals Topic Weak signals Topic Weak signals
Env Peroxymonosulfate activation Mat Surface heterojunction photocatalytics ICT Software-defined vehicular networks
Env Functionalised Biochar Mat Twisted and coiled polymer muscles ICT Hierarchical recurrent neural network
Phy&Eng Photoelectrochemical aptasensors Mat Phagraphene ICT Online multiple object tracking
Phy&Eng Photoelectrochemical immunosensors Mat Perovskite photodetectors ICT 3D convolutional neural networks
Phy&Eng Photoinduced force microscopy Mat Bimetallic organic frameworks ICT Private Blockchain
Phy&Eng Spatial heterodyne raman spectrometer Mat Pet-Raft polymerisation ICT High res. image recognition by NN
Phy&Eng Underwater wireless power transfer Mat Cr2Ge2Te6 ICT Generative adversarial networks
Phy&Eng Stretchable strain sensor Mat Renal clearable nanoparticles ICT Internet of vehicles
Phy&Eng Capacitive wireless power transfer Mat Borophane ICT YOLO
Phy&Eng Cold sintering process Mat Molybdenum disulfide quantum dots ICT Consortium Blockchain
Phy&Eng Wireless powered communication networks Mat Perovskite quantum dots ICT Micro-service architecture
Phy&Eng Hybrid modular multilevel converter Mat Perovskite nanowires ICT Heterogeneous ultra-dense networks
Phy&Eng 4D printing Mat Wearable energy storage ICT Drone detection
Phy&Eng 3D Bioprinting Mat Titanium carbides ICT Massive machine type communication
Phy&Eng Quantum machine learning Mat Planar perovskites ICT Fog computing
Phy&Eng Robocasting Mat Borophene ICT Drone base station
Phy&Eng Wire arc additive printing Viruses Porcine circovirus 3 ICT Public Blockchain
Phy&Eng 3D Concrete printing Viruses Zika virus vaccine ICT Narrowband Internet of Things
Phy&Eng 3D printing of tablets Biology Diagnostics based on circular RNA ICT Ransomware detection
Mat Phosphorene Biology CRISPR/CPF1 ICT Internet of battlefield things
Mat Cesium lead halide perovskite Biology Bacillus velezensis Energy Aqueous organic redox flow batteries
Mat Antimonene Biology Circular RNA Energy Dual-carbon batteries
Mat Perovskite LEDs Health Taurine-upregulated gene 1 Energy Non fullerene organic solar cells
Mat Perovskite nanocrystals Health SC79 Energy Ternary polymer solar cells
Mat Lead free perovskite Health New gout therapies Energy Lithium-Metal batteries
Mat Metasurface lens Health Tyrosine kinases inhibitors Energy Garnet electrolyte
Mat Wearable flexible electronic Health Heat-not-burn tobacco product Energy Sodium-metal batteries
Mat Wearable IoT Health CAR T cells immunotherapy Energy Inverted solar cells
Mat MoTe2 Health Tumor mutation burden Energy Hybrid microgrids
Mat FAPbI3 perovskite Health Ferroptosis Energy Flexible solar cell
Mat Adaptative metasurface Health Programmed death-ligand 1 inhibitors Energy Li-CO2 batteries
Mat Natural deep eutectic solvents Health Cyclin-dependent kinase 4/6 inhibitors Energy Zinc-ion batteries
ICT Residual neural network Energy Potassium-ion batteries
Risk of technological dependency
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4.3 Knowledge and patent imbalances 
 
Figure 12 lists the 8 weak signals that have been flagged for a knowledge or patent imbalance i.e. when research 
activities or patenting in Europe is mainly due to one or two organisations. R&D ecosystems that are characterised by a 
monopoly or a duopoly are considered to be more fragile than ecosystems where research and patenting are performed 
by a large number of actors. 
Figure 12: weak signals with a knowledge or patents imbalance 
 
 
 
 
 
 
 
4.4 Creation or reinforcement of research and development activities in Europe 
R&D activities were very low in Europe for approximately one quarter of the weak signals detected (64 WS). Figure 13 
lists them by topics. Depending on the strategic importance of these technologies, Europe could decide to support the 
development of these burgeoning research and development activities.  
For another quarter of the weak signals (66 WS, listed in figure 14), R&D activities were detected but were at levels 
below the R&D intensity detected for the main competitors of Europe. Measures to support R&D could be considered for 
these weak signals, possibly building on the R&D capacity of some identified knowledgeable organisations in Europe.  
 
Figure 13: weak signals with little or no R&D activity in Europe 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: weak signals for which support to existing R&D activities in Europe could be considered 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Topic Weak signals Topic Weak signals Topic Weak signals
Energy Accident tolerant nuclear fuels Mat 0d 2d heterostructures Health X-inactive specific transcript
Energy Lithium-Metal batteries Mat Tin selenide crystals Health Siderophore cephalosporin
Energy Inverted solar cells Mat Hologram metasurface Health Heat-not-burn tobacco product
Energy Hybrid microgrids Mat Acoustic metasurface Health Senolityc drugs
Energy Flexible solar cell Mat Stanene Health Activated phosphoinositide 3-kin syndrom
Energy Electrolyte free fuel-cell Mat Arsenene Health Targeted memory reactivation
Energy Energy justice Mat Biomimetic nanoparticles Phy&Eng Capacitive wireless power transfer
Energy Home microgrids Mat Single atom catalysis Phy&Eng Visible light positioning
ICT Smart village Mat Perovskite quantum dots Phy&Eng Wireless powered communication networks
ICT Convolutional autoencoders Mat Perovskite nanowires Phy&Eng 4D printing
ICT Dilated convolutional neural network Mat Wearable energy storage Phy&Eng Wire arc additive printing
ICT 3D convolutional neural networks Mat Titanium carbides Phy&Eng 3D Concrete printing
ICT Deep Q learning Mat Planar perovskites Phy&Eng Levitated optomechanics
ICT Internet of vehicles Mat Borophene Phy&Eng 3D printing of tablets
ICT Massive machine type communication Mat Antimonene Phy&Eng Topological photonics
ICT Public Blockchain Mat Perovskite LEDs Biology Double digest RAD Sequencing
ICT Narrowband Internet of Things Mat Metasurface lens Biology Thanatomicrobiome
ICT Internet of battlefield things Mat Wearable flexible electronic Biology Diagnostics based on circular RNA
ICT Residual neural network Mat Nonlinear metasurface Biology CRISPR/CPF1
ICT Internet of drones Viruses Zika virus vaccine Biology Bacillus velezensis
Viruses Quantitative viral outgrowth assay HIV Viruses Atypical porcine pestivirus Biology Retinal organoids
Viruses Porcine circovirus 3 Viruses Herpes zoster vaccine Env Functionalised Biochar
Weak signals for which R&D activity should be reinforced
Topic Weak signals Monopole/Duopole Topic Weak signals Monopole/Duopole
ICT Digital twin in industry Siemens Energy Electrolyte free fuel-cell KTH Sweden
ICT Ultra reliable low latency communication Nokia / Ericsson Energy Mobile maritime microgrids Aalborg University
ICT Massive machine type communication Ericsson Energy Energy justice Aarhus University
ICT Mobile edge computing Nokia Energy Home microgrids Aalto and Aalborg Universities
WS with knowldege or patent imbalance
Topic Weak signals Topic Weak signals Topic Weak signals
Env Coastal blue carbon Mat Surface heterojunction photocatalytics ICT Smartphone spectrometry
Env Marine heatwave Mat Twisted and coiled polymer muscles ICT Hierarchical recurrent neural network
Env Black soldier fly larvae biodiesel Mat Phagraphene ICT Ambient backscatter
Env Peroxymonosulfate activation Mat Perovskite photodetectors ICT Online multiple object tracking
Energy Aqueous organic redox flow batteries Mat Bimetallic organic frameworks ICT Private Blockchain
Energy Dual-carbon batteries Mat Pet-Raft polymerisation ICT YOLO
Energy Non fullerene organic solar cells Mat Cr2Ge2Te6 ICT Consortium Blockchain
Energy Ternary polymer solar cells Mat Renal clearable nanoparticles ICT Ransomware detection
Energy Garnet electrolyte Mat Borophane Phy&Eng Photoelectrochemical aptasensors
Energy Sodium-metal batteries Mat Bismuthene Phy&Eng Photoelectrochemical immunosensors
Energy Li-CO2 batteries Mat Nanocinnamon Phy&Eng Photoinduced force microscopy
Energy Zinc-ion batteries Mat PbTaSe2 superconductor Phy&Eng Spatial heterodyne raman spectrometer
Energy Potassium-ion batteries Mat Eutectic high entropy alloy Phy&Eng Underwater wireless power transfer
Energy Energy trilemma Mat PET hydrolytic enzymes Phy&Eng Stretchable strain sensor
Energy Al-Air batteries Mat FASnI3 perovskite Phy&Eng Cold sintering process
Biology Synthetic Notch Mat Alkaline hydrogen evolution reaction Phy&Eng Hybrid modular multilevel converter
Biology Transcriptome metabolome wide associat. Mat MASnI3 perovskite Viruses Orthotospovirus
Biology De-extinction Mat Molybdenum disulfide quantum dots Viruses MK-8591
Biology Anti-CRISPR Mat Dihydrolevoglucosenone Viruses Grapevine red blotch virus
Biology Acute hepatopancreatic necrosis disease Health Taurine-upregulated gene 1 Viruses Tomato mottle mosaic virus
Biology Spray-induced gene silencing Health SC79
Health Pegvaliase
Health New gout therapies
Weak signals with very little or no R&D activity
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4.5 Transformation of academic knowledge into patents 
 
Figure 15 shows, by topics, the percentage of scientific publications and patents to which organisations from Europe, 
China, South Korea, Japan, and the US are contributing. While European organisations are contributing significantly to 
scientific publications (EU is in the top 3 contributors for each topic of weak signal with the US and China), it can be 
observed that the leading role of European organisations in production of knowledge does not translate into a strong 
position in patenting, as they are indeed significantly less European organisations contributing to patents. 
 
Figure 15: contribution to scientific publications and patents by territory and for each topic of weak signals (percentage 
of publications and patents to which EU organisations contribute are displayed on the graph). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
On figure 16, the ratio #patents/#publications is indicated for each topic and for each of the main territories. This ratio is 
an indirect indication of the capacity of a country to transform knowledge acquired through research (proxy: # of 
scientific publications) into innovations (proxy: # of patents). Comparing this ratio for the main territories confirms that 
Europe is less efficient in transforming knowledge into innovations. China, South Korea, and Japan have the highest ratio 
patents/publications for the various categories of weak signals. The US are either third or fourth (except for the topic 
viruses where it is second), and Europe has the lowest patents/publications ratio for every topic. This is confirmed by the 
graphic shown in figure 17 where one can observe the proportion of companies versus public institutions active in the 
nine weak signals topics.  
 
Figure 16: Knowledge transformation ratio (#patents/#scientific publications) per territory and WS topic. 
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Figure 17: Proportion of companies in the nine weak signals topics and per main territory. 
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It can be observed from figure 17 that for Europe the proportion of companies versus universities and research centres 
varies between 13,5% (Biology) and 36% (Materials). The highest percentage of European companies compared to other 
countries is observed for “Health”. For the other topics, the proportion of European companies is always above the 
average ratio companies/(universities + research centres). This shows that European companies are active in research and 
development related to the 256 weak signals. The lower efficiency in transforming knowledge into innovations observed 
for Europe can therefore not be attributed to a lower number of active companies. 
 
Figure 18 sheds some light on this observation by plotting the ratio [#patents/#scientific publications] against the ratio 
[#companies/(# universities and research centres)] for each of the 9 topics and for each territory. A very high capacity to 
transform knowledge into innovations would locate data points at the bottom right of the graph: the proportion of 
patents is high, and the proportion of companies is low. A low capacity to transform knowledge into patents and 
innovations would locate the data points at the top left of the graph: the proportion of patents is low, but the proportion 
of companies is high. The capacity to transform knowledge into patents varies for China, Japan, South Korea, and the US: 
these countries have a high transformation capacity for some topics of weak signals, and lower capacity for others. It is 
striking to observe that Europe has a low capacity of transformation of knowledge into patents for all categories of weak 
signals (blue dots, all located left of figure 18), and independently of the number of companies active in the various weak 
signals. It does not matter how high the proportion of companies is (from 13,5% to 36%, see figure 17), the 
transformation ratio for Europe is always low (low proportion of patents compared to scientific publications). In other 
words, even when European companies are active in R&D related to one of the weak signals, they do not file as many 
patents as companies in other of the main territories. As we saw above (point 3.5), this cannot be directly related to 
differences in the European patenting system and the causes for the low capacity of European companies to transform 
knowledge into patents are to be found elsewhere.  
 
Figure 18: correlation between the proportion of patents and the proportion of companies for the main territories  
and for each of the 9 topics of weak signals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Considering the above, it is not surprising that measures to support patenting could be implemented for 136 weak 
signals. Europe is indeed lagging behind in patenting for the weak signals listed in figure 19. This could evolve in 
technological dependency for some of these weak signals, which could be detrimental to Europe should these 
technologies become strategically or commercially important.  
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Figure 19: weak signals for which incentives to patenting should be considered 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.6 Multiple countries patents 
 
Figure 20 below shows the number and proportion of patents first filed in the Chinese, American, Japanese, South 
Korean, European patent offices (UK patent office excluded) or at the European Patent Office that are then extended to 
another patent jurisdiction: China, US, South Korea, Japan, EPO, or in one of the patent offices of the 27 Member States. 
The extension of a patent in other territories than the one where it was originally filed is considered to be an indirect 
indication of its economic value. Indeed, it is costly and risky to extend a patent to other countries and applicants will only 
engage in it if they expect a return on investment. Although Chinese organisations have filed significantly more patents 
than other large territories for all of the weak signals, patents that are first filed in China and then extended to other 
territories are actually less numerous than their US equivalent (patents first filed in US, then extended).  
 
Figure 20: numbers of first patents filed by patent jurisdiction (left) extended to another patent jurisdiction (right). 
 
 
 
 
 
 
 
 
 
 
 
 
Topic Weak signals Topic Weak signals Topic Weak signals
Energy Aqueous organic redox flow batteries Mat Surface heterojunction photocatalytics ICT Software-defined vehicular networks
Energy Dual-carbon batteries Mat 0d 2d heterostructures ICT Smart village
Energy Accident tolerant nuclear fuels Mat Tin selenide crystals ICT Convolutional autoencoders
Energy Non fullerene organic solar cells Mat Hologram metasurface ICT Smartphone spectrometry
Energy Ternary polymer solar cells Mat Acoustic metasurface ICT Hierarchical recurrent neural network
Energy Garnet electrolyte Mat Stanene ICT Dilated convolutional neural network
Energy Sodium-metal batteries Mat PbTaSe2 superconductor ICT Ambient backscatter
Energy Inverted solar cells Mat Arsenene ICT Online multiple object tracking
Energy Hybrid microgrids Mat Biomimetic nanoparticles ICT 3D convolutional neural networks
Energy Flexible solar cell Mat PET hydrolytic enzymes ICT Non-orthogonal multiple access
Energy Li-CO2 batteries Mat FASnI3 perovskite ICT LSTM neural network
Energy Zinc-ion batteries Mat Alkaline hydrogen evolution reaction ICT Private Blockchain
Energy Potassium-ion batteries Mat MASnI3 perovskite ICT Deep Q learning
Energy Electrolyte free fuel-cell Mat Single atom catalysis ICT High res. image recognition by NN
Energy Mobile maritime microgrids Mat Molybdenum disulfide quantum dots ICT Generative adversarial networks
Energy Peer-to-peer energy trading Mat Perovskite quantum dots ICT Internet of vehicles
Energy Home microgrids Mat Perovskite nanowires ICT YOLO
Energy Al-Air batteries Mat Wearable energy storage ICT Consortium Blockchain
Health Taurine-upregulated gene 1 Mat Titanium carbides ICT Network slicing
Health SC79 Mat Planar perovskites ICT Digital twin in industry
Health X-inactive specific transcript Mat Borophene ICT Low power wide area network
Health Pegvaliase Mat Phosphorene ICT Micro-service architecture
Health Siderophore cephalosporin Mat Cesium lead halide perovskite ICT Ultra reliable low latency communication
Health New gout therapies Mat Antimonene ICT Heterogeneous ultra-dense networks
Health Tyrosine kinases inhibitors Mat Perovskite LEDs ICT Drone detection
Health Gasdermin Mat Perovskite nanocrystals ICT Massive machine type communication
Health Heat-not-burn tobacco product Mat Lead free perovskite ICT Fog computing
Health CAR T cells immunotherapy Mat Metasurface lens ICT Edge computing
Health Tumor mutation burden Mat Wearable flexible electronic ICT Drone base station
Health Ferroptosis Mat Wearable IoT ICT Mobile edge computing
Health Programmed death-ligand 1 inhibitors Mat MoTe2 ICT Public Blockchain
Health Cyclin-dependent kinase 4/6 inhibitors Mat FAPbI3 perovskite ICT Narrowband Internet of Things
Health Senolityc drugs Mat Adaptative metasurface ICT Ransomware detection
Phy&Eng Capacitive wireless power transfer Mat Natural deep eutectic solvents ICT Internet of battlefield things
Phy&Eng Cold sintering process Biology Double digest RAD Sequencing ICT Residual neural network
Phy&Eng Wireless powered communication networks Biology Thanatomicrobiome ICT Internet of drones
Phy&Eng Hybrid modular multilevel converter Biology Anti-CRISPR Viruses Quantitative viral outgrowth assay HIV
Phy&Eng 4D printing Biology Acute hepatopancreatic necrosis disease Viruses Porcine circovirus 3
Phy&Eng 3D Bioprinting Biology Diagnostics based on circular RNA Viruses Zika virus vaccine
Phy&Eng Quantum machine learning Biology CRISPR/CPF1 Viruses Atypical porcine pestivirus
Phy&Eng Robocasting Biology Bacillus velezensis Viruses Ebola vaccine
Phy&Eng Wire arc additive printing Biology Circular RNA Env Functionalised Biochar
Phy&Eng 3D Concrete printing Biology Spytag spycatcher protein ligase Env Organophosphorus flame retardant
Phy&Eng Levitated optomechanics Biology Single cell RNA sequencing Env Cargo bikes
Phy&Eng 3D printing of tablets Biology Assay for transposas-acc. chromat seq
Biology Retinal organoids
Biology Spray-induced gene silencing
Weak signals for which incentives for patenting are recommended
First filing Extension 
 17 
 
 
Figure 20 (left) shows that the number of patents first filed by Chinese organisations in China for all of the weak signals 
is around 10 times higher than patents first filed in the US (second after China). We have seen above that this striking 
difference is partly related to the particularities of the Chinese patent system (see 3.5). To complement this analysis, it is 
interesting to compare the number of patents that have been subject to an extension in at least one additional territory 
different than the territory of first filing. This number of extended patents for the main territories is shown in figure 20 
(right). It can be observed that only around 300 patents first filed in China have been extended to at least one other 
territory (less than 6,2% of all the patents first filed in China). This proportion is much higher for all the other territories 
(figure 21). 
 
Figure 21: Proportion of non-extended patents and extended patents by patent jurisdiction  
(% extended patents shown on top of the columns). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Despite a much higher number of patents first filed in China, only 6.22% are extended to another patent jurisdiction. 
China files a lot of patents but a small number of them are then extended to another country. The proportion of extended 
patents is much higher for South Korea, the US, Japan, and for the EU where 80% of the patents first filed in one of the 
patent office of an EU Member State is then extended to another jurisdiction. European organisations file a small number 
of patents but many of them are extended to at least one other country.  
 
Even if the proportion of extended patents from China is low, it should be noted that all the patents filed by China (i.e. 
also those that are not extended to other countries or abandoned after a few years) will be part of what is called in the 
patenting system the “prior art”, which consists of all the published knowledge related to an invention prior to the filing of 
a patent for said invention. One essential condition for patentability is novelty i.e. no publication describing an invention in 
whole or in part should exist prior to the filing date of said invention. If the novelty condition is not met, the invention 
cannot be protected by patent. By filing a massive amount of patents (even if they are not extended), China is restricting 
the possibilites for further patenting (by themselves or others) in many technological fields.  
 
 
4.7 Research ecosystems in Europe 
In science, cross-border collaboration is an important contributing factor to papers with a high scientific impact5. There is 
a clear correlation between a nation’s scientific influence and the links it fosters between researchers from different 
countries. The implementation of measures to increase collaboration among European organisations performing R&D 
would be beneficial for the research ecosystem of 97 of the weak signals (Figure 22). These environments are indeed 
characterised by a rather high fragmentation which, for the purpose of this report, is defined as the simple ratio (number 
of organisations)/(number of collaborations), with a collaboration between two organisations being defined as either a co-
publication, a co-patenting, or a joint participation in an EU project. Incentives to collaborations among EU organisations 
could therefore contribute to strengthen the impact and influence of Europe in these weak signals. 
 
 
                                           
5 “Open countries have strong science”, CS Wagner, K Jonkers, Nature News 2017 550 (7674), 32. 
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Figure 22: weak signals with a fragmented research ecosystem. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Various research ecosystems might also be impacted by Brexit. As organisations from the UK will formally leave the 
European Union, some knowledge will leave the EU and the collaboration patterns might also be affected. Organisations 
from the UK and the rest of Europe that were collaborating before Brexit could cease their collaborations. Although it is 
difficult to estimate the real consequences of Brexit on the various research ecosystems for the weak signals analysed 
here, figure 23 shows the research ecosystems that are more likely to be impacted by Brexit. 
 
 
Figure 23: weak signals with research ecosystems that could be impacted by Brexit. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.8 Productivity of European R&D organisations 
Although Europe is the territory with the highest proportion of small organisations with less than 10 documents retrieved, 
this proportion is of the same order of magnitude for the other main territories considered (figure 24). There is about the 
same number of small actors in Europe in terms of production of documents than in the other main territories.  
 
Differences between Europe and the other territories appear when looking at organisations at the other end of the 
spectrum, the ones that produce many documents. As can be observed in figure 25, Europe has less organisations of high 
productivity (in terms of publishing or patenting) active in the weak signals than South Korea, the US, and China. 
 
 
Topic Weak signals Topic Weak signals Topic Weak signals
Energy Aqueous organic redox flow batteries ICT Software-defined vehicular networks Mat Surface heterojunction photocatalytics
Energy Dual-carbon batteries ICT Smart village Mat Twisted and coiled polymer muscles
Energy Non fullerene organic solar cells ICT Smartphone spectrometry Mat Phagraphene
Energy Ternary polymer solar cells ICT Hierarchical recurrent neural network Mat Perovskite photodetectors
Energy Garnet electrolyte ICT Dilated convolutional neural network Mat Bimetallic organic frameworks
Energy Sodium-metal batteries ICT Ambient backscatter Mat Pet-Raft polymerisation
Energy Hybrid microgrids ICT Online multiple object tracking Mat Cr2Ge2Te6
Energy Flexible solar cell ICT 3D convolutional neural networks Mat 0d 2d heterostructures
Energy Li-CO2 batteries ICT Non-orthogonal multiple access Mat Renal clearable nanoparticles
Energy Zinc-ion batteries ICT LSTM neural network Mat Borophane
Energy Potassium-ion batteries ICT Private Blockchain Mat Bismuthene
Energy Electrolyte free fuel-cell ICT Deep Q learning Mat Hologram metasurface
Energy Mobile maritime microgrids ICT High res. image recognition by NN Mat Acoustic metasurface
Energy Energy justice ICT Generative adversarial networks Mat PET hydrolytic enzymes
Energy Energy trilemma ICT Internet of vehicles Mat FASnI3 perovskite
Energy Home microgrids ICT YOLO Mat Alkaline hydrogen evolution reaction
Energy Al-Air batteries ICT Consortium Blockchain Mat MASnI3 perovskite
Health Taurine-upregulated gene 1 ICT Digital twin in industry Mat Molybdenum disulfide quantum dots
Health SC79 ICT Drone detection Mat Perovskite quantum dots
Health X-inactive specific transcript ICT Drone base station Mat Titanium carbides
Health Pegvaliase ICT Public Blockchain Mat Borophene
Health New gout therapies ICT Narrowband Internet of Things Mat Perovskite LEDs
Health Heat-not-burn tobacco product ICT Ransomware detection Mat Metasurface lens
Biology Anti-CRISPR ICT Internet of battlefield things Mat Wearable flexible electronic
Biology Acute hepatopancreatic necrosis disease ICT Internet of drones Mat Wearable IoT
Biology CRISPR/CPF1 Phy&Eng Capacitive wireless power transfer Mat MoTe2
Biology Bacillus velezensis Phy&Eng Visible light positioning Mat Adaptative metasurface
Biology Spytag spycatcher protein ligase Phy&Eng Cold sintering process Mat Nonlinear metasurface
Biology Spray-induced gene silencing Phy&Eng Wireless powered communication networks Mat Dihydrolevoglucosenone
Env Functionalised Biochar Phy&Eng 4D printing Viruses Orthotospovirus
Env Organophosphorus flame retardant Phy&Eng Wire arc additive printing Viruses MK-8591
Env Cargo bikes Phy&Eng 3D Concrete printing Viruses Grapevine red blotch virus
Viruses Zika virus vaccine
Weak signals for which research ecosystem is fragmented
Topic Weak signals Topic Weak signals Topic Weak signals
Phy&Eng Cold sintering process Mat Hologram metasurface ICT Smart village
Phy&Eng Hybrid modular multilevel converter Mat Acoustic metasurface ICT Convolutional autoencoders
Phy&Eng Wire arc additive printing Mat Perovskite quantum dots ICT Dilated convolutional neural network
Phy&Eng 3D printing of tablets Mat Wearable energy storage ICT Online multiple object tracking
Phy&Eng Topological photonics Mat Perovskite LEDs ICT 3D convolutional neural networks
Biology Spytag spycatcher protein ligase Mat Lead free perovskite ICT Non-orthogonal multiple access
Biology Assay for transposas-acc. chromat seq Mat Metasurface lens ICT Private Blockchain
Biology Retinal organoids Mat Wearable flexible electronic ICT Consortium Blockchain
Energy Accident tolerant nuclear fuels Mat FAPbI3 perovskite ICT Drone base station
Energy Garnet electrolyte Mat Nonlinear metasurface ICT Ransomware detection
Energy Potassium-ion batteries Mat Dihydrolevoglucosenone ICT Residual neural network
Energy Energy justice Viruses Glecaprevir/Pibrentasvir ICT Internet of drones
Energy Energy trilemma Viruses Herpes zoster vaccine Soc Sc. Algorithmic fairness
Energy Home microgrids Health Activated phosphoinositide 3-kin syndrom Soc Sc. Civic technologies
Energy Al-Air batteries Health Targeted memory reactivation Soc Sc. Digital humanitarianism
Soc Sc. Drug cryptomarkets
Weak signals that might be impacted by Brexit
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Figure 24: percentage of organisations for the main territories per number of  
documents produced (range 1 to 10 documents). Only the percentage for Europe is shown on the graphic. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25: percentage of organisations for the main territories per number of documents produced. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.9 Top organisations 
The top 10 organisations in terms of number of documents has been extracted for each weak signal and the results 
aggregated by topics. Figure 26 shows the organisations that appear the most frequently in the top 10 organisations for 
each weak signal (grouped by topics). For example, in the topic Energy, the Chinese academy of Sciences appears in the 
top 10 organisations for 16 of the 24 weak signals in this topic. Chinese and US organisations are the most frequent 
organisations in the top 10 organisations for each weak signals i.e. they are the most prolific in terms of documents 
published or patents registered and they perform R&D for most of the weak signals. European organisations do not 
appear as often in the top 10 organisations performing research in the various weak signals. Although it is difficult to 
establish a direct causality, this might be related to the fact that the most productive organisations in Europe are not the 
most productive worldwide (see chapter about the size of organisations at the previous page). 
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Figure 26: Organisations most frequently present in the top 10 organisations engaged in R&D in the 256 weak signals, 
grouped by topics. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27 shows the distribution of the country of origin of the top 10 organisations and confirms the top organisations 
are most often from China and the US. The only exception is the massive presence of organisations from Europe in the 
weak signals related to Environment. This could indicate that European organisations are more prone to perform edge 
research in the field of environment, but this should be nuanced by the fact that none of these organisations are active in 
more than 2 weak signals on the 18 in the topic Environment, and that the more diverse organisations are from China 
and the US. 
 
 
Figure 27: percentage of organisations from the main territories per weak signal topic. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Organisations #WS Organisations #WS Organisations #WS
Chinese Academy Of Sciences 16 Chinese Academy Of Sciences 16 Chinese Academy Of Sciences 7
University of California 14 XI'AN JIAOTONG UNIVERSITY 7 University of California 5
Harvard University 8 Tsinghua University 6 University of Queensland 3
Stanford University 6 Helmholtz Institute 6 VU University Amsterdam 2
Howard Hughes Medical Institute 4 University of Science and Technology of China 5 University of Western Ontario 2
Max Planck Institute 3 Nankai University 5 University of Technology Sydney 2
MIT-Harvard 3 Tianjin University 4 University of Tasmania 2
University of Pennsylvania 3 Shanghai Jiao Tong University 4 TU Delft 2
Sun Yat-Sen University 3 Peking University 4 Tsinghua University 2
University of Queensland 3 Central South University 4 Technical University of Denmark 2
European Commission 2
Chinese Academy Of Sciences 20 Chinese Academy Of Sciences 44 Curtin University 2
Beijing University of Posts and Telecommunications 18 University of California 17 Cornell University 2
XIDIAN UNIVERSITY 12 Peking University 13 CNRS 2
Tsinghua University 12 Nanjing University 12 Aarhus University 2
University of Electronic Science and Technology of China 9 University of Science and Technology of China 10
Shanghai Jiao Tong University 9 Tsinghua University 9 Chinese Academy Of Sciences 11
Nokia CORP 9 Huazhong University of Science and Technology 8 Tsinghua University 8
University of California 8 Jilin University 8 Nanyang Technological University 7
IBM Corp 8 Northwestern University 8 Massachusetts Institute of Technology 5
HUAWEI TECH CO LTD 8 Soochow University 8 Zhejiang University 4
Beihang University 7 Nanjing University of Information Science and Technology (NUST) 7 University of California 4
University of Science and Technology of China 6 Nanyang Technological University 7 Harvard University 4
Fraunhofer Institute 6 National University of Singapore 7 University College London 3
Ericsson AB 6 Collaborative Innovation Center of Quantum Matter 6 NORTHWESTERN POLYTECHNICAL UNIVERSITY 3
Carleton University 6 Shenzhen University 6 Huazhong University of Science and Technology 3
Peking University 5 Wuhan University 6 Ghent University 3
China University of Mining and Technology 5 City University of Hong Kong 5
Harvard University 5 Harvard University 21
University of Toronto 2 Oak Ridge National Laboratory 5 University of California 19
University of Melbourne 2 South China University of Technology 5 CNRS 7
University of California 2 University of Texas M. D. Anderson Cancer Center 6
University of British Columbia 2 University of California 4 Memorial Sloan-Kettering Cancer Center 6
State University of New York 2 National Institutes of Health 4 University of Michigan 5
Queensland University of Technology 2 Cornell University 4 National Institutes of Health 5
Northwestern University 2 Harvard University 3 Cornell University 5
McGill University 2 Yingli Solar co. 2 Chinese Academy Of Sciences 5
Harvard University 2 University of North Carolina at Chapel Hill 2 University of Melbourne 4
Curtin University 2 South China Agricultural University 2 Mayo Clinic 4
Merck and Co. 2
Johns Hopkins University 2
Centers for Disease Control and Prevention 2
Physics & engineering (28 weak signals)
Social Sciences (13 weak signals)
Viruses (13 weak signals)
Biology (24 weak signals) Energy (24 weak signals) Environment (18 weak signals)
Health (39 weak signals)
ICT (40 weak signals) Materials (57 weak signals)
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5 Synopsis of the recommendations for the weak signals 
 
 
A summary of the recommendations is presented in the next pages for each of the scientific topic. A first table 
summarises the key indicators for the weak signals, and a second table then summarises the recommendations and risks. 
 
Two types of risk are flagged, respectively on the risk of dependency to non-EU technologies and on the risk related to a 
knowledge imbalance, and 5 types of recommendations are considered: 
 
 “Risk of technological dependency”: crossed when there is very little knowledge developed in Europe, or very few 
patents owned by European organisations, of very few organisations from Europe active in R&D compared to 
other countries.  
 
 Risk related to “Knowledge imbalance”: checked when knowledge in Europe about the weak signal is 
concentrated in one or two organisations. 
 
 “Create R&D” is checked when there is little or no R&D ongoing in Europe for the weak signal considered. 
 
 “Reinforce R&D” is crossed when there is R&D ongoing in Europe but relatively less than in other countries. 
 
 “Develop network” is checked when the research landscape in Europe is fragmented i.e. when there is R&D in 
Europe but little collaboration between organisations in Europe. 
 
 “Foster innovation” gets a cross when patents have been retrieved for the weak signal but very little of them 
have been registered by European organisations. 
 
 “Support during Brexit” is checked when Brexit will disrupt the landscape of R&D in Europe for a weak signal 
(when a significant proportion of knowledge (publications or patents) or of organisations are from the UK). 
Brexit was not considered as an issue for weak signals where there is no or very little R&D in Europe (there is 
nothing to disturb…). 
 
 
The detailed analysis for each weak signal is presented in the annex to this report.  
  
 22 
 
 
 
 
21 of the 24 weak signals detected are problematic: 14 in the category “EU weak in KW”, 3 in the category “EU weak in 
IP”. In addition, 4 weak signals in the two categories where EU is strong show a Brexit risk.  
 
Figure 28: weak signals in Energy (Brexit risk highlighted in orange).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29: Summary of the recommendations for the weak signals in Energy (Brexit risk highlighted in orange).  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
5.1 Energy 
 
Weak signals
Number 
Patents
% EU 
Patents
% UK 
Patents in 
Europe
Number 
publications
% EU 
Publi
% UK Publi 
in Europe
Aqueous organic redox flow batteries 4 0.00% 0.00% 38 18.42% 28.57%
Dual-carbon batteries 5 0.00% 0.00% 71 12.68% 11.11%
Accident tolerant nuclear fuels 5 0.00% 0.00% 501 11.98% 43.33%
Non fullerene organic solar cells 20 0.00% 0.00% 300 11.67% 37.14%
Ternary polymer solar cells 3 0.00% 0.00% 126 7.14% 33.33%
Lithium-Metal batteries 143 6.29% 0.00% 607 17.96% 10.09%
Garnet electrolyte 6 0.00% 0.00% 56 17.86% 50.00%
Sodium-metal batteries 36 0.00% 0.00% 123 17.65% 25.00%
Inverted solar cells 17 5.88% 0.00% 684 16.08% 30.00%
Hybrid microgrids 61 0.00% 0.00% 538 15.80% 11.76%
Flexible solar cell 36 0.00% 0.00% 197 11.17% 27.27%
Li-CO2 batteries 7 0.00% 0.00% 41 9.76% 25.00%
Zinc-ion batteries 62 0.00% 0.00% 168 9.52% 12.50%
Potassium-ion batteries 84 1.19% 100.00% 431 6.96% 56.67%
Electrolyte free fuel-cell 6 0.00% 0.00% 42 54.76% 13.04%
Mobile maritime microgrids 10 10.00% 0.00% 117 45.30% 3.77%
Peer-to-peer energy trading 10 0.00% 0.00% 224 33.04% 29.73%
Energy justice 0 0.00% 0.00% 173 59.54% 68.93%
Energy trilemma 0 0.00% 0.00% 53 43.40% 73.91%
Home microgrids 5 0.00% 0.00% 75 32.00% 54.17%
Magnesium-sulfur batteries 4 0.00% 0.00% 48 27.08% 0.00%
Li and Mn rich layered oxides 0 0.00% 0.00% 52 25.00% 7.69%
Sodium-metal anodes 5 20.00% 0.00% 132 25.00% 24.24%
EU strong in IP EU patents>25%ww Al-Air batteries 19 31.58% 66.66% 149 12.08% 33.33%
Type of weak signal
EU weak in KW
#Patents<5                                
EU publi>25% ww
#Patents<5                                
EU publi<25%ww
#Patents>5                                    
EU patents<25%ww                              
EU publi>25%ww
#Patents>5                                        
EU patents<25%ww                              
EU publi<25%ww
EU weak in IP
EU strong in KW
Weak signals
Risk of 
technological 
dependency
Knowledge 
or patent 
imbalance
Create 
R&D
Reinforce 
R&D
Develop 
network
Foster 
innovation
Support 
during 
Brexit
Aqueous organic redox flow batteries X X X X
Dual-carbon batteries X X X X
Accident tolerant nuclear fuels X X X
Non fullerene organic solar cells X X X X
Ternary polymer solar cells X X X X
Lithium-Metal batteries X X
Garnet electrolyte X X X X X
Sodium-metal batteries X X X X
Inverted solar cells X X X
Hybrid microgrids X X X X
Flexible solar cell X X X X
Li-CO2 batteries X X X X
Zinc-ion batteries X X X X
Potassium-ion batteries X X X X X
Electrolyte free fuel-cell X X X X
Mobile maritime microgrids X X X
Peer-to-peer energy trading X
Energy justice X X X X
Energy trilemma X X X
Home microgrids X X X X X
Magnesium-sulfur batteries
Li and Mn rich layered oxides
Sodium-metal anodes
EU strong in IP EU patents>25%ww Al-Air batteries X X X X
EU weak in IP
EU strong in KW
Type of weak signal
EU weak in KW
#Patents<5                                
EU publi<25%ww
#Patents>5                                        
EU patents<25%ww                              
EU publi<25%ww
#Patents>5                                    
EU patents<25%ww                             
EU publi>25%ww
#Patents<5                                
EU publi>25% ww
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36 weak signals detected show some vulnerabilities for EU: 18 in the category “EU weak in KW”, 17 in the category “EU 
weak in IP”, and 1 is analysed for the specific risks related to Brexit.  
 
 
Figure 30: weak signals in ICT (Brexit risk highlighted in orange).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weak signals
Number 
Patents
% EU 
Patents
% UK Patents 
in Europe
Number 
publications
% EU 
Publi
% UK Publi in 
Europe
Software-defined vehicular networks 3 0.00% 0.00% 282 24.11% 22.06%
Smart village 1 0.00% 0.00% 96 23.96% 30.43%
Convolutional autoencoders 7 0.00% 0.00% 435 23.22% 33.66%
Smartphone spectrometry 2 0.00% 0.00% 69 20.29% 28.57%
Hierarchical recurrent neural network 5 0.00% 0.00% 67 17.91% 35.71%
Dilated convolutional neural network 5 40.00% 40.00% 51 17.65% 22.22%
Ambient backscatter 5 20.00% 0.00% 131 17.56% 26.09%
Online multiple object tracking 1 0.00% 0.00% 81 11.11% 44.44%
3D convolutional neural networks 52 1.92% 100.00% 529 24.01% 25.98%
Non-orthogonal multiple access 15 0.00% 0.00% 698 23.93% 61.68%
LSTM neural network 114 0.00% 0.00% 2188 23.90% 25.05%
Private Blockchain 44 9.09% 50.00% 200 22.50% 22.22%
Deep Q learning 6 0.00% 0.00% 172 20.93% 33.33%
High res. image recognition by NN 60 1.67% 0.00% 426 19.48% 21.69%
Generative adversarial networks 205 2.44% 20.00% 2050 19.41% 34.17%
Internet of vehicles 1116 0.90% 0.00% 777 18.40% 24.48%
YOLO 25 4.00% 0.00% 336 13.10% 11.36%
Consortium Blockchain 14 0.00% 0.00% 81 11.11% 44.44%
Network slicing 82 15.85% 0.00% 483 61.08% 18.31%
Digital twin in industry 42 23.81% 0.00% 172 57.56% 8.08%
Low power wide area network 136 17.65% 0.00% 611 56.46% 9.57%
Micro-service architecture 37 5.41% 0.00% 407 50.86% 11.11%
Ultra reliable low latency communication 141 10.64% 6.67% 1115 47.53% 18.30%
Heterogeneous ultra-dense networks 10 0.00% 0.00% 147 44.22% 26.15%
Drone detection 30 6.67% 0.00% 105 40.00% 9.52%
Massive machine type communication 26 15.38% 0.00% 338 35.50% 15.83%
Fog computing 91 1.10% 0.00% 2573 34.78% 20.00%
Edge computing 251 9.56% 20.83% 3667 33.92% 22.59%
Drone base station 55 3.64% 0.00% 74 32.43% 45.83%
Mobile edge computing 108 15.74% 10.53% 1342 25.48% 32.02%
Public Blockchain 17 0.00% 0.00% 111 31.53% 22.86%
Narrowband Internet of Things 830 5.42% 2.22% 397 31.23% 16.94%
Ransomware detection 31 3.23% 0.00% 97 28.87% 42.86%
Internet of battlefield things 19 10.53% 0.00% 315 25.71% 20.99%
Residual neural network 12 0.00% 0.00% 126 25.40% 40.63%
Internet of drones 4 25.00% 100.00% 27 48.15% 15.38%
Mobile edge caching 5 20.00% 0.00% 78 35.90% 25.00%
Crypto supersingular isogeny 1 0.00% 0.00% 52 34.62% 33.33%
Quaternion valued neural network 1 0.00% 0.00% 101 26.73% 11.11%
EU strong in IP EU patents>25%ww 5G Security 11 27.27% 0.00% 132 37.88% 32.00%
Type of weak signal
#Patents<5                                
EU publi>25% ww
#Patents<5                                
EU publi<25%ww
#Patents>5                                    
EU patents<25%ww                              
EU publi>25%ww
#Patents>5                            
EU patents<25%ww                              
EU publi<25%ww
EU strong in KW
EU weak in IP
EU weak in KW
5.2 Information and Communication 
Technologies 
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Figure 31: Summary of the recommendations for the weak signals in ICT (Brexit risk highlighted in orange).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Weak signals
Risk of 
technological 
dependency
Knowledge 
or patent 
imbalance
Create 
R&D
Reinforce 
R&D
Develop 
network
Foster 
innovation
Support 
during 
Brexit
Software-defined vehicular networks X X X
Smart village X X X X
Convolutional autoencoders X X X
Smartphone spectrometry X X X
Hierarchical recurrent neural network X X X X
Dilated convolutional neural network X X X X
Ambient backscatter X X X
Online multiple object tracking X X X X X
3D convolutional neural networks X X X X X
Non-orthogonal multiple access X X X
LSTM neural network X X
Private Blockchain X X X X X
Deep Q learning X X X
High res. image recognition by NN X X X
Generative adversarial networks X X X
Internet of vehicles X X X X
YOLO X X X X
Consortium Blockchain X X X X X
Network slicing X
Digital twin in industry X X X
Low power wide area network X
Micro-service architecture X X
Ultra reliable low latency communication X X
Heterogeneous ultra-dense networks X X
Drone detection X X X
Massive machine type communication X X X X
Fog computing X X
Edge computing X
Drone base station X X X X
Mobile edge computing X X
Public Blockchain X X X X
Narrowband Internet of Things X X X X
Ransomware detection X X X X X
Internet of battlefield things X X X X
Residual neural network X X X X
Internet of drones X X X X
Mobile edge caching
Crypto supersingular isogeny
Quaternion valued neural network
EU strong in IP EU patents>25%ww 5G Security
EU strong in KW
#Patents<5                                
EU publi>25% ww
Type of weak signal
EU weak in KW
#Patents<5                                
EU publi<25%ww
#Patents>5                            
EU patents<25%ww                              
EU publi<25%ww
EU weak in IP
#Patents>5                                   
EU patents<25%ww                              
EU publi>25%ww
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17 weak signals are analysed: 8 are related to a lack of knowledge in Europe, 7 are related to a weakness in IP, and 2 are 
related to Brexit.  
 
 
Figure 32: weak signals in Health (Brexit risk highlighted in orange).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weak signals
Number 
Patents
% EU 
Patents
% UK 
Patents in 
Europe
Number 
publications
% EU 
Publi
% UK 
Publi in 
Europe
Taurine-upregulated gene 1 3 0.00% 0.00% 139 5.04% 57.14%
SC79 0 0.00% 0.00% 14 7.14% 100.00%
X-inactive specific transcript 1 0.00% 0.00% 69 18.84% 0.00%
Pegvaliase 0 0.00% 0.00% 10 20.00% 100.00%
Siderophore cephalosporin 1 100.00% 0.00% 57 24.56% 28.57%
New gout therapies 26 0.00% 0.00% 56 16.07% 33.33%
Tyrosine kinases inhibitors 57 1.75% 0.00% 1074 21.23% 25.00%
Gasdermin 7 0.00% 0.00% 198 22.22% 15.91%
Heat-not-burn tobacco product 88 0.00% 0.00% 135 25.19% 35.29%
CAR T cells immunotherapy 106 2.83% 0.00% 1471 25.70% 24.87%
Tumor mutation burden 9 11.11% 0.00% 338 26.92% 15.38%
Ferroptosis 7 0.00% 0.00% 240 30.83% 14.86%
Programmed death-ligand 1 inhibitors 304 3.62% 31.58% 1956 35.79% 15.86%
Cyclin-dependent kinase 4/6 inhibitors 62 4.84% 33.33% 816 37.13% 20.79%
Senolityc drugs 6 16.67% 100.00% 140 46.43% 41.54%
Christensenellaceae 3 33.33% 0.00% 24 33.33% 25.00%
Activated phosphoinositide 3-kin syndrom 1 100.00% 0.00% 27 48.15% 61.54%
Network neuroscience 0 0.00% 0.00% 81 25.93% 28.57%
Radiomics machine learning 2 0.00% 0.00% 137 30.66% 23.81%
New synthetic opioids 0 0.00% 0.00% 109 31.19% 17.65%
Nlrp3 inhibitor 0 0.00% 0.00% 106 35.85% 23.68%
Anti-PDGFR monoclonal antibodies 5 20.00% 0.00% 93 38.71% 25.00%
Glymphatic system 2 50.00% 0.00% 179 40.78% 21.92%
Nusinersen 0 0.00% 0.00% 126 41.27% 26.92%
Adenosine deaminase 2 deficiency 1 0.00% 0.00% 100 44.00% 29.55%
Androgen receptors inhibition 2 50.00% 0.00% 76 46.05% 14.29%
Chronnectomics 0 0.00% 0.00% 21 47.62% 30.00%
Semaglutide 0 0.00% 0.00% 23 47.83% 45.45%
Radiotheranostics 0 0.00% 0.00% 60 48.33% 20.69%
Targeted memory reactivation 0 0.00% 0.00% 45 53.33% 54.17%
Tau PET 12 16.67% 0.00% 361 30.47% 25.64%
Anti-CGRP antibodies 0 0.00% 0.00% 120 54.17% 32.31%
Flash Glucose Monitoring 2 0.00% 0.00% 126 56.35% 33.80%
Rovalpituzumab tesirine 0 0.00% 0.00% 21 57.14% 25.00%
Precision psychiatry 1 0.00% 0.00% 42 57.14% 29.17%
Fluorescence lifetime imaging ophthalmos 0 0.00% 0.00% 36 61.11% 0.00%
PCSK9 inhibitors 6 50.00% 0.00% 798 53.63% 28.74%
Octapeptins 5 60.00% 0.00% 16 18.18% 0.00%
Anti-CD38 antibodies 14 64.29% 0.00% 57 56.14% 9.38%
EU strong in IP EU patents>25%ww
#Patents>5                            
EU patents<25%ww                              
EU publi<25%ww
#Patents<5                                
EU publi<25%ww
EU weak in KW
Type of weak signal
EU strong in KW
#Patents<5                                
EU publi>25% ww
#Patents>5                                    
EU patents<25%ww                              
EU publi>25%ww
EU weak in IP
5.3 Health 
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Figure 33: Summary of the recommendations for the weak signals in Health (Brexit risk highlighted in orange).  
 
 
  
Weak signals
Risk of 
technological 
dependency
Knowledge 
or patent 
imbalance
Create 
R&D
Reinforce 
R&D
Develop 
network
Foster 
innovation
Support 
during 
Brexit
Taurine-upregulated gene 1 X X X X
SC79 X X X X
X-inactive specific transcript X X X
Pegvaliase X X X
Siderophore cephalosporin X X
New gout therapies X X X X
Tyrosine kinases inhibitors X X
Gasdermin X
Heat-not-burn tobacco product X X X X
CAR T cells immunotherapy X X
Tumor mutation burden X X
Ferroptosis X X
Programmed death-ligand 1 inhibitors X X
Cyclin-dependent kinase 4/6 inhibitors X X
Senolityc drugs X X
Christensenellaceae
Activated phosphoinositide 3-kin syndrom X X
Network neuroscience
Radiomics machine learning
New synthetic opioids
Nlrp3 inhibitor
Anti-PDGFR monoclonal antibodies
Glymphatic system
Nusinersen
Adenosine deaminase 2 deficiency
Androgen receptors inhibition
Chronnectomics
Semaglutide
Radiotheranostics
Targeted memory reactivation X X
Tau PET
Anti-CGRP antibodies
Flash Glucose Monitoring
Rovalpituzumab tesirine
Precision psychiatry
Fluorescence lifetime imaging ophthalmos
PCSK9 inhibitors
Octapeptins
Anti-CD38 antibodies
EU strong in IP EU patents>25%ww
EU strong in KW
#Patents<5                                
EU publi>25% ww
Type of weak signal
EU weak in KW
#Patents<5                                
EU publi<25%ww
#Patents>5                            
EU patents<25%ww                              
EU publi<25%ww
EU weak in IP
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16 weak signals are analysed: 11 are related to a lack of knowledge in Europe, 2 are related to a weakness in IP, and 3 
are related to Brexit.  
 
Figure 34: weak signals in Biology (Brexit risk highlighted in orange).  
 
 
 
 
Figure 35: Summary of the recommendations for the weak signals in Biology (Brexit risk highlighted in orange).  
 
 
 
 
 
 
  
Weak signals
Number 
Patents
% EU 
Patents
% UK 
Patents in 
Europe
Number 
publications
% EU 
Publi
% UK 
Publi in 
Europe
Synthetic Notch 0 0.00% 0.00% 10 0.00% 0.00%
Transcriptome metabolome wide associat. 0 0.00% 0.00% 5 0.00% 0.00%
Double digest RAD Sequencing 0 0.00% 0.00% 128 21.88% 25.00%
Thanatomicrobiome 0 0.00% 0.00% 53 22.64% 33.33%
Anti-CRISPR 3 0.00% 0.00% 91 23.08% 19.05%
De-extinction 0 0.00% 0.00% 77 23.38% 61.11%
Acute hepatopancreatic necrosis disease 10 0.00% 0.00% 135 8.89% 25.00%
Diagnostics based on circular RNA 11 9.09% 0.00% 453 7.51% 11.76%
CRISPR/CPF1 39 5.13% 0.00% 184 21.20% 30.77%
Bacillus velezensis 59 1.69% 0.00% 167 15.57% 3.85%
Circular RNA 146 2.74% 0.00% 2138 17.82% 13.91%
Spytag spycatcher protein ligase 6 0.00% 0.00% 94 28.72% 55.56%
Single cell RNA sequencing 8 0.00% 0.00% 1124 33.81% 44.74%
CRISPR interference 2 0.00% 0.00% 192 29.69% 29.82%
Brain organoids 2 0.00% 0.00% 154 30.52% 27.66%
Biomolecular condensates 0 0.00% 0.00% 82 31.71% 19.23%
Assay for transposas-acc. chromat seq 5 0.00% 0.00% 288 32.29% 39.78%
In silico DNA-DNA hybridization 0 0.00% 0.00% 345 33.62% 14.66%
Parageobacillus thermoglucosidasius 0 0.00% 0.00% 14 42.86% 0.00%
Retinal organoids 1 0.00% 0.00% 78 47.44% 43.24%
Spray-induced gene silencing 3 0.00% 0.00% 13 53.85% 42.86%
Dynamic in vitro digestion 0 0.00% 0.00% 56 64.29% 16.67%
Seed microbiome 0 0.00% 0.00% 19 68.42% 7.69%
Melt Electrowriting 0 0.00% 0.00% 39 87.18% 5.88%
EU strong in IP EU patents>25%ww
Type of weak signal
EU weak in KW
#Patents<5                                
EU publi<25%ww
#Patents>5                            
EU patents<25%ww                              
EU publi<25%ww
#Patents<5                                
EU publi>25% ww
EU strong in KW
EU weak in IP
#Patents>5                                   
EU patents<25%ww                              
EU publi>25%ww
5.4 Biology 
 
Weak signals
Risk of 
technological 
dependency
Knowledge 
or patent 
imbalance
Create 
R&D
Reinforce 
R&D
Develop 
network
Foster 
innovation
Support 
during 
Brexit
Synthetic Notch X
Transcriptome metabolome wide associat. X
Double digest RAD Sequencing X X
Thanatomicrobiome X X
Anti-CRISPR X X X
De-extinction X
Acute hepatopancreatic necrosis disease X X X
Diagnostics based on circular RNA X X X
CRISPR/CPF1 X X X X
Bacillus velezensis X X X X
Circular RNA X X
Spytag spycatcher protein ligase X X X
Single cell RNA sequencing X
CRISPR interference
Brain organoids
Biomolecular condensates
Assay for transposas-acc. chromat seq X X
In silico DNA-DNA hybridization
Parageobacillus thermoglucosidasius
Retinal organoids X X X
Spray-induced gene silencing X X X
Dynamic in vitro digestion
Seed microbiome
Melt Electrowriting
EU strong in IP EU patents>25%ww
EU strong in KW
#Patents<5                                
EU publi>25% ww
Type of weak signal
EU weak in KW
#Patents<5                                
EU publi<25%ww
#Patents>5                            
EU patents<25%ww                              
EU publi<25%ww
EU weak in IP
#Patents>5                                    
EU patents<25%ww                              
EU publi>25%ww
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11 weak signals are analysed: 7 are related to a lack of knowledge in Europe, 1 is related to a weakness in IP, and 3 are 
related to Brexit.  
 
 
Figure 36: weak signals in Viruses (Brexit risk highlighted in orange).  
 
 
 
 
 
 
 
 
 
Figure 37: Summary of the recommendations for the weak signals in Viruses (Brexit risk highlighted in orange).  
 
 
 
 
  
Weak signals
Number 
Patents
% EU 
Patents
% UK 
Patents in 
Europe
Number 
publications
% EU 
Publi
% UK 
Publi in 
Europe
Orthotospovirus 0 0.00% 0.00% 33 15.15% 0.00%
MK-8591 1 0.00% 0.00% 13 15.38% 0.00%
Grapevine red blotch virus 0 0.00% 0.00% 52 17.31% 0.00%
Quantitative viral outgrowth assay HIV 0 0.00% 0.00% 69 21.74% 20.00%
Tomato mottle mosaic virus 0 0.00% 0.00% 18 22.22% 0.00%
Porcine circovirus 3 21 0.00% 0.00% 77 23.38% 27.78%
Zika virus vaccine 29 13.79% 25.00% 192 21.35% 29.27%
Atypical porcine pestivirus 6 0.00% 0.00% 41 36.59% 6.67%
Ebola vaccine 3 0.00% 0.00% 222 25.68% 52.63%
Glecaprevir/Pibrentasvir 1 0.00% 0.00% 94 40.43% 52.63%
Nonavalent  human papillomavirus vaccine 0 0.00% 0.00% 87 47.13% 39.02%
Herpes zoster vaccine 1 0.00% 0.00% 48 60.42% 41.38%
Staphylococcal kayvirus 0 0.00% 0.00% 9 100.00% 11.11%
EU strong in IP EU patents>25%ww
Type of weak signal
EU weak in KW
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Weak signals
Risk of 
technological 
dependency
Knowledge 
or patent 
imbalance
Create 
R&D
Reinforce 
R&D
Develop 
network
Foster 
innovation
Support 
during 
Brexit
Orthotospovirus X X
MK-8591 X X
Grapevine red blotch virus X X
Quantitative viral outgrowth assay HIV X X
Tomato mottle mosaic virus X
Porcine circovirus 3 X X X
Zika virus vaccine X X X X
Atypical porcine pestivirus X X
Ebola vaccine X
Glecaprevir/Pibrentasvir X
Nonavalent  human papillomavirus vaccine
Herpes zoster vaccine X X
Staphylococcal kayvirus
EU strong in IP EU patents>25%ww
EU strong in KW
#Patents<5                                
EU publi>25% ww
Type of weak signal
EU weak in KW
#Patents<5                                
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EU patents<25%ww                              
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EU weak in IP
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47 weak signals are analysed: 40 are related to a lack of knowledge in Europe, 5 is related to a weakness in IP, and 2 are 
related to Brexit.  
 
 
 
Figure 38: weak signals in Materials (Brexit risk highlighted in orange).  
 
 
 
 
 
 
Weak signals
Number 
Patents
% EU 
Patents
% UK Patents 
in Europe
Number 
publications
% EU Publi
% UK Publi 
in Europe
Surface heterojunction photocatalytics 3 0.00% 0.00% 53 3.77% 0.00%
Twisted and coiled polymer muscles 0 0.00% 0.00% 18 5.56% 0.00%
Phagraphene 0 0.00% 0.00% 23 8.70% 50.00%
Perovskite photodetectors 4 0.00% 0.00% 175 9.71% 29.41%
Bimetallic organic frameworks 3 0.00% 0.00% 169 10.06% 5.88%
Pet-Raft polymerisation 0 0.00% 0.00% 76 10.53% 62.50%
Cr2Ge2Te6 0 0.00% 0.00% 37 10.81% 25.00%
0d 2d heterostructures 1 0.00% 0.00% 194 12.89% 44.00%
Renal clearable nanoparticles 2 0.00% 0.00% 46 13.04% 0.00%
Borophane 0 0.00% 0.00% 24 16.67% 0.00%
Tin selenide crystals 5 0.00% 0.00% 168 17.26% 13.79%
Bismuthene 3 0.00% 0.00% 51 19.61% 0.00%
Nanocinnamon 0 0.00% 0.00% 10 20.00% 50.00%
Hologram metasurface 4 0.00% 0.00% 236 20.34% 52.08%
Acoustic metasurface 3 0.00% 0.00% 193 20.73% 27.50%
Stanene 4 0.00% 0.00% 255 20.78% 13.21%
PbTaSe2 superconductor 0 0.00% 0.00% 24 20.83% 0.00%
Eutectic high entropy alloy 2 0.00% 0.00% 61 21.31% 0.00%
Arsenene 0 0.00% 0.00% 179 14.53% 7.69%
Biomimetic nanoparticles 0 0.00% 0.00% 131 21.37% 3.57%
PET hydrolytic enzymes 2 0.00% 0.00% 14 21.43% 66.67%
FASnI3 perovskite 0 0.00% 0.00% 45 22.22% 20.00%
Alkaline hydrogen evolution reaction 3 0.00% 0.00% 180 22.78% 7.32%
MASnI3 perovskite 1 0.00% 0.00% 46 23.91% 18.18%
Single atom catalysis 1 0.00% 0.00% 124 24.19% 16.67%
Molybdenum disulfide quantum dots 28 0.00% 0.00% 81 6.17% 40.00%
Perovskite quantum dots 133 0.00% 0.00% 426 7.28% 45.16%
Perovskite nanowires 18 0.00% 0.00% 162 11.73% 15.79%
Wearable energy storage 68 2.94% 0.00% 317 12.62% 42.50%
Titanium carbides 44 0.00% 0.00% 576 13.54% 23.08%
Planar perovskites 23 0.00% 0.00% 1172 14.93% 32.00%
Borophene 6 0.00% 0.00% 265 15.09% 7.50%
Phosphorene 77 0.00% 0.00% 1469 17.09% 16.33%
Cesium lead halide perovskite 111 0.00% 0.00% 1466 17.19% 34.92%
Antimonene 14 0.00% 0.00% 189 19.58% 5.41%
Perovskite LEDs 46 0.00% 0.00% 397 19.65% 56.41%
Perovskite nanocrystals 34 0.00% 0.00% 712 20.93% 25.50%
Lead free perovskite 31 3.23% 0.00% 563 21.14% 40.34%
Metasurface lens 23 4.35% 0.00% 445 22.25% 38.38%
Wearable flexible electronic 59 6.78% 0.00% 863 24.41% 33.33%
Wearable IoT 26 0.00% 0.00% 356 26.12% 21.51%
MoTe2 14 7.14% 100.00% 533 26.27% 20.71%
FAPbI3 perovskite 10 10.00% 100.00% 407 27.27% 27.93%
Adaptative metasurface 24 0.00% 0.00% 225 29.78% 23.88%
Natural deep eutectic solvents 7 14.29% 0.00% 185 47.57% 9.09%
Gelatin methacrylate hydrogel 2 0.00% 0.00% 265 28.30% 29.33%
Nonlinear metasurface 2 0.00% 0.00% 184 30.98% 43.86%
Cs2HfCl6 0 0.00% 0.00% 16 37.50% 0.00%
Triple cation perovskites 0 0.00% 0.00% 94 39.36% 37.84%
CrMnFeCoNi high entropy alloys 1 0.00% 0.00% 83 40.96% 14.71%
Microplastics sampling 4 0.00% 0.00% 104 47.12% 20.41%
Dihydrolevoglucosenone 2 50.00% 0.00% 27 51.85% 71.43%
CaKFe4As4 superconductor 0 0.00% 0.00% 32 53.13% 11.76%
Microplastic ingestion 0 0.00% 0.00% 103 58.25% 40.00%
ReS2 20 10.00% 0.00% 238 12.61% 31.82%
Platinium free catalysts 33 24.24% 0.00% 271 32.10% 22.99%
Vitrimers 10 50.00% 20.00% 144 33.33% 10.42%
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EU weak in IP
#Patents>5                                    
EU patents<25%ww                              
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Figure 39: Summary of the recommendations for the weak signals in Materials (Brexit risk highlighted in orange).  
 
  
Weak signals
Risk of 
technological 
dependency
Knowledge or 
patent 
imbalance
Create 
R&D
Reinforce 
R&D
Develop 
network
Foster 
innovation
Support 
during 
Brexit
Surface heterojunction photocatalytics X X X X
Twisted and coiled polymer muscles X X X
Phagraphene X X X
Perovskite photodetectors X X X
Bimetallic organic frameworks X X X
Pet-Raft polymerisation X X X
Cr2Ge2Te6 X X X
0d 2d heterostructures X X X
Renal clearable nanoparticles X X X
Borophane X X X
Tin selenide crystals X X
Bismuthene X X
Nanocinnamon X
Hologram metasurface X X X X
Acoustic metasurface X X X X
Stanene X X
PbTaSe2 superconductor X X
Eutectic high entropy alloy X
Arsenene X X
Biomimetic nanoparticles X X
PET hydrolytic enzymes X X X
FASnI3 perovskite X X X
Alkaline hydrogen evolution reaction X X X
MASnI3 perovskite X X X
Single atom catalysis X X
Molybdenum disulfide quantum dots X X X X
Perovskite quantum dots X X X X X
Perovskite nanowires X X X
Wearable energy storage X X X X
Titanium carbides X X X X
Planar perovskites X X X
Borophene X X X X
Phosphorene X X
Cesium lead halide perovskite X X
Antimonene X X X
Perovskite LEDs X X X X X
Perovskite nanocrystals X X
Lead free perovskite X X X
Metasurface lens X X X X X
Wearable flexible electronic X X X X X
Wearable IoT X X X
MoTe2 X X X
FAPbI3 perovskite X X X
Adaptative metasurface X X X
Natural deep eutectic solvents X X
Gelatin methacrylate hydrogel
Nonlinear metasurface X X X
Cs2HfCl6
Triple cation perovskites
CrMnFeCoNi high entropy alloys
Microplastics sampling
Dihydrolevoglucosenone X X X
CaKFe4As4 superconductor
Microplastic ingestion
ReS2
Platinium free catalysts
Vitrimers
EU strong in KW
#Patents<5                                
EU publi>25% ww
EU strong in IP EU patents>25%ww
Type of weak signal
EU weak in KW
#Patents<5                                
EU publi<25%ww
#Patents>5                            
EU patents<25%ww                              
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19 weak signals are analysed: 11 are related to a lack of knowledge in Europe, 7 are related to a weakness in IP, and 1 is 
related to Brexit.  
 
Figure 40: weak signals in Physics and Engineering (Brexit risk highlighted in orange).  
 
 
 
Figure 41: Summary of recommendations for weak signals in Physics & Engineering (Brexit risk highlighted in orange).  
  
Weak signals
Number 
Patents
% EU 
Patents
% UK Patents 
in Europe
Number 
publications
% EU 
Publi
% UK Publi 
in Europe
Photoelectrochemical aptasensors 0 0.00% 0.00% 76 2.63% 0.00%
Photoelectrochemical immunosensors 5 0.00% 0.00% 91 4.40% 25.00%
Photoinduced force microscopy 0 0.00% 0.00% 39 12.82% 0.00%
Spatial heterodyne raman spectrometer 4 0.00% 0.00% 31 12.90% 75.00%
Underwater wireless power transfer 2 0.00% 0.00% 34 17.65% 0.00%
Stretchable strain sensor 7 0.00% 0.00% 155 9.03% 42.86%
Capacitive wireless power transfer 16 6.25% 0.00% 257 14.01% 19.44%
Visible light positioning 115 0.00% 0.00% 189 14.29% 48.15%
Cold sintering process 20 5.00% 0.00% 127 19.69% 48.00%
Wireless powered communication networks 60 3.33% 0.00% 332 20.48% 29.90%
Hybrid modular multilevel converter 22 0.00% 0.00% 145 23.45% 70.59%
4D printing 34 0.00% 0.00% 266 23.68% 34.92%
0.00% 0.00%
3D Bioprinting 558 2.51% 27.27% 1043 25.60% 29.21%
Quantum machine learning 7 14.29% 0.00% 140 28.57% 40.00%
Robocasting 15 0.00% 0.00% 496 34.48% 25.15%
Wire arc additive printing 27 3.70% 100.00% 326 41.72% 58.09%
3D Concrete printing 36 0.00% 0.00% 124 42.74% 1.89%
Levitated optomechanics 6 16.67% 0.00% 157 55.41% 31.03%
3D printing of tablets 8 0.00% 0.00% 56 57.14% 81.25%
0.00% 0.00%
Topological photonics 2 0.00% 0.00% 203 26.11% 43.40%
Out-of-time-ordered correlator 0 0.00% 0.00% 118 34.75% 24.39%
Ratiometric thermometer 0 0.00% 0.00% 161 44.10% 1.41%
Structure-from-motion photogrammetry 0 0.00% 0.00% 146 60.27% 39.77%
Dynamic in vitro digestion 0 0.00% 0.00% 56 64.29% 16.67%
Air-Filled Substrate Integrated Waveguide 1 0.00% 0.00% 51 74.51% 0.00%
Supraharmonics 0 0.00% 0.00% 65 78.46% 7.84%
Ultra-fast silicon detectors 0 0.00% 0.00% 35 91.43% 0.00%
0.00% 0.00%
EU strong in IP EU patents>25%ww Remote photoplethysmography 7 71.43% 0.00% 120 53.33% 1.56%
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EU publi>25% ww
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Risk of 
technological 
dependency
Knowledge 
or patent 
imbalance
Create 
R&D
Reinforce 
R&D
Develop 
network
Foster 
innovation
Support 
during 
Brexit
Photoelectrochemical aptasensors X X
Photoelectrochemical immunosensors X X
Photoinduced force microscopy X X
Spatial heterodyne raman spectrometer X X
Underwater wireless power transfer X X
Stretchable strain sensor X X
Capacitive wireless power transfer X X X X
Visible light positioning X X
Cold sintering process X X X X X
Wireless powered communication networks X X X X
Hybrid modular multilevel converter X X X X
4D printing X X X X
3D Bioprinting X X
Quantum machine learning X X
Robocasting X X
Wire arc additive printing X X X X X
3D Concrete printing X X X X
Levitated optomechanics X X
3D printing of tablets X X X X
Topological photonics X X
Out-of-time-ordered correlator
Ratiometric thermometer
Structure-from-motion photogrammetry
Dynamic in vitro digestion
Air-Filled Substrate Integrated Waveguide
Supraharmonics
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Europe is strong in knowledge and in IP for all of the weak signals related to Social Sciences. Four weak signals are 
analysed for the risks related to Brexit.  
 
 
Figure 42: weak signals in Social Sciences (Brexit risk highlighted in orange).  
 
 
 
 
 
 
 
Measures to support organisations active in “algorithmic fairness”, “civic technologies”, “digital humanitarism”, and “drug 
cryptomarkets” could be put in place during the Brexit transition. 
 
 
 
 
 
 
 
 
 
  
Weak signals
Number 
Patents
% EU 
Patents
% UK 
Patents in 
Europe
Number 
publications
% EU 
Publi
% UK 
Publi in 
Europe
#Patents<5                                
#Patents>5                                        
EU patents<25%ww                              
EU publi<25%ww
EU weak in IP
#Patents>5                                    
EU patents<25%ww                              
EU publi>25%ww
Algorithmic fairness 0 0.00% 0.00% 84 28.57% 40.74%
Biophilic cities 0 0.00% 0.00% 82 29.27% 25.00%
Circular bioeconomy 0 0.00% 0.00% 70 74.29% 15.38%
Civic technologies 0 0.00% 0.00% 68 50.00% 47.06%
Digital consitutionalism 0 0.00% 0.00% 9 55.56% 0.00%
Digital humanitarianism 0 0.00% 0.00% 31 41.94% 69.23%
Drug cryptomarkets 0 0.00% 0.00% 59 55.93% 60.61%
Immersive journalism 0 0.00% 0.00% 54 62.96% 17.65%
Sociology of quantification 0 0.00% 0.00% 25 68.00% 17.65%
Small private online course 2 0.00% 0.00% 130 31.54% 2.44%
Crowd shipping 3 0.00% 0.00% 49 46.94% 4.35%
Take over request in self driving 4 25.00% 0.00% 71 80.28% 5.26%
EU strong in IP EU patents>25%ww Algorithmic journalism 6 33.33% 0.00% 238 33.33% 20.17%
EU weak in KW
#Patents<5                                
EU publi>25% ww
EU strong in KW
Type of weak signal
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7 weak signals are analysed: 5 are related to a lack of knowledge in Europe, 2 are related to a weakness in IP.  
 
Figure 43: weak signals in Environment (Brexit risk highlighted in orange).  
 
 
 
 
 
Figure 44: Summary of the recommendations for the weak signals in Environment (Brexit risk highlighted in orange).  
 
 
 
 
 
Weak signals
Number 
Patents
% EU 
Patents
% UK Patents 
in Europe
Number 
publications
% EU 
Publi
% UK Publi 
in Europe
Coastal blue carbon 0 0.00% 0.00% 29 20.69% 50.00%
Marine heatwave 0 0.00% 0.00% 74 24.32% 44.44%
Black soldier fly larvae biodiesel 1 0.00% 0.00% 32 15.63% 0.00%
Peroxymonosulfate activation 13 0.00% 0.00% 404 4.95% 5.00%
Functionalised Biochar 16 0.00% 0.00% 334 16.77% 30.36%
Organophosphorus flame retardant 6 0.00% 0.00% 90 45.56% 4.88%
Cargo bikes 15 20.00% 0.00% 43 86.05% 2.70%
Climate clubs 0 0.00% 0.00% 26 34.62% 11.11%
Deep decarbonization 0 0.00% 0.00% 30 56.67% 35.29%
Environmental DNA metabarcoding 0 0.00% 0.00% 110 43.64% 37.50%
Flex crops 0 0.00% 0.00% 24 62.50% 26.67%
Land degradation neutrality 0 0.00% 0.00% 68 64.71% 34.09%
Octane on demand 0 0.00% 0.00% 28 35.71% 30.00%
Ultra-low-temp. district heating 0 0.00% 0.00% 16 100.00% 0.00%
Comammox 1 0.00% 0.00% 65 38.46% 16.00%
Ecoacoustic 1 0.00% 0.00% 231 45.89% 33.02%
Electro-fermentation 1 0.00% 0.00% 47 40.43% 21.05%
NOB suppression 2 0.00% 0.00% 28 28.57% 12.50%
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Risk of 
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dependency
Knowledge 
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imbalance
Create 
R&D
Reinforce 
R&D
Develop 
network
Foster 
innovation
Support 
during 
Brexit
Coastal blue carbon X
Marine heatwave X
Black soldier fly larvae biodiesel X
Peroxymonosulfate activation X X
Functionalised Biochar X X X X
Organophosphorus flame retardant X X
Cargo bikes X X
Climate clubs
Deep decarbonization
Environmental DNA metabarcoding
Flex crops
Land degradation neutrality
Octane on demand
Ultra-low-temp. district heating
Comammox
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Electro-fermentation
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Documents (patents, scientific publications, EU projects) have been accumulating over many years for some of the weak 
signals. Figure 45 below shows the distribution of the weak signals per number of years in which documents were 
produced. 
 
 
 
 
 
Figure 45: Distribution of weak 
signals per number of years for 
which documents were retrieved 
 
 
 
Most of the weak signals show a number of years with documents between 3 and 12. Even though it is field dependant, 
this time range could correspond to some standard speed of research and development. But for some of these weak 
signals, this number of years for which documents were retrieved is higher (up to 25 years). The “persistent” weak signals 
with documents retrieved for more than 14 years are listed in figure 46.  
 
This constitutes some kind of paradox: how to explain that R&D spreads over 25 years for weak signals i.e. new 
technologies? The indicators used by JRC to detect the weak signals have been used precisely to include weak signals of 
this sort (with many years of documents accumulation)6. Although it was not the main objective of the study, the aim was 
to also detect weak signals that correspond to a new application/product/service related to an existing and well-known 
technology. These signals would be characterised both by a peak of documents over the last years (signature of a typical 
weak signal) and by an accumulation of documents over many years (signature of a known technology).  
There are various reasons for such accumulations of documents over a long period of time. For most of the persistent 
weak signals, the research phase is simply longer than for others. For some, it is the retrieval of false positive documents 
(noise) during the semantic queries that explains the persistence in whole or in part. Although semantic queries are 
optimised, they are never perfect. For some, it could be explained by the discovery of a new application of a known 
technology or by a longer R&D phase than average, for example due to some technological barrier. For some others, it 
could be related to a policy decision that triggered a renewed interest for a particular known technology or topic of 
research. 
 
Out of these 46 persistent weak listed in figure 46, 9 have been linked to new applications of known technologies or 
materials (in green), 2 were linked to technological barriers that have been resolved or about to be resolved (in blue), and 
1 was linked to a policy making decision that triggered a surge in R&D (in orange).  
 
Figure 46: List of persistent weak signals.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                           
6 Various “activeness” indicators have been used. See report EUR 29900 EN 
Weak signals
#Years doc 
retrieved
Weak signals
#Years doc 
retrieved
Edge computing 25 Ecoacoustic 18
ReS2 24 Perovskite nanowires 18
Circular RNA 24 Ebola vaccine 18
Lithium-Metal batteries 23 Al-Air batteries 17
Platinium free catalysts 23 0d 2d heterostructures 17
Programmed death-ligand 1 inhibitors 23 Perovskite nanocrystals 17
Levitated optomechanics 22 Tau PET 17
High res. image recognition by NN 22 Gasdermin 17
Anti-PDGFR monoclonal antibodies 22 Sodium-metal batteries 16
Cold sintering process 21 Topological photonics 15
MoTe2 21 Internet of battlefield things 15
LSTM neural network 21 New synthetic opioids 15
Cyclin-dependent kinase 4/6 inhibitors 21 Bacillus velezensis 15
Robocasting 21 Alkaline hydrogen evolution reaction 15
Algorithmic fairness 21 X-inactive specific transcript 15
Algorithmic journalism 21 Biomolecular condensates 15
Wearable flexible electronic 21 Planar perovskites 14
Lead free perovskite 20 Anti-CD38 antibodies 14
Wearable energy storage 19 Photoelectrochemical immunosensors 14
Internet of vehicles 19 Metasurface lens 14
Wireless powered communication networks 18 Hybrid microgrids 14
Tin selenide crystals 18 Biomimetic nanoparticles 14
Organophosphorus flame retardant 18 Phosphorene 14
5.10 Persistent weak signals  
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6 Conclusions 
 
1. Europe is:   
 Strong in 80 of the weak signals detected (30%); 
 Not transforming its scientific leadership into patents in 44 of the weak signals (17%); 
 Lacking scientific knowledge and lagging behind in patenting in 114 weak signals (45%).  
 
2. Europe is strong in weak signals related to social Sciences, Health, and Environment. Europe shows vulnerabilities in 
Physics & Engineering, Biology, ICT, Viruses, Energy, and Materials.  
 
3. Looking at sub-topics, Europe is strong in weak signals related to biomaterials, microbiology, neurosciences, new 
medicines, and digital social sciences. Europe is vulnerable in weak signals related to the 27 other sub-topics, including 
perovskite, solar cells, 5G, Internet of Things, 3D printing, Neural Networks, viruses, new materials (2D materials, 
nanomaterials, metasurfaces, new catalysts).  
 
4. Overall, European companies are participating in research and development efforts in the various weak signals. The 
proportion of companies versus universities and research centres varies between 13,5% (Biology) and 36% (Materials). 
Europe has the highest percentage of companies active in the topic “Health” and this proportion for the other topics is 
always above the average ratio of company participation.  
 
5. Europe suffers from a low capacity of transformation of knowledge into patents for many of the weak signals. Even 
when European companies are very active, there is not as many patents filed in Europe than in the other main territories 
like the US, China, Japan, or South Korea.  
 
6. Europe has less large size organisations (publishing or patenting) involved in the weak signals than South Korea, the 
US, and China. There is about the same number of small actors in Europe than in the other main territories.  
 
7. Despite a much higher number of patents first filed in China (10 times more than the US which is second in patenting), 
a small number of these patents (6.22%) are extended to another patent jurisdiction. The proportion of patents extended 
is much higher for South Korea, the US, Japan, and for the EU. 
 
8. European organisations file a smaller number of patents than organisations in the US, Japan, South Korea or Japan, 
but many of them are extended to at least one other country (80% of the patents first filed in one of the patent office of 
an EU Member State is then extended to another jurisdiction). 
 
9. In terms of absolute numbers of patents, organisations in the US are the ones extending the most patents to other 
jurisdictions. China is second ahead of South Korea, Japan, and the EU. 
 
10. Leading organisations are most often from China and the US, with the exception of weak signals in Environment 
where the majority of the top organisations are form Europe.  
 
11.  Recommendations: 
 98 weak signals present a risk of future technology dependency of Europe. 
 There is an imbalance of knowledge distribution in Europe for 8 of the weak signals (knowledge monopoly or 
duopoly). 
 There is no or little R&D activities in Europe for 64 weak signals, requiring the creation of R&D activities (very 
few or no active EU organisations). 
 The research ecosystems in 66 weak signals should be reinforced (there are EU actors but they are not leading 
and there is a risk of Europe losing grip). 
 Research ecosystems in Europe are fragmented in 97 of the weak signals and measures to develop 
collaborations among EU organisations should be implemented. 
 Incentives to innovation and patenting should be put in place for more than half (136) of the weak signals. 
 Measures to support European R&D ecosystems during Brexit are suggested for 42 of the weak signals.  
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7 Annex  
 
Figure 47 shows the information displayed for each weak signal that is analysed in the annex of the present report.  
 
Figure 47: Information contained in the analysis of the weak signals. 
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EU is weak in knowledge production 
Weak signal Actors in Europe (not UK) Indicators Analysis and recommendations 
Accident tolerant 
nuclear fuels 
 
Top Countries (Publications) 
US (319) 
China (80) 
Europe (65/38)  
 
Patents Cont. Europe/World 
0/5 
 
Fragmentation: 1 
US leads in this technology in terms of scientific publications; Europe is third after China. More 
than 40% of the publications in Europe involve organisations in the UK. After Brexit, 26 research 
organisations (with 38 publications) will remain in Europe, in a fairly well connected environment 
(fragmentation~1). The 5 patents retrieved are all owned by US organisations. 
Should this WS be deemed important, R&D in Europe could be reinforced by relying on the existing 
R&D activities. Measures to mitigate the impact of Brexit should also be implemented. Incentives 
to increase patenting by European organisations should be put in place to avoid technological 
dependency.  
Aqueous organic 
redox flow 
batteries 
 Top Countries (Publications) 
US (27) 
South Korea (8) 
Europe (8/6) 
 
Patents Cont. Europe/World 
0/4 
 
Fragmentation: 1,66 
There is little R&D activities for this technology (38 publications worldwide). Europe is third in 
publications behind South Korea (2nd) and the US which is leading by far. There are very few 
actors in Europe and they do not collaborate with each other (high fragmentation). 4 patents have 
been filed, all owned by US organisations.  
 
If this technology appears to be of strategic importance for Europe, major efforts will have to be 
made to make sure R&D and patenting activities take place in Europe. There is a significant risk of 
technological dependency. 
Dual-carbon 
batteries 
 Top Countries (Publications) 
China (55) 
US (9) 
Europe (9/8) 
 
Patents Cont. Europe/World 
0/5 
 
Fragmentation: 1 
There is little R&D activities for this technology (71 publications worldwide). Europe occupies the 
third place in terms of publications behind China (leading by far) and the US. There are very few 
actors in Europe, all located in Germany. Some degree of collaboration is observed. 4 of the 
patents retrieved are owned by Chinese organisations, one by a US organisation.  
 
Should this WS be deemed important, major efforts will have to be made to reinforce R&D 
activities in Europe. Measures to encourage innovation and patenting should also be considered. 
There is a significant risk of technological dependency for Europe in this technology. 
Flexible solar cell 
 Top Countries (Publications) 
China (118) 
South Korea (57) 
 US (40), Europe (27/21)  
 
Patents Cont. Europe/World 
0/36 
 
Fragmentation: 1,6 
Europe is fourth in terms of scientific publications, after the US (3rd), South Korea (2nd), and China 
(1st). The research landscape in Europe is fragmented i.e. there is little collaboration. The 
community around TU Eindhoven, TNO, and the University of Rome II is strong and produces most 
of the research in Europe. 36 patents have been filed worldwide but none has been registered by 
EU actors so far. 35 of these patents are owned by Chinese organisations or individuals. 
 
Should this WS be deemed important, R&D in Europe could be reinforced by relying on the existing 
strong research community. Incentives to increase patenting by European organisations should be 
put in place to avoid future technological dependency. 
Garnet electrolyte 
 
 
 
 
Top Countries (Publications) 
US (26) 
China (25) 
Europe (10/7)  
 
Patents Cont. Europe/World 
0/6 
 
Fragmentation: 0,81 
 
There is little R&D activities for this technology (56 publications worldwide). China and the US lead 
the R&D, with Europe following. Very few patents have been filed worldwide (6 patents all owned 
by US organisations). One can notice that the actors in Europe are from Spain of from Germany.  
 
Should this WS be deemed important, major efforts will have to be made to develop the R&D 
activities in Europe. Patenting activities should also be encouraged. 
7.1 Energy 
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Hybrid microgrids 
 Top Countries (Publications) 
China (217) 
Europe (91/79) 
US (65) 
 
Patents Cont. Europe/World 
0/61 
 
Fragmentation 
2,93 
538 publications and 61 patents were retrieved for this weak signal. China clearly leads the field 
and Europe comes in second position. The research landscape in Europe is fragmented i.e. there is 
little scientific collaboration. The organisation leading in EU is the Aalborg University, and it is also 
the leader worldwide (34 publications). This knowledge monopole makes the research landscape 
fragile. Despite this leadership, none of the patents retrieved have been filed by European 
organisations (58 for China, 2 for US, 1 for South Korea).  
 
Should this WS be deemed important, R&D in Europe could be reinforced by relying on existing 
knowledge in Aalborg University. Incentives to increase patenting by European organisations 
should be put in place to avoid technological independency. 
Inverted solar cells 
 
 
 
 
Top Countries (Publications) 
China (394) 
US (111) 
Europe (120/85) 
 
Patents Cont. Europe/World 
1/17 
 
Fragmentation: 0,98 
With 684 publications, this weak signal is characterised by a rather intensive ongoing research. 
China clearly leads the field, followed by the US then Europe. A rather high degree of collaboration 
is observed for actors in Europe (fragmentation~1). Among the 17 patents retrieved, only one was 
filed by a European actor while 13 are from China. 
 
Should this WS be deemed important, R&D in Europe could be reinforced by relying on the existing 
R&D networks. The knowledge built in EU but is not (yet) translated into patents, and measures to 
incentivise patenting by European organisations should be put in place to avoid technological 
independency. 
Li-CO2 batteries 
 Top Countries (Publications) 
China (40) 
US (8), Japan (5) 
Europe (4/3)  
 
Patents Cont. Europe/World 
0/7 
 
Fragmentation: 1,88 
 
R&D activities on this weak signal are still limited (41 publications worldwide). Europe is clearly 
lagging behind with only 3 publications and comes fourth behind China, the US, and Japan. There 
are 5 actors in Europe. 7 patents have been filed for this technology, all by Chinese organisations.  
 
Should this WS be deemed important, major efforts will have to be made to develop R&D 
activities in Europe. There is very little knowledge to rely on and no strong R&D community 
working on this technology. There is a significant risk of technological dependency. 
Lithium-Metal 
batteries 
 
 
 
 
 
Top Countries (Publications) 
China (346) 
US (226) 
Europe (123/102)  
 
Patents Cont. Europe/World 
6/143 
 
Fragmentation 
0,86 
With 607 publications and 143 patents retrieved, this weak signal is characterised by a rather 
intensive ongoing research and patenting. China clearly leads the R&D in this technology, followed 
by the US and Europe. A rather high degree of collaboration is observed for actors in Europe. One 
can observe two strong R&D communities respectively around German and French organisations. 
Among the 143 patents retrieved, only 6 were filed by European actors (Philips, TNO, Bosch, and 
Volkswagen). China leads in patenting with 54 patents. South Korea and the US follow with 
respectively 35 and 30 patents. Should this WS be deemed important, R&D in Europe could be 
reinforced by relying on the existing research communities. There is knowledge available in Europe 
but it is not (yet) translated into patents. Measures to incentivise patenting by European 
organisations should be put in place for EU to be technologically independent.  
Non-fullerene 
organic solar cells 
 Top Countries (Publications) 
China (216) 
 US (43), Honk Kong (31) 
Europe (39/30)  
 
Patents Cont. Europe/World 
0/20 
 
Fragmentation 
1,93 
This weak signal is characterised by a rather high research activity (300 publications retrieved) but 
still modest patenting activity (20 patents detected). Europe is 4th in publications behind China 
(leading by far), the US, and Honk-Kong. There are few organisations active in research on Europe, 
with only 30 publications (9 publications with only UK organisations), and the collaboration 
landscape is fragmented. None of the 20 patents has been registered by an organisation based in 
Europe; 17 out of these patents are owned by Chinese organisations. Should this WS be deemed 
important, massive efforts will have to be made to develop research, collaboration and patenting 
in Europe. There is little knowledge to rely on, the R&D community working on this technology is 
very fragmented. There is a significant risk of technological dependency. 
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Potassium-ion 
batteries 
 Top Countries (Publications) 
China (384) 
US (87), Australia (32) 
Europe (37/20)  
 
Patents Cont. Europe/World 
0/84 
 
Fragmentation 
1,64 
431 publications and 84 patents were retrieved for this weak signal. There is little R&D ongoing in 
Europe with few actors, a fragmented collaboration landscape, and only 20 scientific publications 
(17 publications involving only UK organisations). Europe is 4th in publications behind China 
(leading by far), the US, and Australia. Out of the 84 patents retrieved, 75 are owned by Chinese 
organisations (US: 3, JP:1, UK:1) and none has been registered by a European organisation. 
 
Should this WS be deemed important, massive efforts will have to be made to support R&D and 
patenting in Europe. There is very little knowledge to rely on and the R&D community working on 
this technology is very fragmented. There is a significant risk of technological dependency. 
Sodium-metal 
batteries 
 Top Countries (Publications) 
US (68), China (49) 
South Korea (19) 
Europe (22/18)  
 
Patents Cont. Europe/World 
0/36 
 
Fragmentation 
2,57 
123 publications and 26 patents were retrieved for this weak signal. There is little R&D ongoing in 
Europe with few actors, a fragmented collaboration landscape, and only 18 publications (4 
publications involving only UK organisations). Europe is 4th in publications behind the US, China 
and South Korea. Out of the 36 patents retrieved, 15 are from the US, 10 from China, and 8 from 
South Korea. No patents have been registered by European organisations. 
 
Should this WS be deemed important, massive efforts will have to be made to create R&D and 
patenting activities in Europe. There is very little knowledge to rely on and the R&D community 
working on this technology is fragmented. The possibility of a future technological dependency 
should not be underestimated. 
Ternary polymer 
solar cells 
 
 
 
Top Countries (Publications) 
China (95), US (19) 
South korea (10) 
Europe (7/4)  
 
Patents Cont. Europe/World 
0/3 
 
Fragmentation 
1 
126 publications and only 3 patents were retrieved for this weak signal. There is very little R&D 
ongoing in Europe with only 6 organisations involved in 4 publications. China, the US and South 
Korea occupy the three top positions in publications. Only 3 patents owned by Chinese 
organisations were retrieved. 
 
Should this technology be deemed important, massive efforts will have to be made to create R&D 
and patenting activities in Europe. There is very little knowledge to rely on and there is a risk of 
technological dependency. 
Zinc-ion batteries 
 
Top Countries (Publications) 
China (141), US (30)  
South Korea (21) 
Europe (17/16)  
 
Patents Cont. Europe/World 
0/62 
 
Fragmentation 
1,6 
168 publications and 62 patents were retrieved for this weak signal. There is little R&D ongoing in 
Europe with few actors, a fragmented collaboration landscape, and only 16 publications. Europe is 
4th in publications and far behind China. Out of the 62 patents retrieved, none has been filed by a 
European organisation (China:54 ,Japan:2, US: 2, South Korea:4). 
 
Should this WS be deemed important, massive efforts will have to be made to have R&D and 
patenting activities in Europe. There is very little knowledge to rely on and the R&D community 
working on this technology is fragmented. There is a significant risk of technological dependency. 
 
 
 
 
 
 
 
 
 40 
 
 
 
EU is weak in patenting 
Weak signal Actors in Europe (not UK) Indicators Analysis and recommendations 
Electrolyte free 
fuel-cell 
 
Top Countries (Publications) 
China (25) 
EU (23/22)  
US (4) 
 
Patents Cont. Europe/World 
0/6 
 
Fragmentation 
1,38 
Only 36 publications and 6 patents were retrieved for this weak signal. EU and China produce 
most of the knowledge in this weak signal. There is a strong collaboration between Europe and 
China (18 joint-publications), with a strong collaboration between the KTH institute in Sweden and 
Hubei University in China (11 joint publications). EU organisations are involved in more than 63% 
of the publications, mainly through research ongoing at the KTH royal institute of technology of 
Sweden, which leads the field. Despite European leadership in knowledge production, none of the 
6 patents retrieved were filed by a European organisation (China:3, US:2, Japan:1). 
Efforts to support R&D activities in Europe in this technology should build on the existing 
knowledge, which is rather fragile as it mainly relies on one organisation. Measures to encourage 
innovation and patenting should be implemented as well. 
Mobile maritime 
microgrids 
 Top Countries (Publications) 
EU (55/49)  
US (45) 
China (21) 
 
Patents Cont. Europe/World 
0/10 
 
Fragmentation 
2,18 
EU and the US produce most of the knowledge in this weak signal with EU organisations involved 
in about 45% of the publications. Research activities in Europe are mostly performed by a 
community of five organisations centred on Aalborg University, which leads in number of 
publications worldwide. Despite European leadership in knowledge production, none of the 10 
patents retrieved were filed by European organisations (China: 6, Japan: 2, Norway: 1, US: 1).  
 
Efforts to support R&D activities of European organisations in this technology should build on the 
existing knowledge, which is rather fragile as it mainly relies on one organisation. Measures to 
encourage patenting should be considered to ensure Europe acquires IP rights and avoid 
technological dependency. 
Peer-to-peer 
energy trading 
 
Top Countries (Publications) 
China (83) 
 EU (81/51)  
US (43) 
 
Patents Cont. Europe/World 
0/10 
 
Fragmentation 
1,32 
234 publications, 10 patents, and 5 EU projects were retrieved for this weak signal. European 
organisations account for 25% of the publications in the field, which places Europe second with 
81 publications behind China (after Brexit: 51 publications). Research activities in Europe are 
fragmented with R&D communities around e.g. University of Oulu, Aalborg University, CNRS, 
University of Palermo, ATOS. Despite R&D activities in Europe by both research centres and 
companies (e.g. ATOS, EDF, Engineering, Nokia, Energynautics, ENDESA), none of the 10 patents 
retrieved were filed by organisations in Europe (China: 7, US: 2, Australia: 1). 
 
Support to R&D activities in Europe in this technology have been made (5 EU projects) and should 
be pursued. Measures to encourage patenting should be considered to ensure Europe could gain 
some technological independence. 
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Weak signals with Brexit-risk 
Weak signal Actors in Europe (not UK) Indicators Analysis and recommendations 
Al-Air batteries 
 Top Countries (Publications) 
China (92) 
 EU (25/13)  
US (12) 
 
Patents Cont. Europe/World 
2/19 
 
Fragmentation  
3,75 
Chinese organisations are involved in 92 publications out of 149 and 50% of the patents. 
While Europe is strong in patents for this weak signal (6 patents out of 19), 4 of these 
patents are from the UK ad only 2 from Europe. In addition, 33% of the publications involve 
UK organisations (China leads with 7 patents). Brexit will therefore create a significant loss 
of knowledge for Europe in this technology. The landscape of R&D activities on Europe is 
very fragmented with very few actors. 
Should this WS be deemed important, massive efforts will have to be made to reinforce R&D 
and patenting activities in Europe after Brexit. There is little knowledge to rely on and no 
research communities. The possibility of a future technological dependency should not be 
underestimated. 
Energy justice 
 
 
 
 
 
Top Countries (Publications) 
UK (53) 
 EU (102/49)  
US (48) 
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation: 4,57 
This weak signal relates to an emerging cross-cutting issue in energy policy. UK 
organisations are involved in more publications than the rest of European organisations 
together, and a significant loss of knowledge will occur due to Brexit. The landscape of 
research on this topic will drastically change, with a high fragmentation of the research 
environment in Europe after Brexit.  
 
Should the loss of policy knowledge on this topic be deemed important, efforts will have to 
be made to reinforce research activities in Europe and to develop scientific collaboration. 
There is some knowledge to rely on, mainly located at Aarhus University, but the landscape 
is very fragmented. 
Energy trilemma 
 Top Countries (Publications) 
UK (17) 
 EU (22/7)  
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
2.25 
This weak signal relates to an emerging cross-cutting issue in of energy policy. UK 
organisations publish or are involved in most of the publications in the field (32%), a 
significant loss of knowledge due to Brexit will therefore occur. The landscape of research on 
this topic will drastically change, with a high fragmentation and very few organisations 
active in Europe.  
 
Should the loss of policy knowledge on this topic be deemed important, massive efforts will 
have to be made to reinforce research activities. There is little knowledge to rely on and the 
landscape in Europe is fragmented. 
Home microgrids 
 
 
 
Top Countries (Publications) 
EU (25/17) 
 China (15) 
US (15)  
UK (13) 
 
Patents Cont. Europe/World 
0/5 
 
Fragmentation: 1,83 
In this technology, European organisations are involved in 32% of the publications. Due to 
Brexit, this proportion will be reduced to 21% (17 publications). None of the patents retrieved 
have been registered by organisations in Europe (China: 3, South Korea: 1, India: 1). 
 
Should this technology be deemed important for Europe, and considering the loss of 
knowledge due to Brexit, massive efforts will have to be made to reinforce research 
activities in Europe. There is little knowledge to rely on, mainly located at Aalto and Aalborg 
Universities, and the landscape in Europe is fragmented. Measures to push patenting 
activities should also be considered. 
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EU is weak in knowledge production 
Weak signal Actors in Europe (not UK) Indicators Analysis and recommendations 
3D convolutional 
neural networks 
 Top Countries (Publications) 
China (245) 
US (145) 
 EU (137/100)  
 
Patents Cont. Europe/World 
0/52 
 
Fragmentation  
1,64 
Chinese organisations are involved in 46% of the publications in this technology. Organisations 
from Europe are involved in 100 publications (37 only with UK organisations). None of the 52 
patents retrieved has been filed by a European organisation (China: 47/52 patents, 1 patent in 
the UK). The landscape of R&D activities in Europe is fragmented. 
 
Should this WS be deemed important, measures to accompany the Brexit transition should be 
put in place, together with long term measures to support R&D, increase collaboration among 
organisations in Europe (EU projects) and, more importantly, push innovation using EU 
knowledge (patenting activities). There is a risk of future technological dependency. 
Ambient 
backscatter 
 
 
 
Top Countries (Publications) 
China (71) 
US (35), South Korea (27) 
EU (27/22) 
 
Patents Cont. Europe/World 
1/5 
 
Fragmentation  
1,86 
131 publications and 5 patents were retrieved for this technology. EU comes at the fourth place 
in terms of scientific publications (16% of worldwide publications). There are very few actors in 
Europe and the landscape is fragmented. One of the five patents retrieved was filed by an 
Austrian organisation.  
 
Should this WS be deemed important, some efforts will have to be made to support R&D 
activities. Measures to ensure that knowledge is transformed into innovations and patents 
should also be considered. EU projects could be launched to increase the number of 
organisations active in this technology and connect them to each other. 
Consortium 
Blockchain 
 
Top Countries (Publications) 
China (66) 
 US (15) 
Australia (7) 
EU (5/3)  
 
Patents Cont. Europe/World 
0/14 
 
Fragmentation: 3 
Only 3 publications were retrieved for Europe, which is lagging behind in this technology. China 
leads in terms of scientific publications, followed by the US and Australia. Only 3 organisations 
in Europe have published and none of the 14 patents are from a European organisation (China: 
12 patents, US: 2).  
 
Should this WS be deemed important, massive efforts will have to be made to develop research 
activities in Europe. There is indeed very little knowledge available and very few actors in 
Europe. Measures to ensure that knowledge is transformed into patents will also need to be 
devised.  
Convolutional 
autoencoders 
 Top Countries (Publications) 
China (169) 
EU (105/65)  
 US (96) 
 
Patents Cont. Europe/World 
0/7 
 
Fragmentation  
1,31 
Chinese organisations lead in this technology in terms of publications. Europe comes second 
with 105 publications, but slightly less than 40% of them are only involving UK organisations. In 
Europe, 84 actors are involved in 65 publications and the research environment is slightly 
fragmented with no obvious leader. 7 patents have been filed with 5 from Chinese 
organisations, 1 from the US, and 1 from South Korea. 
 
Should this WS be deemed important, some efforts will have to be made to support research 
activities, but mostly to push innovation and patenting. There is knowledge in EU but the 
possibility of a future technological dependency should not be underestimated. Support during 
the Brexit phase could also be envisaged. 
7.2 Information and Communication 
Technologies 
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Deep Q learning 
 Top Countries (Publications) 
China (70) 
 US (44) 
EU (41/29)  
 
Patents Cont. Europe/World 
0/6 
 
Fragmentation  
7,75 
172 publications and 6 patents were retrieved for this weak signal. EU comes at the third place 
in terms of scientific publications. There are a few actors in Europe and the research 
environment is very fragmented. None of the 6 patents retrieved were filed by a European 
organisation (China: 5, US: 1).  
 
Should this WS be deemed important, measures to reinforce R&D in Europe and create a 
network of knowledgeable actors will have to be implemented. This could possibly be done 
through EU funding projects. Measures to ensure that knowledge is transformed into 
innovations and patents should also be considered. 
 
Dilated 
convolutional 
neural network 
 Top Countries (Publications) 
China (27) 
EU (12/8)  
 US (10) 
 
Patents Cont. Europe/World 
0/5 
 
Fragmentation  
1,5 
Few publications and patents have been retrieved for this technology. With 27 publications, 
China clearly leads in knowledge production. The number of actors in Europe is very small. Out 
of the five patents detected, 2 are from UK, 2 from US, and 1 from China.  
 
Should this WS be deemed important, massive efforts will have to be made to reinforce R&D in 
Europe and create a network of knowledgeable actors. This could possibly be done EU funded 
projects. Measures to ensure that knowledge is transformed into innovations and patents should 
also be considered.  
 
Generative 
adversarial 
networks 
 Top Countries (Publications) 
China (964) 
 US (612) 
EU (445/274)  
 
Patents Cont. Europe/World 
2/205 
 
Fragmentation  
2 
2050 publications and 205 patents have been retrieved for this weak signal most of which have 
published or registered since 2017. European organisations China leads in number of 
publications and in patenting (181 patents). Other countries follow: US (14), Australia (4), south 
Korea (3). There are many R&D actors in Europe but they are not highly connected. Only 2 
patents have been filed by organisations in Europe (Ericsson and Philips, 1 patent each), This 
shows a clear lack of capability to transform knowledge into innovation.  
 
Should this WS be deemed important, measures to connect R&D actors and to ensure that the 
EU knowledge is transformed into innovations and patents should be put in place. There is a 
significant risk of technology dependency.  
High res. image 
recognition by NN 
 Top Countries (Publications) 
China (240) 
 US (94) 
EU (90/68)  
 
Patents Cont. Europe/World 
0/60 
 
Fragmentation  
2,53 
China leads in publications for this weak signal, before the US and Europe. In Europe, there is 
production of knowledge (with 68 publications) but the research environment is fragmented. 
None of the patents retrieved has been filed by a European organisation, and China owns 56 of 
these 60 patents. 
 
Should this WS be deemed important, measures to connect R&D actors and to push patenting 
activities should be put in place. There is a risk of future technological dependency. 
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Hierarchical 
recurrent neural 
network 
 Top Countries (Publications) 
China (32) 
 Japan (9) 
EU (14/7)  
 
Patents Cont. Europe/World 
0/5 
 
Fragmentation: 9 
Few publications and patents have been retrieved for this WS. With 32 publications, China leads 
in knowledge production. The number of actors in Europe is very small (each actor only has 1 
publication). None of the five patents detected originates from EU (US: 2, China: 2, Japan: 1).  
 
Should this WS be deemed important, massive efforts will have to be made to create R&D 
activities in Europe and create a network of knowledgeable actors. This could possibly be done 
through EU funded projects. Measures to ensure that knowledge is transformed into innovations 
and patents should also be considered to avoid technology dependency in the future. 
Internet of vehicles 
 
Top Countries (Publications) 
China (428) 
 US (137) 
EU (167/111)  
 
Patents Cont. Europe/World 
2/1116 
 
Fragmentation  
2,15 
This is one of the few weak signals for which the 
filing of patents precedes the publication of scientific 
articles. Looking only at scientific publications, this 
technology shows the characteristics of a weak 
signal. But its foreseen market potential has pushed 
the industry, mostly in China, to invest massively in 
patenting. Although there is knowledge produced, 
Europe, but also the US, is lagging behind in 
publication of scientific articles. But the striking 
feature here is the patenting strategy of China which, 
owning 1066 of the 1116 patents retrieved, can be 
qualified as IP flooding strategy (US :14, Taiwan: 7, SK: 6, JP:4, EU : 2 patents) 
 
Should this technology be deemed important, massive support should be allocated to academic 
and industrial actors in Europe. The risk of technological dependency is very high. 
Non-orthogonal 
multiple access 
 Top Countries (Publications) 
China (357) 
 EU (181/90)  
US (110) 
 
Patents Cont. Europe/World 
0/15 
 
Fragmentation 
1,47 
EU is second in terms of publications behind China. But if the publications where the only 
European organisations involved are from the UK are removed, Europe occupies the third place 
behind the US with 90 publications, with a slightly fragmented collaboration environment. Brexit 
will have a significant impact for this technology (35 very active research actors will leave the 
EU). There were very little number of patents retrieved, none of which was registered by an EU 
organisation (China: 8, South Korea: 5, US:2). 
 
Although there are very few patents filed so far, measures to make sure that European 
organisations have incentives to transform their knowledge into innovations should be put in 
place. Knowledge creation should also be reinforced through appropriate measures. 
Online multiple 
object tracking 
 
Top Countries (Publications) 
China (31), US (23) 
South Korea (19) 
EU (14/10)  
 
Patents Cont. Europe/World 
0/1 
 
Fragmentation 
2,75 
A small number of publications and patents was retrieved for this weak signal. With only 10 
publications from Europe (14 including publications where only UK organisations are involved 
from Europe), EU is fourth behind China, the US and South Korea. The number of R&D actors in 
EU is also very small, with only 11 actors detected. Only one patent was retrieved and it is 
owned by Xerox in the US. 
 
If this weak signal is deemed as important for EU, massive support should be provided to R&D 
actors. The number of actors should be increased and scientific collaboration fostered. 
Measures to ensure the transformation of knowledge into innovations should also be put in 
place to avoid technology dependency. 
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Private Blockchain 
 
Top Countries (Publications) 
US (66) 
China (59) 
EU (53/33)  
 
Patents Cont. Europe/World 
2/44 
Fragmentation 
1,73 
EU is third in knowledge production and appear to be close to the US and China. But if the 20 
publications from UK organisations are removed, the gap between Europe and the two leaders 
increases. It is again in the transformation of knowledge into innovations that EU (2 patents) 
lags behind China (10 patents), the US (17 patents), and other countries. There are not many 
actors in Europe and they do not strongly collaborate together (fragmentation > 1).  
 
If this weak signal is deemed as important for EU, massive support should be provided to R&D 
organisations in Europe. The number of actors should be increased and the creation of research 
communities encouraged. Measure to ensure the transformation of knowledge into innovations 
should also be put in place to avoid technology dependency for this sensitive technology. 
Smartphone 
spectrometry 
 
 
 
Top Countries (Publications) 
 US (27) 
EU (17/11)  
 
Patents Cont. Europe/World 
0/2 
 
Fragmentation 
1,42 
 
The US lead in terms of scientific publications for this technology, Europe is second. Very few 
actors are active in Europe, with VTT taking a leading role (but with only 2 publications…). Both 
patents retrieved are owned by US organisations.  
 
Although little R&D activities has been detected for this technology, Europe is already lagging 
behind the US in research. The importance of this WS and the positioning of EU organisations 
should be monitored to ensure timely measures are put in place to support European actors if 
necessary.  
Smart village 
 Top Countries (Publications) 
India (28) 
 EU (26/16) 
US (23) 
 
Patents Cont. Europe/World 
0/1 
 
Fragmentation 
5 
 
India leads in terms of number of scientific publications, with Europe occupying the second 
position (third position if Brexit is taken into account). Very few actors in Europe are engaged in 
research, with a very high fragmentation of the collaboration environment. 1 patent has been 
retrieved and no conclusions can be drawn.  
 
R&D activities are only starting and EU is well placed in knowledge production. Measures to 
support actors in Europe should be put in place, both to support research and innovation. Some 
transitional support during Brexit could be considered.  
Software-defined 
vehicular networks 
 Top Countries (Publications) 
China (87) 
 EU (68/54)  
US (44) 
 
Patents Cont. Europe/World 
0/3 
 
Fragmentation 
2,7 
282 publications and only 3 patents were retrieved for this weak signal. China leads in terms of 
publications, with EU at the second position (even if the 14 publications from UK are removed). 
There is some R&D activities ongoing in Europe with CNRS and the University of Luxembourg 
leading. Collaboration in Europe is limited, with a rather high fragmentation of the research 
environment. The 3 patents retrieved are owned by Chinese (2) and US (1) organisations. 
 
Should this WS be deemed important, efforts will have to be made to support R&D in Europe 
and defragment the research environment. Measures to ensure European organisations engage 
into patenting should also be considered. 
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YOLO 
 Top Countries (Publications) 
China (162) 
EU (51/41)  
US (46) 
 
Patents Cont. Europe/World 
1/25 
 
Fragmentation 
4,5 
 
EU lags behind both in publications and patenting (41 publications in Europe). China leads in 
both (162 publications, 24 patents). There are only a few actors in Europe with a high 
fragmentation of the research landscape.  
 
Should this WS be deemed important, massive efforts will have to be made to allow European 
actors to catch up in publications and patenting. There is little knowledge to rely on and the 
research community working on this technology is very fragmented. There is a significant risk of 
future technological dependency. 
LSTM neural 
network 
 
 
 
 
 
Top Countries (Publications) 
China (799) 
EU (549/437) 
US (514) 
 
Patents Cont. Europe/World 
0/114 
 
Fragmentation 
1,81 
Europe is second in publications with around 25% of the scientific articles, but will be third after 
Brexit with 437 publications. China and the US lead both in publications and patenting (China: 
77, US: 28). There is significant knowledge in Europe but within a fragmented research 
environment, characterised by two large research communities around TU Munich and CNRS and 
a lot of isolated smaller actors. With none of the patents retrieved coming from a European 
organisation, Europe so far failed to transform this knowledge into innovations. 
 
Strong measures are needed to encourage patenting should if one wishes to avoid technological 
dependency in the future. Some measures could also be put in place to connect more R&D 
actors in Europe in this field. 
 
EU is weak in patenting 
Weak signal Actors in Europe (not UK) Indicators Analysis and recommendations 
Network slicing 
 Top Countries (Publications) 
EU (314/247) 
China (144) 
US (86) 
 
Patents Cont. Europe/World 
15/82 
 
Fragmentation 
0,51 
483 publications, 82 patents, and 11 EU projects were retrieved for this technology. European 
organisations lead in terms of publications in the field (50% of the publications), with China and 
US respectively second and third. This leadership position is maintained for Europe if UK 
publications are not taken into account (247 publications). Research actors in Europe are well-
connected scientifically (fragmentation < 1). Despite R&D activities in Europe by both research 
centres and companies (e.g. Nokia, Deutsch Telekom) only 15 of the 82 patents detected were 
filed by European organisations (China: 34, South Korea: 12, US: 12, Japan:6). 
Measures to encourage patenting should be considered to ensure Europe can continue 
competing in this field. In this technology, EU support to R&D activities in Europe has been given 
(11 EU projects), which resulted in a highly collaborative environment.  
Digital twin in 
industry 
 
 
 
Top Countries (Publications) 
EU (118/90) 
US (40) 
China (34) 
 
Patents Cont. Europe/World 
11/42 
 
Fragmentation: 1,46 
EU leads in publications (even if UK publications are removed). Although EU is one of the leader, 
the landscape of research is fragmented and dominated by one strong actor: Siemens. All of the 
patents from Europe have been registered by one single company (Siemens). 22 patents are 
owned by US organisations, 11 by Chinese organisations. 
EU leading position in this technology is fragile as both its knowledge and patenting mainly 
relies on one strong actor (Siemens). Measures could be put in place to build a community of 
R&D actors around Siemens, to better connect research actors in Europe, and to break the IP 
monopoly of Siemens by encouraging patenting activities by other actors. 
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Low power wide 
area network 
 Top Countries (Publications) 
EU (371/294) 
China (92) 
US (79) 
 
Patents Cont. Europe/World 
20/136 
 
Fragmentation 
1,77 
  
EU leads by far in publications (even considering Brexit) and is third in patenting (20 patent), 
behind China with 60 patents and South Korea with 33 patents. 7 European companies own 
patents but the strongest actors are the German companies Gieseck&Devrient gmbh and 
Deutsche Telekom. The landscape of research is relatively fragmented. 
 
Measures to encourage the transformation of knowledge into innovations should be put in 
place. The leading position of Europe in terms of publications should be reflected in strong IP 
portfolios.  
Micro-service 
architecture 
 Top Countries (Publications) 
EU (213/188) 
US (62) 
China (45) 
 
Patents Cont. Europe/World 
2/37 
 
Fragmentation 
2,52 
EU leads by far in publications and is third in patenting (2 patent), far behind China and the US 
both with 13 patents in this technology. Despite a relatively high number of actors, the 
landscape of research in Europe is fragmented. The two patents in Europe are owned by SAP 
(China: 21, US: 13).  
 
European organisations did not manage to translate their knowledge on this technology into 
innovations protected by patents. Measures to encourage the transformation of knowledge into 
innovations should be put in place.  
Ultra reliable low 
latency 
communication 
 Top Countries (Publications) 
EU (581/478) 
China (276) 
US (266) 
 
Patents Cont. Europe/World 
12/141 
 
Fragmentation 
0,45 
EU leads in terms of publications and is fifth in patenting with 12 patents, behind the US (61), 
China (33), South Korea (25). There is a significant number of R&D actors (>300) and the 
landscape of research in Europe is not fragmented. Out of the 12 European patents, 9 are 
owned by Nokia and 3 by Ericsson. 
 
European organisations did not manage to translate their knowledge on this technology into 
innovations protected by patents. In addition, the few patents by European organisations are 
owned by two companies, which makes the IP rights situation fragile. Measures to encourage 
patenting should be put in place to transform the significant knowledge of EU organisations into 
innovations. 
Heterogeneous 
ultra-dense 
networks 
 Top Countries (Publications) 
China (93) 
EU (67/49) 
US (20) 
 
Patents Cont. Europe/World 
0/10 
 
Fragmentation 
0,5 
EU is second behind China in terms of publications. Despite the relatively low number of actors, 
the landscape of research in Europe is not fragmented. This low fragmentation could be the 
result of the 2 European projects funded by the EU in this technology. All of the ten patents 
retrieved are owned by Chinese organisations.  
 
China leads both in publications and patenting. Europe has some knowledge in the field but 
none of the patents retrieved have been filed by European organisations. Measures to 
encourage the transformation of knowledge into innovations should be put in place to ensure 
that Europe keeps some technological sovereignty. 
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Drone detection 
 Top Countries (Publications) 
EU (47/38) 
US (28) 
South Korean (22) 
 
Patents Cont. Europe/World 
2/30 
 
Fragmentation 
0,58 
EU leads in terms of publications but is fourth in patenting behind China (5), the US (11), and 
South Korea (9), with only 2 patents. There are very few R&D actors in this technology but the 
four EU projects funded on this topic have ensured some connections between European 
organisations (low fragmentation). 
 
European organisations did not manage so far to translate their knowledge on this technology 
into innovations protected by patents. Measures to encourage patenting should be put in place 
to transform the significant knowledge of EU organisations into innovations. Support to EU 
organisations engaged in R&D could be envisaged to allow EU to keep its leading position in this 
technology. Collaboration between EU organisations should also be encouraged. 
Massive machine 
type 
communication 
 
Top Countries (Publications) 
EU (138/109) 
China (111) 
US (36) 
 
Patents Cont. Europe/World 
4/26 
 
Fragmentation 
0,28 
Europe and China lead in terms of publications. In patenting, South Korea leads with 6 patents, 
followed by the US and China (5 patents each) and Japan and the EU (4 patents each). The R&D 
landscape in Europe is not fragmented, which is possibly the consequence of the 4 EU projects 
funded on this. All patents originating from Europe are owned by Ericsson. Competition in this 
weak signal is still open, as the five major actors (Japan, South Korea, the US, China, and 
Europe) have all produced around 5 patents each. EU is leading in terms of publications and 
could therefore potentially remain technologically independent in this field if knowledge is 
effectively transformed into IP rights. The industrial champion in this field is Ericsson, owning all 
of the EU patents, which makes the IP position of EU fragile.  
 
Measures relying on the existing knowledge and actors should be put in place to reinforce R&D 
in this field and to ensure that more innovations are patented. 
Fog computing 
 Top Countries (Publications) 
EU (915/737) 
China (645) 
US (555) 
 
Patents Cont. Europe/World 
1/91 
 
Fragmentation 
1,06 
EU leads in publications with more than 30% of the scientific articles (even if Brexit is 
considered). China and the US are respectively second and third in number of publications, but 
they lead in patenting with 53 Chinese patents and 20 US patents. Only one of the 91 patents 
retrieved coming from Europe (Erle robotics). There is significant knowledge in the field in 
Europe with a relatively well connected landscape.  
 
Organisations in Europe have so far failed to transform their knowledge into 
innovations. .Strong measures are needed to encourage patenting should if one wishes to avoid 
technological dependency in the future. 
Edge computing 
 Top Countries (Publications) 
EU (1317/1010) 
China (1177) 
US (1050) 
 
Patents Cont. Europe/World 
22/251 
 
Fragmentation 
0,46 
China, the US and the EU are producing the same range of number of publications. Europe leads 
for the moment but will be at the third position after Brexit. There is significant knowledge in 
the field in Europe with a well-connected landscape and many R&D actors. In patenting, China 
(122) and the US (61 patents) are by far leading. 22 patents are owned by organisations in 
Europe, most of which are owned by Nokia (16/22).  
 
No measures are needed to support research in Europe on this topic, as the number of R&D 
actors is very high and the landscape not fragmented. But strong measures are needed to 
encourage patenting should one wishes to avoid technological dependency in the future. 
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Drone base station 
 
Top Countries (Publications) 
China (34) 
US (27) 
EU (26/18) 
 
Patents Cont. Europe/World 
2/55 
 
Fragmentation 
1 ,46 
China leads in terms of publications in this technology. There is little knowledge in Europe with 
few actors and a slightly fragmented landscape. When it comes to patenting, EU (2 patent) is 
far behind China (33), South Korea (12) and the US (5), reflecting the strong capacity of China 
and the US to transform knowledge into innovation, contrary to Europe.  
 
Should this weak signal be deemed important, measures to support both the research activities 
and patenting in Europe are needed. The risk of technological dependency should not be 
underestimated.  
Mobile edge 
computing 
 
Top Countries (Publications) 
China (560) 
EU (438/328) 
US (262) 
 
Patents Cont. Europe/World 
18/108 
 
Fragmentation 
0,51 
China leads in publishing in this WS, with EU and the US respectively second and third. There is 
significant knowledge in the field in Europe with a well-connected landscape and many R&D 
actors. In patenting, China (49 patents) leads in front of the US (21) and EU (17). 14 of the 17 
patents in EU are owned by Nokia. 
 
No specific measures are needed to support research in Europe on this topic, as the number of 
R&D actors is very high and the landscape not fragmented. Some knowledge is transformed 
into innovations by European organisations, but most of the patents in Europe is in the hands of 
Nokia, which makes the EU IP position fragile. Measures to encourage patenting should be put in 
place to transform the significant knowledge of EU organisations into innovations and to 
increase the number of European actors owning inventions in the WS. 
Public Blockchain 
 Top Countries (Publications) 
US (37) 
EU (35/24) 
China (29) 
 
Patents Cont. Europe/World 
0/17 
 
Fragmentation 
5 
The US is leading in terms of publications in this technology, followed by China and the EU. 
There is little knowledge in Europe with few actors and a very fragmented research 
environment. When it comes to patenting, European organisations have not filed any patents 
(US: 6 patents, South Kore: 6 patents, China: 3 patents).  
 
Should this weak signal be deemed important, measures to support both the research activities 
and patenting in Europe are needed. There is a risk of technological dependency in the near 
future. 
Narrowband 
Internet of Things 
 Top Countries (Publications) 
China (534) 
EU (188/123) 
US (98) 
 
Patents Cont. Europe/World 
37/830 
 
Fragmentation 
1,41 
Chinese organisations lead by far in publishing of scientific articles. EU and the US follow with 
roughly four to five times less publications. In patenting, China also leads with 648 patents, 
followed by the US (73) and South Korea (40). Europe is fourth with 37 patents. There is some 
knowledge in Europe but not a high number of actors, which could be more connected (slight 
fragmentation). 
  
There is a risk of technological dependency for this weak signal if specific support is not put in 
place to encourage European organisations to transform knowledge into innovations and file 
patents. There is knowledge in this technology in Europe, but measures to increase the number 
of active organisations and to create a well-connected landscape could be considered. 
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Ransomware 
detection 
 
Top Countries (Publications) 
EU (29/18) 
US (26) 
China (13) 
 
Patents Cont. Europe/World 
0/31 
 
Fragmentation 
2,71 
A small number of publications has been retrieved for this weak signal (97). EU and the US 
produce most of the publications. There are very few actors in Europe and they are not 
collaborating much (high fragmentation). In patenting, US and Chinese organisations lead (US: 
15 patents, China: 10 patents). No patents has been filed so far by European organisations.  
 
Should this weak signal be deemed important, measures to support both the research activities 
and patenting in Europe are needed. The risk of technological dependency will be real if 
European organisations do not engage in patenting. 
 
 
Internet of 
battlefield things 
 
Top Countries (Publications) 
EU (93/70) 
US (84) 
China (63) 
 
Patents Cont. Europe/World 
0/19 
 
Fragmentation 
2,2 
315 publications has been retrieved for this weak signal. The US, EU and China produce most of 
the publications. There are very few actors in Europe and they are not collaborating much 
(fragmentation > 2). In Europe, the community of R&D actors built around the Polish Military 
university of Technology is quite strong in publications. With only 19 patents filed worldwide, 
patenting activities are only starting. China and South Korea have respectively 13 and 4 patents. 
No patents has been filed so far by European organisations.  
 
Should this weak signal be deemed important, measures to support both the research activities 
and patenting in Europe are needed. The risk of technological dependency will be real if 
European organisations do not engage in more R&D and in patenting. 
Residual neural 
network 
 Top Countries (Publications) 
China (60) 
US (38) 
EU (36/22) 
 
Patents Cont. Europe/World 
0/12 
 
Fragmentation 
1,67 
China, the US and EU produce most of the publications in this technology. There are very few 
actors in Europe and they could collaborate more together. With only 12 patents filed 
worldwide, patenting activities are only starting. All patents have been filed by Chinese 
organisations.  
 
Should this weak signal be deemed important, measures to support both the research activities 
and patenting in Europe are needed. The risk of technological dependency will be real if 
European organisations do not engage in more R&D and in patenting. 
 
Weak signals with Brexit-risk 
Weak signal Actors in Europe (not UK) Indicators Analysis and recommendations 
Internet of drones 
 
Top Countries (Publications) 
EU (14/10) 
US (6) 
 China (6)  
 
Patents Cont. Europe/World 
0/4 
 
Fragmentation  
2,2 
R&D and patenting started very recently for this weak signal. With 14 publications out of 27, EU 
is well placed in research activities. Due to Brexit, 2 of the 13 actors will quit the research 
environment, leaving 11 actors in Europe. The landscape is fragmented and the main actor is 
the Polytechnic institute of Porto. In patenting, 1 out of the 4 patents is owned by a UK based 
organisation and will therefore leave the European sphere (China: 1, US: 1, South Korea: 1).  
 
Brexit will impact the R&D environment for this technology. Measures to reinforce research 
activities and patenting should be considered. 
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EU is weak in knowledge production 
Weak signal Actors in Europe (not UK) Indicators Analysis and recommendations 
Taurine-
upregulated gene 1 
 
Top Countries (Publications) 
China (113) 
EU (14/12) 
 US (11)  
 
Patents Cont. Europe/World 
0/3 
 
Fragmentation  
1,8 
 
Chinese organisations have taken a clear role in this weak signal, with ten times more 
publications than US and EU. There are very few European actors and the landscape of R&D 
activities in Europe is fragmented. 
  
Should this WS be deemed important, important efforts will have to be made to develop 
European R&D in this area as there is very little knowledge and actors to rely on. Measures to 
ensure that knowledge is transformed into innovations and patents should also be considered to 
avoid future technology dependency. 
 
SC79 
 
 
Top Countries (Publications) 
China (10) 
US (3) 
Japan (2) 
EU, South Korea, Taiwan (1) 
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
- 
 
China leads the R&D and only one publications from EU was retrieved. This EU publication 
comes from an organisation in the UK and no knowledge in Europe has been detected. The 
volume of publications is also very small for other territories. No patents were retrieved. 
 
There is no knowledge detected for Europe for this weak signal, which should be monitored to 
ensure adequate measures to support R&D and patenting in Europe can be timely taken should 
it become an important technology. 
 
X-inactive specific 
transcript 
 
 
Top Countries (Publications) 
China (45) 
 EU (17/13) 
US (13) 
 
Patents Cont. Europe/World 
0/1 
 
Fragmentation  
0,91 
 
China leads the R&D, followed by the EU and the US. Twenty organisations in Europe are 
involved in 13 publications. These organisations are fairly well connected. One patent was 
retrieved (China).  
 
Should this WS be deemed important, significant efforts will have to be made to support R&D 
activities in Europe and ensure that knowledge is transformed into innovations.  
Pegvaliase 
 
 
Top Countries (Publications) 
US (9) 
EU (2)  
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
- 
 
The US leads the R&D (but with only 9 publications) and only two publications from EU were 
retrieved. These publication come from UK-based organisations and no knowledge in Europe has 
been detected. No patents were retrieved. 
 
There is no knowledge detected for Europe for this weak signal, which should be monitored to 
ensure adequate measures to support R&D and patenting in Europe can be timely taken should 
it become an important technology. 
 
7.3 Health 
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Siderophore 
cephalosporin 
 
 Top Countries (Publications) 
US (32) 
 Japan (29) 
EU (18/13)  
 
Patents Cont. Europe/World 
1/1 
 
Fragmentation  
0,35 
R&D activities in this weak signal are led by the US and Japan. EU comes third with 18 
publications. There are not many actors in Europe but they are fairly well connected together 
(low fragmentation). One patent was retrieved and is owned by a European organisation 
(Mutabilis, France).  
 
Should this WS be deemed important, some efforts will have to be made to reinforce R&D 
activities in Europe. There is some knowledge and a network of collaboration to rely on. 
Measures to ensure that knowledge is transformed into innovations and patents should also be 
considered.  
 
New gout therapies 
 
 Top Countries (Publications) 
US (32) 
 EU (18/15) 
China (11)  
 
Patents Cont. Europe/World 
0/26 
 
Fragmentation  
1,25 
US organisations are leading research activities in this weak signal. EU is second in terms of 
scientific publications. Only ten active organisations in Europe have been detected for a slightly 
fragmented landscape. Astrazeneca seems to play a key role, which should be considered in 
view of Brexit. 26 patents were retrieved: none were filed by organisations in Europe, 25 were 
filed by Chinese organisations. 
 
Should this WS be deemed important, measures to support the nascent R&D activities in Europe 
should be implemented. Patenting activities have started and measures to foster innovation in 
Europe should be put in place to avoid technological dependency in the future. 
Tyrosine kinases 
inhibitors 
 
 
Top Countries (Publications) 
China (484) 
 EU (281/250) 
US (238), Japan (139)  
 
Patents Cont. Europe/World 
1/57 
 
Fragmentation  
0,36 
Europe is second in scientific publications, well behind China but before the US and Japan. 313 
organisations in Europe are active in R&D for this weak signal. Many collaborations link the EU 
actors together (low fragmentation of the R&D environment). Despite a relatively high 
knowledge production, only 1 patents out of the 57 patents retrieved have been filed by an 
organisations in Europe (Astrazeneca, UK-Swedish company). 51 of the 57 patents are owned by 
Chinese organisations. 
 
Should this WS be deemed important, measures to push innovation and to ensure that IP rights 
are obtained by European organisations should be put in place to avoid future dependency on 
non-EU patents.  
Gasdermin  
Top Countries (Publications) 
China (69) 
 US (64) 
EU (45/41)  
 
Patents Cont. Europe/World 
0/7 
 
Fragmentation  
0,85 
China and the US lead in terms of scientific publications for this weak signal. In Europe, there is 
production of knowledge (41 publications) and active organisations are fairly well connected. 
None of the seven patents retrieved was registered by a European organisation, which may be 
an early sign of the difficulty to transform knowledge into innovations in Europe for this specific 
weak signal. 3 patents are owned by US organisations, 3 by Chinese ones and 1 by Japan. 
 
Should this WS be deemed important, measures to push innovation based on the acquired 
knowledge and to ensure that IP rights are obtained by European organisations should be put in 
place. 
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EU is weak in patenting 
Weak signal Actors in Europe (not UK) Indicators Analysis and recommendations 
Heat-not-burn 
tobacco product 
 
 Top Countries (Publications) 
US (45) 
 EU (38/19) 
Switzerland (34) 
China (19) 
  
Patents Cont. Europe/World 
0/88 
 
Fragmentation 
2,62 
134 scientific publications and 88 patents were retrieved for this weak signal. The US lead in 
terms of publications in the field, with Europe second (but third if Brexit is taken into account). 
Only 21 actors from Europe were spotted and they do not collaborate much together (high 
fragmentation of the landscape). Although EU is active in knowledge production, none of the 88 
patents retrieved has been filed by an organisation from Europe. Most of the patents (84) are 
indeed owned by Chinese tobacco companies.  
 
Should this weak signal be deemed of importance to Europe, measures to develop further R&D 
activities and to ensure the transformation of this knowledge into innovations should be put in 
place to avoid technology dependency. 
CAR T cells 
immunotherapy 
 
 
Top Countries (Publications) 
US (863) 
 EU (408/311) 
China (239)  
 
Patents Cont. Europe/World 
4/106 
 
Fragmentation 
 0,68 
 
The US leads this area of research with more scientific publications than EU and China together. 
There is a significant number of actors in Europe (>300), with a well-connected R&D landscape. 
As observed for many other WS, very few patents have been filed by EU organisations (4 out of 
106). China and the US are leading with respectively 53 and 32 patents. 
 
There is knowledge and ongoing collaborations in Europe in this weak signal. But measures 
should be put in place to encourage patenting should if one wishes to avoid technological 
dependency in the future. 
Tumor mutation 
burden 
 
 
Top Countries (Publications) 
US (189) 
 EU (103/92) 
China (54)  
 
Patents Cont. Europe/World 
1/11 
 
Fragmentation 
0,62 
 
The US leads this area of research with more scientific publications than EU and China together. 
There is a high number of actors in Europe (>150), evolving in a well-connected R&D 
environment. One out of the 11 patents retrieved has been filed by an EU organisation 
(Siemens), 10 of the 11 patents are owned by US organisations. 
 
There is knowledge and ongoing collaborations in Europe in this weak signal. But measures 
should be put in place to encourage patenting to avoid technological dependency in the future. 
Ferroptosis 
 
 
Top Countries (Publications) 
US (99) 
China (79) 
EU (78/69)  
 
Patents Cont. Europe/World 
0/7 
 
Fragmentation 
0,625 
  
Europe is at the third position in term of scientific publications, behind the US (1st) and China 
(2nd). There is more than a hundred organisations with knowledge in this field in Europe, with a 
fairly high number of scientific collaborations (low fragmentation). None of the 7 patents 
retrieved is owned by an EU organisations (4 patents in the US, 2 in South Korea, 1 in Japan).  
 
There is some knowledge and ongoing collaborations in Europe in this weak signal. But 
measures should be put in place to encourage patenting should if one wishes to avoid possible 
technological dependency in the future. 
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Programmed 
death-ligand 1 
inhibitors 
 
 Top Countries (Publications) 
US (1033) 
EU (786/659)  
China (331) 
Japan (308) 
 
Patents Cont. Europe/World 
11/304 
 
Fragmentation 
0,23 
The US are leading in terms of scientific publications. There are many active organisations in 
Europe (>800) and scientific collaboration is very intense (very low fragmentation). Despite this 
knowledge, Europe is lagging behind in patenting with only 11 patents out of 304 (86 patents 
from the US, 85 from China).  
 
Europe is very knowledgeable in this weak signal but European organisations did not manage to 
translate their knowledge into innovations protected by patents. Measures to encourage the 
transformation of knowledge into innovations should be put in place to avoid technological 
dependency.  
Cyclin-dependent 
kinase 4/6 
inhibitors 
 
 Top Countries (Publications) 
US (455) 
EU (309/250)  
China (105) 
  
 
Patents Cont. Europe/World 
2/62 
 
Fragmentation 
0,33 
US leads in terms of scientific publications. Europe is second in knowledge production, with a 
significant number of R&D actors (>300). The R&D landscape in Europe is very well connected 
(no fragmentation). Despite this, Europe is lagging behind in patenting with only 2 patents out of 
62 retrieved (15 from the US, 22 from China). 
 
For this WS, European organisations did not manage to translate their knowledge into 
innovations protected by patents. Measures to encourage patenting should be put in place to 
transform the significant knowledge of EU organisations into innovations. 
Senolityc drugs 
 Top Countries (Publications) 
US (82)  
EU (66/47) 
China (9) 
  
 
Patents Cont. Europe/World 
0/6 
 
Fragmentation 
0,67 
The US are leading in terms of scientific publications, Europe is second. 83 organisations are 
active in Europe and they collaborate together. None of the 6 patents retrieved is owned by an 
EU organisations (5 in the US, 1 in the UK).  
 
There is knowledge and ongoing collaborations in Europe in this weak signal. To avoid possible 
technological dependency in the future, measures should be put in place to make sure EU 
organisations develop innovations protected by patents. 
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Weak signals with Brexit-risk 
Weak signal Actors in Europe (not UK) Indicators Analysis and recommendations 
Activated 
phosphoinositide 
3-kin syndrom 
 
Top Countries (Publications) 
US (17) 
EU (14/10) 
 
Patents Cont. Europe/World 
1/1 
 
Fragmentation  
0,24 
 
R&D and patenting started very recently for this weak signal. With only 17 publications for the 
US (leading) and 14 for the EU (2nd). Due to Brexit, the knowledge of 28 UK organisations will 
leave Europe. These organisations were involved in 8 of the 13 publications from EU and their 
departure will create significant perturbations in ongoing R&D activities. The only patent 
detected for this WS is owned by UCB based in Belgium.  
 
Brexit will have a significant impact in this weak signal if measures to reinforce currently 
ongoing research activities are not put in place. 
Targeted memory 
reactivation 
 
 
 
 
 
 
 
 
 
 
 
 
Top Countries (Publications) 
EU (25/12) 
US (21) 
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
1,2 
 
R&D and patenting started very recently for this weak signal. Europe leads in terms of scientific 
output, but with only 25 publications. Due to Brexit, half of this knowledge will leave Europe, 
leaving only 14 R&D organisations in a fragmented landscape.  
 
 
Brexit will have significant impact in this weak signal and measures to reinforce currently 
ongoing research activities and to promote patenting should be put in place. 
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EU is weak in knowledge production 
Weak signal Actors in Europe (not UK) Indicators Analysis and recommendations 
Synthetic Notch 
 
 
Top Countries (Publications) 
US (10)  
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
- 
R&D activities started very recently in this weak signal. All publications retrieved have been 
published by US organisations.  
 
Should this WS be deemed important, massive efforts will have to be made to support R&D in 
Europe and to make sure that the acquired knowledge is transformed into innovations protected 
by patents. There will be a risk of future technological dependency if this weak signal turns out 
to become an important technology. 
 
Transcriptome 
metabolome wide 
associat. 
 
 
Top Countries (Publications) 
US (5) 
South Korea (1) 
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
- 
All publications retrieved for this weak signal have been published by US and South Korea.  
 
Should this WS be deemed important, massive efforts will have to be made to support R&D in 
Europe and to make sure that the acquired knowledge is transformed into innovations protected 
by patents. There will be a risk of future technological dependency if this weak signal turns out 
to become an important technology. 
 
Double digest RAD 
Sequencing 
 
 Top Countries (Publications) 
US (58) 
 EU (33/31) 
China (19) 
Japan (18) 
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
1,075 
EU is second in production of scientific knowledge for this technology, even if Brexit is taken into 
account. The US is leading and China is not far behind. A small number of actors are active in 
Europe and the landscape is slightly fragmented. The risk here is to see US organisations 
continuing to lead and China catching up fast, leaving EU behind.  
 
The R&D activities in this WS should be monitored, and should it appear to be important for 
Europe, measures to support current ongoing R&D in Europe will have to be put in place (little 
knowledge so far and few actors). Measures to ensure that patenting activities are pursued will 
also need to be devised.  
Thanatomicrobiome 
 
 
Top Countries (Publications) 
US (38) 
 EU (14/8) 
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
0,5 
 
EU is second in production of scientific knowledge for this WS, with US leading. 24 organisations 
based in Europe have been detected as active in R&D in the field. They are already fairly well 
connected together. The risk here is to see US organisations continuing to lead and other 
countries catching up fast, leaving EU behind.  
 
The R&D activities in this WS should be monitored, and should it appear to be important for 
Europe, measures to support current ongoing R&D in Europe will have to be put in place (little 
knowledge so far and few actors). Measures to ensure that patenting activities are pursued will 
also need to be devised. 
7.4 Biology 
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Anti-CRISPR 
 
 Top Countries (Publications) 
US (50) 
Canada (24) 
EU (23/20) 
China (13)  
 
Patents Cont. Europe/World 
0/3 
 
Fragmentation  
0,85 
EU comes at the third place in terms of scientific publications, after the US and Canada. Despite 
the few actors in Europe, the research environment is not fragmented, which might be due to 
the 3 EU projects related to this technology. The 3 patents retrieved were all filed by US 
organisations.  
 
Should this WS be deemed important, some efforts will have to be made to reinforce R&D in 
Europe and create a network of knowledgeable actors. This could possibly be done through the 
EU funding programme Horizon Europe. Measures to ensure that knowledge is transformed into 
innovations and patents should also be considered.  
 
De-extinction 
 
 Top Countries (Publications) 
US (36) 
 EU (19/10) 
Australia (12)  
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
2 
 
Few publications and patents have been retrieved for this WS. With 36 publications, US leads in 
knowledge production. Almost half of the European knowledge in this technology is located in 
the UK. The number of actors in Europe is very small (10) and the landscape is fragmented. No 
patents were detected yet.  
 
Should this WS be deemed important, massive efforts will have to be made to create R&D 
activities in Europe and create a network of knowledgeable actors. This could possibly be done 
through the EU funding programme Horizon Europe.  
 
Acute 
hepatopancreatic 
necrosis disease 
 
 Top Countries (Publications) 
Thailand (53), US (34) 
China (26), Japan (16) 
EU (16/12)  
 
Patents Cont. Europe/World 
0/10 
 
Fragmentation  
2 
 
EU is lagging behind in terms of number of scientific publications in this weak signal which is led 
by organisations from Thailand. The number of actors in Europe is very small (8) and the 
landscape is fragmented. 10 patents were detected but none is owned by an organisations from 
the EU.  
 
Should this WS be deemed important, massive efforts will have to be made to create R&D 
activities in Europe and create a network of knowledgeable actors. This could possibly be done 
through the EU funding programme Horizon Europe. Measures to ensure that knowledge is 
transformed into patented innovations should also be considered. 
Diagnostics based 
on circular RNA 
 
 Top Countries (Publications) 
China (402) 
 EU (60/53) 
US (52)  
 
Patents Cont. Europe/World 
1/11 
 
Fragmentation  
0,86 
 
With 396 publications, China leads in knowledge production in this technology. Europe is second 
with 53 publications and an R&D landscape that shows some degree of collaborations between 
actors. One out of the 11 patents has been filed by a European organisation, all the others are 
owned by Chinese entities. 
 
Should this WS be deemed important, measures to further develop R&D in Europe, to connect 
R&D actors and to ensure that IP rights are obtained by European organisations should be 
implemented. There is a risk of technological dependency if Europe does not invest in patenting. 
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CRISPR/CPF1 
 
 Top Countries (Publications) 
US (92) 
China (84) 
 EU (42/34)  
 
Patents Cont. Europe/World 
2/39 
 
Fragmentation  
1,65 
 
Europe is in 3rd position in number of publications in this WS. The R&D landscape is slightly 
fragmented and only 2 out of the 39 patents retrieved are owned by European organisations. 
Organisations in China and the US owning respectively 21 and 10 patents.  
 
Should this WS be deemed important, measures to further develop R&D in Europe, to connect 
R&D actors and to ensure that IP rights are obtained by European organisations should be 
implemented. There is a risk of technological dependency. 
Bacillus velezensis 
 
 Top Countries (Publications) 
China (89) 
 EU (35/30)  
South Korea (33), US (25) 
 
Patents Cont. Europe/World 
1/59 
 
Fragmentation  
5,17 
Europe is in second in number of publications in this WS, behind China (third behind China and 
South Korea if Brexit is taken into account). The R&D landscape is highly fragmented and there 
are few European actors. Only 1 out of the 59 patents retrieved are owned by European 
organisations. Chinese and South Korean organisations own more than half of the patents 
(China: 33 patents, South Korea: 22 patents).  
 
Should this WS be deemed important, measures to further develop R&D in Europe, to connect 
R&D actors and to ensure that IP rights are obtained by European organisations should be 
implemented. There is a risk of technological dependency. 
Circular RNA 
 
Top Countries (Publications) 
China (1461) 
 EU (467/417) 
US (418)  
 
Patents Cont. Europe/World 
4/146 
 
Fragmentation  
0,68 
More than 2000 scientific publications related to circular RNA have been retrieved. China clearly 
leads, followed by EU and the US. Europe accounts only for around 18% of the publications in 
the field. There is a significant number of actors in Europe (336) and there is high level of 
collaboration (low fragmentation). Only 4 patents out of the 146 retrieved are owned by 
organisations in Europe (Germany). 13 patents are owned by US organisations, 121 by Chinese 
individuals or organisations. 
Europe does produce knowledge in this weak signal but account for less than 18% of the 
publications in the field. European organisations did not manage so far to translate this 
knowledge into innovations protected by patents. Measures to encourage R&D and the 
transformation of knowledge into innovations should be put in place to avoid future 
technological dependency. 
 
EU is weak in patenting 
Weak signal Actors in Europe (not UK) Indicators Analysis and recommendations 
Spytag spycatcher 
protein ligase 
 
 Top Countries (Publications) 
China (37), US (31) 
EU (28/13) 
  
Patents Cont. Europe/World 
0/6 
 
Fragmentation 
1,4 
30 out of the 88 scientific publications in this WS are from European organisations. With half of 
these published by (or in collaboration with) organisations located in the UK, Brexit will 
significantly disturb this nascent R&D community. Only 14 R&D organisations in Europe will be 
active after Brexit. In addition, none of the 6 patents retrieved was filed by an organisations 
from Europe (US:1, Australia:1, China:4). 
 
Should this WS be deemed important, measures to further develop R&D in Europe, to connect 
R&D actors and to ensure that IP rights are obtained by European organisations should be 
implemented. 
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Single cell RNA 
sequencing  
Top Countries (Publications) 
US (693) 
EU (418/283) 
China (161)  
 
Patents Cont. Europe/World 
0/8 
 
Fragmentation 
0,46 
34% of the scientific publications in this technology involve European organisations, placing EU 
at the second place in knowledge production after the US. But with 44% of these publications 
published by (or in collaboration with) organisations located in the UK, Brexit will significantly 
disturb the European R&D community. Nevertheless, even with UK organisations leaving EU, 
there will still be significant R&D actors in Europe, in a very well connected landscape (low 
fragmentation). In patenting, EU owns none of the patent out of the eight detected (US: 6, 
China:2). 
Should this WS be deemed important, measures to ensure that knowledge developed by 
European organisations are transformed into innovations and that IP rights are acquired should 
be implemented. 
 
Weak signals with Brexit-risk 
Weak signal Actors in Europe (not UK) Indicators Analysis and recommendations 
Assay for 
transposas-acc. 
chromat seq 
 Top Countries (Publications) 
US (210) 
EU (103/73) 
 China (26)  
 
Patents Cont. Europe/World 
0/5 
 
Fragmentation  
0,84 
In terms of publications, Europe is second for this weak signal behind China. As UK is involved or 
responsible for around 40% of the scientific publications, Brexit will disturb the R&D landscape 
in Europe. After Brexit, 98 R&D actors will still be active in Europe and they will be relatively well 
connected through scientific collaborations. In patenting, all patents are owned by Chinese 
organisations. 
 
Brexit will have significant impact in this weak signal if measures to reinforce research activities 
and patenting are not put in place. In addition, measures to support innovation in the field 
should be implemented. 
Retinal organoids  
Top Countries (Publications) 
US (38) 
EU (37/24) 
China (8)  
 
Patents Cont. Europe/World 
0/1 
 
Fragmentation  
1,04 
 
Europe occupies the second position in terms of publications. As UK is involved or responsible for 
around 43% of the scientific publications, Brexit will disturb the R&D landscape in Europe. After 
Brexit, only 24 R&D actors will still be active in Europe and they will be weakly connected. In 
patenting, only one patents was retrieved in this field and is owned by a US based company.  
 
Brexit will have significant impact in this weak signal if measures to reinforce research activities 
and patenting are not put in place. In addition, measures to support innovation in the field 
should be implemented. 
Spray-induced 
gene silencing 
 
Top Countries (Publications) 
US (7) 
EU (7/4) 
 
 
Patents Cont. Europe/World 
0/3 
 
Fragmentation: 4 
Europe and the US “lead” in this technology where R&D started very recently. 8 European 
organisations are involved and with Brexit, 4 of these will leave Europe and leave only 4 actors 
in EU. In patenting, none of the three patents is from an EU based organisations, but the field is 
very recent. All patents are owned by Monsanto. 
 
Brexit will cut in half the number of actors from Europe in this WS characterized by a very 
nascent R&D. Should the technology be deemed important for Europe, measures to reinforce 
research activities and patenting have to be in place. In addition, measures to support innovation 
in the field should be implemented to avoid technology dependency. 
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EU is weak in knowledge production 
Weak signal Actors in Europe (not UK) Indicators Analysis and recommendations 
Orthotospovirus 
 
 
Top Countries (Publications) 
US (12), India (7) 
 China, Brazil (5)  
EU (5/4) 
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
4 
 
Only 33 publications were retrieved for this WS, with the US leading. Very few publications from 
European organisations and very few actors. No patents were retrieved. 
 
Little R&D activity has been detected in this weak signal and it is too early to recommend specific 
support measures. The importance of this WS and the positioning of EU organisations should be 
monitored to ensure timely measures are put in place to support European actors if necessary.  
MK-8591 
 
 
Top Countries (Publications) 
US (12) 
EU (2/1) 
 
Patents Cont. Europe/World 
1/1 
 
Fragmentation  
2 
Very few publications were retrieved for this WS, with the US involved in 12 of the 13 scientific 
publications. In Europe, Spanish institutions have published on this topic. One patent was filed by a 
US-based organisation. 
 
Little R&D activities have been detected in this weak signal and it is too early to recommend 
specific support measures. The importance of this WS and the positioning of EU organisations 
should be monitored to ensure timely measures are put in place to support European actors if 
necessary.  
Grapevine red 
blotch virus 
 
 
Top Countries (Publications) 
US (37) 
EU (12/12)  
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
2,6 
52 publications were retrieved for this WS, with the US leading. Very few publications from 
European organisations and very few actors. No patents were retrieved. 
 
Little R&D activities have been detected in this weak signal and it is too early to recommend 
specific support measures. The importance of this WS and the positioning of EU organisations 
should be monitored to ensure timely measures are put in place to support European actors if 
necessary.  
Quantitative viral 
outgrowth assay 
HIV 
 
 Top Countries (Publications) 
 US (56) 
EU (14/12) 
Canada (13)  
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
0,31 
69 publications were retrieved for this WS .The US has a clear leading role with involvement in 56 
publications. 38 organisations in Europe are collaborating in this WS (low fragmentation). No 
patents were retrieved. 
 
This WS and the positioning of EU organisations should be monitored to ensure timely measures 
are put in place to support R&D by European actors if necessary. The US have taken a clear 
leading role and this could lead to technological dependency if European organisations do not 
engage in patenting. 
7.5 Viruses 
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Tomato mottle 
mosaic virus 
 
 Top Countries (Publications) 
US (8) 
China (7) 
EU (4/4)  
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
4 
Very few publications (18) were retrieved for this WS. 4 European organisations are active (4 
publications) but are not collaborating together. No patent were retrieved. 
 
Little R&D activities have been detected in this weak signal and it is too early to recommend 
specific support measures. The importance of this WS and the positioning of EU organisations 
should be monitored to ensure timely measures are put in place to support European actors if 
necessary.  
 
Porcine circovirus 3 
 
 
Top Countries (Publications) 
China (60) 
 EU (24/16) 
US (11)  
 
Patents Cont. Europe/World 
0/21 
 
Fragmentation  
1,125 
77 publications were retrieved for this WS. China leads with Chinese organisations taking part in 
60 publications, EU is second. 18 European organisations in Europe are engaged in R&D and are 
fairly well connected. Out of the 21 patents retrieved, 20 are owned by Chinese organisations. 
 
Should this WS be deemed important, measures to support R&D activities in Europe and to 
encourage European organisations to transform knowledge into innovations and that IP rights are 
acquired should be put in place. There is a risk of technological dependency if European 
organisations do not engage in patenting activities. 
Zika virus vaccine 
 Top Countries (Publications) 
US (122) 
 EU (53/35) 
 
Patents Cont. Europe/World 
3/29 
 
Fragmentation  
3,4 
 
The US lead this weak signal with 122 publications, well in front Europe (47). R&D organisations 
active in Europe are not collaborating much with each other (high fragmentation). 3 patents out of 
29 are owned by French organisations (Sanofi and Institut Pasteur). China and the US own the 
others.  
 
Should this WS be deemed important, measures to connect R&D actors and to ensure that IP 
rights are obtained by European organisations should be put in place. There is a risk of 
technological dependency if European organisations do not engage in patenting activities. 
 
EU is weak in patenting 
Weak signal Actors in Europe (not UK) Indicators Analysis and recommendations 
Atypical porcine 
pestivirus 
 Top Countries (Publications) 
China (20) 
EU (16/16) 
US (11) 
  
Patents Cont. Europe/World 
0/6 
 
Fragmentation 
0,58 
 
China leads for this weak signal in terms of publications. R&D actors in Europe are well connected. 
In patenting, Chinese and US organisations are owning the 6 patents retrieved.  
 
Should this WS be deemed important, measures will be needed to ensure that Europe continues to 
lead and to push patenting. 
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Weak signals with Brexit-risk 
Weak signal Actors in Europe (not UK) Indicators Analysis and recommendations 
Ebola vaccine 
 Top Countries (Publications) 
US (122) 
EU (80/53) 
 Switzerland (29)  
 
Patents Cont. Europe/World 
0/3 
 
Fragmentation  
0,54 
 
Europe comes second in terms of scientific publications for this weak signal. More than half of the 
publications from Europe involve organisations from the UK. Actors in Europe will remain fairly well 
connected after Brexit (low fragmentation). In patenting, no patent is owned by European 
organisations. 
 
20% of the R&D actors in Europe are based in the UK. Brexit will disturb the research environment 
but organisations in Europe should resist the perturbation. Measures to ensure Europe is able to 
patent its knowledge in this field should be put in place.  
Glecaprevir/Pibrentasvir 
 Top Countries (Publications) 
US (64) 
EU (41/36) 
 Japan (20)  
 
Patents Cont. Europe/World 
0/1 
 
Fragmentation  
0,54 
 
Europe comes second in terms of scientific publications for this WS. More than half of the 
publications from Europe involve organisations from the UK. Actors in Europe will remain fairly well 
connected (low fragmentation). The patent retrieved is owned by a US company. 
 
15 UK based organisations will leave Europe after Brexit. This should not affect too much R&D 
actors in Europe (83) which are fairly well connected, but measures to support this research 
ecosystem could be considered.  
Herpes zoster vaccine 
 
Top Countries (Publications) 
EU (29/23) 
US (28) 
 Australia (7)  
 
Patents Cont. Europe/World 
0/1 
 
Fragmentation  
0,55 
 
Europe and the US lead in R&D on Herpes Zoster Vaccine. 7 R&D organisations from the UK, 
including GSK, are involved (20% of the European actors). Organisations in Europe will remain 
connected (low fragmentation). 
 
Due to the low number of R&D organisations in Europe, Brexit could impact negatively currently 
ongoing R&D activities. Measures to support R&D actors active on this topic should be considered.  
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EU is weak in knowledge production 
Weak signal Actors in Europe (not UK) Indicators Analysis and recommendations 
Surface 
heterojunction 
photocatalytics 
 Top Countries (Publications) 
China (49) 
Saudi Arabia (5) 
 Taiwan (3) 
US , Japan, EU Australia (2) 
  
Patents Cont. Europe/World 
0/3 
 
Fragmentation  
1,25 
 
Europe (and other countries) is lagging behind for this weak signal, with China clearly leading. 
They are very few actors in Europe and little knowledge production. All three patents were filed by 
Chinese organisations.  
 
Should this WS be deemed important, significant support will have to be put in place to create 
R&D activities and patenting in Europe. There is very little knowledge in EU and there is a 
possibility of technological dependency. 
 
Twisted and coiled 
polymer muscles 
 
Top Countries (Publications) 
US (16) 
EU, China (1) 
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
- 
Europe is lagging behind for this weak signal, with US being clearly ahead in terms of publications. 
Only one research organisation from Europe was spotted.  
 
Should this WS be deemed important, significant support will have to be put in place to create 
R&D activities and patenting in Europe. There is very little knowledge in EU and there is a 
possibility of technological dependency. 
Phagraphene 
 
Top Countries (Publications) 
China (12), US (5) 
Russia (4), Brazil (3)  
EU (3/2) 
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
- 
 
Europe is lagging behind for this weak signal, with US being clearly ahead in terms of publications. 
Only one research organisation from Europe was spotted.  
 
Should this WS be deemed important, significant support will have to be put in place to create 
R&D activities and patenting in Europe. There is very little knowledge in EU and there is a 
possibility of technological dependency. 
Perovskite 
photodetectors 
 Top Countries (Publications) 
China (136) 
 US (41) 
EU (19/12)  
 
Patents Cont. Europe/World 
0/4 
 
Fragmentation  
4 
 
Chinese organisations are leading in publishing in this WS. There are very few R&D organisations 
from Europe engaged in R&D on this topic. The 4 patents detected were filed by Chinese 
organisations. 
 
Should this WS be deemed important, significant supporting measures will have to be put in place 
to support R&D and to push innovation. There is very little knowledge in EU and there is a 
possibility of technological dependency. 
7.6 Materials 
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Bimetallic organic 
frameworks 
 Top Countries (Publications) 
China (115) 
 US (21) 
EU (20/19)  
 
Patents Cont. Europe/World 
0/3 
 
Fragmentation  
3,6 
 
Chinese organisations are leading in publishing in this WS. There are few R&D organisations from 
Europe engaged in R&D on this topic, and they are not well connected through scientific 
collaboration. The 3 patents retrieved were filed by Chinese organisations. 
 
Should this WS be deemed important, significant supporting measures will have to be put in place 
to support R&D and to push innovation. There is very little knowledge in EU and there is a 
possibility of technological dependency. 
Pet-Raft 
polymerisation 
 
Top Countries (Publications) 
China (48)  
Australia (24) 
 US (19)  
EU (8)  
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
3 
 
Europe is lagging behind for this weak signal, with China being clearly ahead in terms of 
publications. Out of the 8 publications retrieved for Europe, 5 are from UK based organisations. 
After Brexit, only 3 organisations will be active on this topic in Europe. No patents were retrieved. 
 
Should this WS be deemed important, significant support will have to be put in place to create 
R&D activities and patenting in Europe. There is very little knowledge in EU and there is a 
possibility of technological dependency. 
Cr2Ge2Te6 
 
 Top Countries (Publications) 
China (21), US (13) 
Japan (10), South Korea (4)  
EU (4/3) 
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
2,5 
 
Europe is behind in this weak signal, with China leading in terms of publications. 5 organisations 
from Europe have published on the topic. No patents were retrieved. 
 
Should this WS be deemed important, significant support will have to be put in place to create 
R&D activities and patenting in Europe. There is very little knowledge in EU and there is a 
possibility of technological dependency. 
0d 2d 
heterostructures 
 
 Top Countries (Publications) 
China (116) 
 US (43) 
EU (31/21)  
 
Patents Cont. Europe/World 
0/1 
 
Fragmentation  
2,11 
 
EU occupies the third place in terms of scientific publications. China is in the lead. 19 
organisations in Europe are engaged in R&D in this particular technology. Despite 2 EU projects on 
the matter, the R&D landscape in Europe could be more collaborative. The patent retrieved is 
owned by a Chinese organisation.  
 
In this WS, measures to support R&D should be put in place. There is some knowledge developed 
in Europe on which to rely on. Patenting should be pushed whenever possible. 
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Renal clearable 
nanoparticles 
 
 Top Countries (Publications) 
China (25) 
 US (25) 
EU (7/6)  
 
Patents Cont. Europe/World 
0/2 
 
Fragmentation  
2 
 
Europe is behind in this weak signal, with China and the US leading in terms of publications. Only 
10 organisations from Europe have published on the topic. The two patents retrieved were filed by 
US organisations. 
 
Should this WS be deemed important, significant support will have to be put in place to create 
R&D activities and patenting in Europe. There is very little knowledge in EU and there is a 
possibility of technological dependency. 
Borophane 
 
 
Top Countries (Publications) 
China (14) 
 EU (4/4)  
US (3) 
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
4 
 
Only 24 scientific publications have been retrieved. Europe is behind (so are other countries), China 
leads. Only 4 organisations from EU have been involved in knowledge production. No patents were 
retrieved for this weak signal. 
 
The evolution of this WS should be monitored. If it turns out to be of strategic relevance 
(important innovations related to it), significant measures to support R&D in Europe will have to 
be put in place. There is very little knowledge in EU and there is a possibility of technological 
dependency. 
Tin selenide 
crystals 
 
 Top Countries (Publications) 
China (80) 
EU (31/28)  
 US (28) 
 
Patents Cont. Europe/World 
0/5 
 
Fragmentation  
1,26 
 
EU and the US occupy the 2nd and 3rd position in terms of publications, behind China. 44 
organisations in Europe are engaged in R&D activities. The collaboration landscape could be 
denser (slight fragmentation). The 5 patent retrieved are owned by Chinese organisations.  
 
In this WS, measures to support R&D and increase the degree of collaboration should be put in 
place. There is some knowledge to rely on in Europe. Transformation of knowledge into 
innovations and patents should be encouraged. 
Bismuthene 
 
 
Top Countries (Publications) 
China (37) 
 US (13) 
EU (10/10)  
 
Patents Cont. Europe/World 
0/3 
 
Fragmentation  
7/1 
 
Only 50 publications and 3 patents were retrieved for this WS. China leads in publications and 
patenting. In Europe, the 6 organisations engaged in R&D do not collaborate together (high 
fragmentation).  
 
The evolution of this WS should be monitored. If it turns out to be of strategic relevance 
(important innovations related to it), significant measures to support R&D in Europe will have to 
be put in place as there is very little knowledge in EU and very few actors. 
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Nanocinnamon  
Top Countries (Publications) 
Malaysia (7) 
EU (3/2)  
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
- 
 
Very few publications have been retrieved for this weak signal. Only one organisation in Europe 
has some research activities. 
 
The evolution of this WS should be monitored. If it turns out to be of strategic relevance 
(important innovations related to it), significant measures to support R&D in Europe will have to 
be put in place as there is very little knowledge in EU and only one actor. 
Hologram 
metasurface 
 
 Top Countries (Publications) 
China (119) 
 US (90) 
EU (51/28)  
 
Patents Cont. Europe/World 
0/4 
 
Fragmentation  
2,375 
 
EU occupies the third place in terms of scientific publications. China is in the lead. After Brexit, 19 
organisations in Europe will be engaged in R&D in this particular technology. The R&D landscape 
in Europe could be more collaborative. The patents retrieved are owned by US, Taiwanese, and 
Chinese organisations.  
 
In this WS, measures to support R&D should be put in place. There is some knowledge developed 
in Europe on which to rely on. Patenting should be encouraged to avoid future technology 
dependency. 
Acoustic 
metasurface 
 
 Top Countries (Publications) 
China (118) 
 EU (41/30) 
US (39)  
 
Patents Cont. Europe/World 
0/3 
 
Fragmentation  
2,33 
 
EU is second behind China in terms of scientific publications. Only 14 organisations in Europe are 
engaged in R&D in a slightly fragmented landscape. All three patents are owned by Chinese 
organisations.  
 
In this WS, measures to support R&D should be put in place. There is some knowledge developed 
in Europe on which to rely on. Patenting has started and measures to encourage EU organisations 
to innovate should be put in place to avoid future technology dependency. 
Stanene 
 
 Top Countries (Publications) 
China (99) 
 EU (54/47)  
US (53) 
 
Patents Cont. Europe/World 
0/4 
 
Fragmentation  
1,52 
 
EU and the US are second behind China in terms of scientific publications. 38 organisations in 
Europe are engaged in R&D in a slightly fragmented landscape. The retrieved patents are owned 
by Chinese and Malaysian organisations.  
 
In this WS, measures to support R&D should be put in place. Patenting activity has started and 
measures to encourage EU organisations to innovate should be put in place to avoid future 
technology dependency. 
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PbTaSe2 
superconductor 
 
 Top Countries (Publications) 
China (15), US (12) 
Taiwan (9) 
EU (5/5)  
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
2,5 
 
Only 24 scientific articles were retrieved. China and the US are involved in most of the 
publications, Europe is fourth in terms of publishing. Only 5 organisations performing R&D on this 
topic have been spotted in Europe. No patents were retrieved. 
 
The evolution of this WS should be monitored. If it turns out to be of strategic relevance 
(important innovations related to it), significant measures to support R&D in Europe will have to 
be put in place as there is very little knowledge in EU and very few actors. 
Eutectic high 
entropy alloy 
 
 
Top Countries (Publications) 
China (38) 
 EU (13/13) 
India (11)  
 
Patents Cont. Europe/World 
0/2 
 
Fragmentation  
1,33 
 
China leads for this technology in terms of scientific publications, with EU second. There are only 8 
organisations in Europe active in R&D. The 2 patents retrieved are owned by Chinese 
organisations.  
 
The evolution of this WS should be monitored. If it turns out to be of strategic relevance 
(important innovations related to it), significant measures to support R&D in Europe will have to 
be put in place as there is very little knowledge in EU and very few actors. 
Arsenene 
 Top Countries (Publications) 
China (123) 
 EU (27/25) 
US (25)  
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
0,85 
 
China leads by far for this weak signal in terms of scientific publications, with EU and the US 
second. 29 European organisations are performing research. No patents were retrieved.  
 
The evolution of patenting for this WS should be monitored. If the patent race started, measures 
will be needed to encourage patenting by organisations in EU. If it turns out to be of strategic 
relevance, measures to support R&D in Europe will have to be put in place as there is very little 
knowledge in EU and few actors. 
Biomimetic 
nanoparticles 
 
 Top Countries (Publications) 
US (60) 
China (52) 
EU (29/28)  
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
1,22 
 
US and Chinese organisations lead in scientific publications for this WS. Europe lags a bit behind. 
There are 39 actors in Europe in a fairly well connected collaborative landscape. No patents have 
been retrieved for this technology. 
 
Should this WS be deemed important, measures to support R&D actors in Europe should be put in 
place. There is some knowledge developed in Europe on which to rely on. Patenting has not started 
yet and measure to encourage EU organisations to innovate should be put in place to avoid future 
technology dependency. 
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PET hydrolytic 
enzymes 
 
 Top Countries (Publications) 
China (7) 
 EU (4/2) 
Japan (3) 
US (2)  
 
Patents Cont. Europe/World 
0/2 
 
Fragmentation  
2 
 
Only 14 scientific articles were retrieved and no leading role can be attributed at this point. Only 4 
actors were detected in Europe. The two patents retrieved are owned by Chinese entities. 
 
The evolution of this WS should be monitored. If it turns out to be of strategic relevance 
(important innovations related to it), significant measures to support R&D in Europe will have to 
be put in place as there is very little knowledge in EU and very few actors. Patenting activities 
should be encouraged as well. 
FASnI3 perovskite 
 
 Top Countries (Publications) 
US (21) 
China (17) 
EU (13/11)  
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
4,5 
 
45 scientific publications were retrieved, with US and China taking a leading role. In Europe, 9 
organisations are engaged in research in this topic. The collaboration landscape is fragmented. No 
patents were retrieved.  
 
Should this WS be deemed important, measures to support R&D actors in Europe should be put in 
place. There is some knowledge developed in Europe on which to rely on. Patenting has not started 
yet and measure to encourage EU organisations to innovate should be put in place to avoid future 
technology dependency. 
Alkaline hydrogen 
evolution reaction 
 
 Top Countries (Publications) 
China (69) 
 EU (43/37) 
US (25)  
 
Patents Cont. Europe/World 
0/3 
 
Fragmentation  
1,63 
 
Chinese organisations lead in scientific publications for this technology, with Europe at the second 
position, even if Brexit is taken into account. There are 31 actors in Europe in a slightly 
fragmented collaborative landscape. No patents from EU for this technology. 
 
Should this WS be deemed important, measures to support R&D actors in Europe should be put in 
place. There is some knowledge developed in Europe on which to rely on. Measures to encourage 
EU organisations to innovate should be put in place to avoid future technology dependency. 
MASnI3 perovskite 
 
 Top Countries (Publications) 
 US (14) 
EU (12/11) 
Japan (10) 
China (10)  
 
Patents Cont. Europe/World 
0/1 
 
Fragmentation  
5 
 
45 scientific publications were retrieved for this material. No clear leading role can be attributed 
at this stage. In Europe, 10 organisations are engaged in research. The collaboration landscape is 
fragmented. The patent retrieved belongs to a Chinese organisation.  
 
Should this WS be deemed important, measures to support R&D actors in Europe should be put in 
place. There is some knowledge developed in Europe on which to rely on. Patenting has not started 
yet and measure to encourage EU organisations to innovate should be put in place to avoid future 
technology dependency. 
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Single atom 
catalysis 
 Top Countries (Publications) 
China (85) 
 US (30) 
EU (29/25)  
 
Patents Cont. Europe/World 
0/1 
 
Fragmentation  
1 
 
Chinese organisations lead in scientific publications for this WS, with Europe coming third shortly 
after the US. There are 33 actors in Europe in a fairly well connected collaboration landscape. The 
patent that was retrieved for this technology is owned by a Chinese organisation. 
 
Should this WS be deemed important, measures to support R&D actors in Europe should be put in 
place. There is some knowledge developed in Europe on which to rely on. Measures to encourage 
EU organisations to innovate should be put in place to avoid future technology dependency. 
Molybdenum 
disulfide quantum 
dots 
 
 
Top Countries (Publications) 
China (82), India (11), 
 US (8), South Korea (5),  
EU (5/4) 
 
Patents Cont. Europe/World 
0/28 
 
Fragmentation  
2,5 
 
China clearly leads in this technology with 58 scientific publications and all of the 28 patents 
belonging to Chinese organisations. Europe lags behind with other countries, and after Brexit only 
5 actors in Europe have been spotted.  
 
Should this WS be deemed important, significant measures to support R&D in Europe should be 
put in place (very little knowledge in Europe on which to rely on). Measures to encourage EU 
organisations to innovate should be put in place to avoid future technology dependency. 
Perovskite 
quantum dots 
 
 Top Countries (Publications) 
China (389), US (66) 
EU (43/27)  
South Korea (37) 
 
Patents Cont. Europe/World 
0/133 
 
Fragmentation  
2,72 
China clearly leads in this technology with 291 scientific publications (far more than the US or EU) 
and with most of the patents belonging to Chinese organisations. Europe comes third in terms of 
scientific publications (4th if Brexit is taken into account) and the collaboration landscape appears 
to be fragmented. None of the 133 patents retrieved turns out to be owned by a European 
organisation. Chinese organisations or individuals own 128 of the patents 
 
Should this WS be deemed important, measures to support R&D in Europe should be put in place 
(there is some knowledge in Europe on which to rely on). Europe lags behind in terms of patenting 
and measures to encourage EU organisations to innovate should be put in place to avoid future 
technology dependency. 
Perovskite 
nanowires 
 
 Top Countries (Publications) 
China (103) 
 US (46) 
EU (20/15)  
 
Patents Cont. Europe/World 
0/18 
 
Fragmentation  
1 
China clearly leads in this technology with 92 scientific publications (twice as more than the US 
and four times more than EU) and with 17 out of the 18 patents belonging to Chinese 
organisations. Europe comes third in terms of scientific publications with a fairly well connected 
collaborative landscape in Europe. None of patents retrieved is owned by a European organisation. 
Ownership of the patents: China 15, US 2, South Korea 1. 
 
Should this WS be deemed important, measures to support R&D in Europe should be put in place. 
Europe lags behind in terms of patenting and measures to encourage EU organisations to innovate 
should be put in place to avoid future technology dependency. 
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Wearable energy 
storage 
 
 
Top Countries (Publications) 
China (203), US (75) 
EU (47/26) 
South Korea (36)  
 
Patents Cont. Europe/World 
2/68 
 
Fragmentation  
1 
 
China clearly leads in this technology with 181 scientific publications (significantly more than the 
US and EU). If Brexit is taken into account, Europe is fourth in terms of scientific publications. 42 
research organisations are active in Europe and collaborate together (fragmentation=1). 3 patents 
retrieved were filed by a European organisations or individuals (Philips 2). US: 19 patents, China: 
28, South Korea: 10. 
 
Should this WS be deemed important, measures to support R&D in Europe should be put in place. 
Europe lags behind in terms of patenting and measures to encourage EU organisations to innovate 
should be put in place to avoid future technology dependency. 
Titanium carbides 
 
 Top Countries (Publications) 
China (421) 
 US (184) 
EU (84/66)  
 
Patents Cont. Europe/World 
0/44 
 
Fragmentation  
1,81 
 
China clearly leads in this technology in terms of scientific publications (significantly more than 
the US and EU). 49 research organisations are active in Europe and could collaborate more 
together. None of the patents retrieved is owned by an organisation in Europe (43 of the patents 
are owned by Chinese organisations, 1 by a US entity).  
 
Europe is behind in knowledge production and patenting for this WS. Should it be deemed 
important, significant measures will have to be put in place to support R&D actors and encourage 
them to innovate and patent to avoid future technology dependency. 
Planar perovskites 
 
 Top Countries (Publications) 
China (722) 
 US (205) 
EU (191/136)  
 
Patents Cont. Europe/World 
0/23 
 
Fragmentation  
1,15 
China leads in this technology in terms of scientific publications (significantly more than the US 
and EU). Even if there will a significant loss of knowledge due to Brexit, Europe remains third in 
knowledge production. 113 organisations in Europe are engaged in research on this topic and they 
fairly well collaborate together (fragmentation close to 1). China owns more than half of the 23 
patents retrieved (15), followed by South Korea (5), US (2) and Canada (1).  
 
There is production of knowledge in Europe for this WS. Other countries have started to apply for 
patents and there is a risk of technology dependency should European organisations not engage in 
transforming their knowledge into innovations. Measures should be put in place to encourage 
patenting. 
Borophene 
 
 
Top Countries (Publications) 
China (150) 
 US (57) 
EU (44/37)  
 
Patents Cont. Europe/World 
0/6 
 
Fragmentation  
1,74 
China leads in this technology in terms of scientific publications (3 times more than EU and the 
US). Europe is at the third position behind the US. Only 33 organisations in Europe are engaged in 
research on this topic, in a fragmented collaboration landscape (fragmentation at 1,74). Four of 
the six patents retrieved are owned by US organisations, one by a Japanese entity, and one by a 
Chinese organisation. 
 
There is a risk for future technology dependence in this WS. There is indeed less production of 
knowledge in Europe and although patenting has recently started for this WS, Europe does not 
own any patents. Should this WS be deemed important for EU, significant measures will have to 
be put in place to support research and patenting. 
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Phosphorene 
 
 
Top Countries (Publications) 
China (699) 
 US (421) 
EU (274/226)  
 
Patents Cont. Europe/World 
0/77 
 
Fragmentation  
0,93 
Europe is third in terms of scientific publications for this material, behind China and the US. 164 
organisations in Europe are engaged in research on this topic and they fairly well collaborate 
together (fragmentation close to 1). China leads in patenting (57 patents out of 77), Japan is 
second (10) and South Korea third (6). None of the patents is owned by an organisation based in 
Europe.  
 
There is production of knowledge in Europe for this WS. Other countries have started to apply for 
patents and there is a risk of technology dependency should European organisations not engage in 
transforming their knowledge into innovations. Measures should be put in place to encourage 
patenting. 
Cesium lead halide 
perovskite 
 
 Top Countries (Publications) 
China (861) 
 US (312) 
EU (283/212)  
 
Patents Cont. Europe/World 
0/111 
 
Fragmentation  
0,86 
Europe is third in terms of scientific publications in this weak signal, behind the US and China 
(which clearly leads). 150 organisations in Europe are engaged in research on this topic and they 
fairly well collaborate together (fragmentation < 1). China also leads in patenting, with 108 out of 
the 111 patents detected owned by Chinese organisations or individuals. None of the patents is 
owned by an organisation based in Europe.  
 
There is production of knowledge in Europe for this WS. China owns most of the patents on this 
topic so far and there is a risk of technology dependency should European organisations not 
engage in transforming their knowledge into innovations. Measures could be put in place to 
encourage patenting. 
Antimonene 
 
 Top Countries (Publications) 
China (139) 
 EU (40/38)  
US (21) 
 
Patents Cont. Europe/World 
0/14 
 
Fragmentation  
1,06 
China leads in this technology in terms of scientific publications. Europe occupies the second 
position. Only 34 organisations in Europe are engaged in research on this topic, in a slightly 
fragmented collaboration landscape (fragmentation at 1,06). All of the 14 patents detected are 
owned by Chinese organisations. 
 
There is a risk for future technology dependence in this WS. There is relatively little production of 
knowledge in Europe and although patenting has recently started for this WS, Europe does not 
own any patents. Should this WS be deemed important for EU, significant measures will have to 
be put in place to support research and patenting. 
Perovskite LEDs 
 
 Top Countries (Publications) 
China (225) 
EU (96/56)  
 US (70) 
 
Patents Cont. Europe/World 
0/46 
 
Fragmentation  
1,53 
Europe is second in terms of scientific publications in this WS, behind China. 19 Organisations 
from the UK are involved in more than 50% of the publications from Europe. 49 organisations 
engaged in research will remain in in a slightly fragmented landscape (fragmentation > 1). China 
also leads in patenting, with 38 out of the 46 patents detected owned by Chinese organisations 
(South Korea: 6, US: 1; UK:1). None of the patents is owned by an organisation based in Europe.  
 
Brexit will impact research in Europe in this topic but some knowledge in Europe will remain (49 
active organisations). China owns most of the patents on this topic so far and there is a risk of 
technology dependency should European organisations not engage in transforming their 
knowledge into innovations. Measures could be put in place to encourage patenting and support 
research. 
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Perovskite 
nanocrystals 
 
 
Top Countries (Publications) 
China (365) 
 EU (181/141)  
US (170) 
 
Patents Cont. Europe/World 
0/34 
 
Fragmentation  
0,78 
Europe is second in terms of scientific publications in this WS, well behind China and close to the 
US. 102 Organisations from Europe actively engaged in research and are well connected together 
through scientific collaborations (fragmentation < 1). China and South Korea lead in patenting 
with respectively 17 and 11 patents registered. None of the patents is owned by an organisation 
based in Europe.  
 
Europe develops knowledge on this topic but lags behind in patenting. To avoid future technology 
dependency, European organisations should be encouraged to transform their knowledge into 
innovations protected by patents.  
Lead free 
perovskite 
 
 Top Countries (Publications) 
China (253) 
 EU (141/96) 
US (118)  
 
Patents Cont. Europe/World 
1/31 
 
Fragmentation  
1,57 
Europe is second in terms of scientific publications for this material, but falls behind the US hen 
Brexit is taken into account. Both the US and Europe are well behind China with 242 publications. 
107 organisations are active in Europe, but with Brexit leading 24 UK based organisations to leave 
the European networks, only 83 Organisations from Europe will remain in a slightly fragmented 
research environment. China and Japan lead in patenting with respectively 15 and 11 patents 
registered. 1 patent is owned by an organisation based in Europe (University of Madrid).  
 
Europe develops knowledge on this topic but lags behind in patenting. To avoid future technology 
dependency, European organisations should be encouraged to transform their knowledge into 
innovations protected by patents. 
Metasurface lens 
 
 Top Countries (Publications) 
China (210) 
 US (139) 
EU (103/74)  
 
Patents Cont. Europe/World 
1/23 
 
Fragmentation  
2,23 
China leads in this technology in terms of scientific publications. Europe occupies the third position 
with 102 publications. After Brexit, 58 organisations in Europe ill remain engaged in research on 
this topic, in a fragmented collaboration landscape (fragmentation = 2). US is first in patenting (13 
patents out of 23), followed by China with 6 patents. One patent is owned by a European 
organisation (CEA, France). 
 
There is a risk for future technology dependence in this WS. There is some knowledge to rely on in 
Europe, but EU lags behind in patenting. If this weak signal appears to be of strategic importance, 
strong measures will have to be put in place to support research and patenting by EU 
organisations. 
Wearable flexible 
electronic 
 Top Countries (Publications) 
China (300) 
EU (236/152)  
 US (176) 
 
Patents Cont. Europe/World 
4/59 
 
Fragmentation  
1,575 
Europe is second in terms of scientific publications, and Europe third behind the US after Brexit. 
126 organisations in Europe are performing research on this technology. The landscape of 
collaboration is slightly fragmented. China leads in patenting with 29 patents registered so far. 
The US is second in patenting with 11 patents and é patents has been filed by the Siemens and 
Nokia. It should be noted that the two patents retrieved from Nokia and Siemens both date back 
to 2001 and will soon fall in the public domain.  
 
Europe develops knowledge on this topic but lags behind in patenting. To avoid future technology 
dependency, European organisations should be encouraged to continue R&D activities and to 
transform their knowledge into innovations protected by patents. 
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EU is weak in patenting 
Weak signal Actors in Europe (not UK) Indicators Analysis and recommendations 
Wearable IoT 
 
 Top Countries (Publications) 
 US (125) 
EU (96/72) 
South Korea (39), China (36)  
 
Patents Cont. Europe/World 
0/26 
 
Fragmentation  
1,76 
Europe is second to the US in terms of scientific publications. 81 organisations in Europe are 
performing research on this technology. As can be seen on the graphic, some degree of 
collaboration is ongoing between R&D organisations but the landscape is slightly fragmented 
(fragmentation > 1). Patenting is led by the US (10 patents), followed by South Korea (8 patents) 
and China (7). None of the patents retrieved is owned by an organisation based in Europe. 
 
Europe develops knowledge on this topic but lags behind in patenting. To avoid future technology 
dependency, European organisations should be encouraged to transform their knowledge into 
innovations protected by patents. 
MoTe2 
 
 Top Countries (Publications) 
China (193) 
 US (149) 
EU (142/121)  
 
Patents Cont. Europe/World 
0/14 
 
Fragmentation  
1,11 
Europe is third in terms of publishing of scientific publications. 108 organisations in Europe are 
performing research on this technology. As can be seen on the graphic, some degree of 
collaboration is ongoing between R&D organisations (fragmentation ~ 1). China leads in patenting 
as well, with 8 of the 14 patents retrieved, while the US owns 3 and South Korea, Japan and the 
UK own 1 patent each. None of the patents retrieved is owned by an organisation based in Europe. 
 
Europe develops knowledge on this topic but lags behind in patenting. To avoid future technology 
dependency, European organisations should be encouraged to transform their knowledge into 
innovations protected by patents. 
FAPbI3 perovskite 
 
 
Top Countries (Publications) 
China (158) 
 EU (121/93)  
US (84) 
 
Patents Cont. Europe/World 
0/10 
 
Fragmentation  
1,12 
Europe occupies the second position in terms of publishing of scientific publications. 86 
organisations in Europe are performing research on this technology. As can be seen on the graphic, 
some degree of collaboration is ongoing between R&D organisations (fragmentation ~ 1). China 
leads in patenting with 6 patents out of the 10 patents retrieved. None of the patents retrieved is 
owned by an organisation based in Europe. 
 
Europe develops knowledge on this topic but lags behind in patenting. To avoid future technology 
dependency, European organisations should be encouraged to transform their knowledge into 
innovations protected by patents. 
Adaptative 
metasurface 
 
 Top Countries (Publications) 
 China (90) 
EU (72/54) 
US (68) 
  
Patents Cont. Europe/World 
0/24 
 
Fragmentation 
1,15 
225 publications and 24 patents were retrieved for this weak signal. Europe is second to China in 
terms of publications in the field. R&D actors in Europe could be slightly more connected 
(fragmentation ~ 1). Despite ongoing R&D activities, none of the patents retrieved for this 
technology have been registered by an organisation from Europe. US leads in patenting with 15 
patents, followed by china (8) and South Korea (1). 
 
Europe develops some knowledge on this topic but lags behind in patenting. To avoid future 
technology dependency, European organisations should be encouraged to transform their 
knowledge into innovations protected by patents. 
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Natural deep 
eutectic solvents 
 Top Countries (Publications) 
EU (97/84)  
China (31) 
 US (15) 
 
Patents Cont. Europe/World 
1/7 
 
Fragmentation  
1,2 
185 publications were retrieved for this technology. Europe leads in terms of scientific 
publications. R&D actors in Europe could be slightly more connected (fragmentation ~ 1). One 
patent was filed by an organisation in Europe (TU Eindhoven). China owns four patents, the US and 
South Korean one patent each. 
 
Europe develops some knowledge on this topic but lags behind in patenting. To avoid future 
technology dependency, European organisations should be encouraged to transform their 
knowledge into innovations protected by patents. 
 
 
 
Weak signals with Brexit-risk 
Weak signal Actors in Europe (not UK) Indicators Analysis and recommendations 
Nonlinear metasurface 
 Top Countries (Publications) 
US (87) 
EU (57/43) 
China (37)  
 
Patents Cont. Europe/World 
0/2 
 
Fragmentation  
2,27 
Europe is second in knowledge production for this technology, but organisations from UK are 
involved in more than 40% of the publications from Europe. 8 actors will leave the EU after the 
Brexit, which will disturb the ongoing R&D activities in Europe.  
 
Brexit might impact R&D activities in this technology in Europe and measures to accompany the 
transition should be considered.  
Dihydrolevoglucosenone 
 
Top Countries (Publications) 
EU (13/4)  
Australia (8) 
 US (5) 
 
Patents Cont. Europe/World 
1/2 
 
Fragmentation  
4 
Europe leads in number of scientific publications in this technology, but 8 out of the 13 
publications retrieved have been published solely by UK organisations. R&D activities in Europe will 
be disturb by Brexit (e.g. Merck was collaborating with UK).  
 
Brexit will impact R&D activities in this technology in Europe and measures to accompany the 
transition should be considered. 
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EU is weak in knowledge production 
Weak signal Actors in Europe (not UK) Indicators Analysis and recommendations 
Photoelectrochemical 
aptasensors 
 
 
Top Countries (Publications) 
China (72) 
 EU (2)  
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
- 
 
Chinese organisations are responsible for 72 out of the 76 publications retrieved. In Europe, only 
two French organisations have published about this technology. No patents were retrieved. 
 
Should this WS be deemed important, significant efforts will have to be made to create R&D and 
push innovation in Europe. There is almost zero knowledge in EU and the possibility of a future 
technological dependency should not be underestimated. 
Photoelectrochemical 
immunosensors 
 
 
Top Countries (Publications) 
China (84) 
US (5) 
EU (4) 
 
Patents Cont. Europe/World 
0/5 
 
Fragmentation  
- 
Chinese organisations are responsible for 84 out of the 91 publications retrieved. In Europe, only 
two French organisations have published 4 scientific articles about this technology. The five 
patents retrieved are all owned by Chinese organisations. 
 
Should this WS be deemed important, significant efforts will have to be made to create R&D and 
push innovation in Europe. There is almost zero knowledge in EU and the possibility of a future 
technological dependency should not be underestimated. 
Photoinduced force 
microscopy 
 
 Top Countries (Publications) 
US (32) 
South Korea (6) 
EU (5), China (4)  
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
3 
With only 5 publications retrieved, Europe is lagging behind in this technology. The US are leading 
the R&D. Only 6 organisations from Europe have published. No patents was retrieved.  
 
Should this WS be deemed important, massive efforts will have to be made to start R&D activities 
in Europe. There is almost zero knowledge in EU and the possibility of a future technological 
dependency should not be underestimated. 
Spatial heterodyne 
raman spectrometer 
 
 
Top Countries (Publications) 
US (20) 
China (10) 
EU (4/1)  
 
Patents Cont. Europe/World 
0/4 
 
Fragmentation  
- 
Chinese and US organisations lead in this technology in terms of publications. Europe comes third 
with 4 publications, out of which 3 are from the UK. After Brexit, the landscape of R&D activities 
will consist in one organisation. None of the patents retrieved was filed by an organisation from 
Europe (China: 3, US: 1). 
 
Should this WS be deemed important, strong measures will have to be implemented to create 
R&D in Europe and to foster innovation. There is almost no knowledge in EU and the possibility of 
a future technological dependency should not be underestimated. 
7.7 Physics and Engineering 
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Underwater wireless 
power transfer 
 
 
Top Countries (Publications) 
China (13) 
 Japan (9), US (8) 
EU (6)  
 
Patents Cont. Europe/World 
0/2 
 
Fragmentation  
- 
Only 34 scientific publications and 2 patents have been retrieved. In Europe, publications from 
only three organisations have been retrieved (EU occupies the fourth place). The two patents 
retrieved belong to a Japanese (1) and a South Korean organisations (1). 
 
Should this WS be deemed important, massive efforts will have to be made to induce R&D in 
Europe and create a network of knowledgeable organisations. Measures to ensure that knowledge 
is transformed into innovations and patents should also be considered.  
 
Stretchable strain 
sensor 
 
 
Top Countries (Publications) 
China (59) 
South Korea (36)  
US (17) 
EU (14/8) 
  
Patents Cont. Europe/World 
0/7 
 
Fragmentation  
5 
China and South Korea have taken the lead in this weak signal. 14 publications have been 
retrieved for Europe, out of which 6 are from UK organisations. 5 actors are active in R&D in 
Europe. None of the patents retrieved belongs to an organisation from Europe (US: 4, China: 2, 
South Korea: 1). 
 
Should this WS be deemed important, strong measures will have to be implemented to create 
R&D in Europe and to foster innovation. There is almost no knowledge in EU and the possibility of 
a future technological dependency should not be underestimated. 
Capacitive wireless 
power transfer 
 
 Top Countries (Publications) 
US (63) 
China (57) 
EU (35/28)  
 
Patents Cont. Europe/World 
1/16 
 
Fragmentation  
4,6 
China and the US have taken the lead in this weak signal. Europe is third in publications (35). 5 
actors are active in R&D in Europe and the degree of collaboration is very low (high 
fragmentation). One patents out of the 16 retrieved has been registered by an organisation from 
Europe (Phillips). (China: 7, US: 5). 
 
Should this WS be deemed important, strong measures will have to be implemented to further 
develop R&D activities in Europe and to foster innovation. There is little knowledge in EU and the 
possibility of a future technological dependency should not be underestimated. 
Visible light 
positioning 
 
 
Top Countries (Publications) 
China (113) 
 EU (30/12)  
US (21) 
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
2 
China leads in this weak signal, well in front of EU and the US. Out of the 30 publications retrieved 
for EU, 13 are made by or in collaboration with UK organisations (with one big actor, Northumbria 
University, involved in 8 publications). Brexit will therefore perturb the knowledge production 
landscape for this technology in Europe, leaving only 8 organisations engaged in R&D and not 
collaborating together. No patents have been retrieved. 
 
If this technology is deemed of some importance, strong measures will be needed to accompany 
R&D actors in Europe during the Brexit-transition, to increase the number of R&D actors and 
reinforce collaborations, and to encourage the development of innovations. 
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Cold sintering 
process 
 
 Top Countries (Publications) 
US (44) 
EU (29/15)  
China (27) 
 
Patents Cont. Europe/World 
1 (expired)/20 
 
Fragmentation  
4,5 
The US leads in this weak signal and EU occupies the second position close to China. Out of the 29 
publications retrieved for EU, 12 are made by or in collaboration with UK organisations. Brexit will 
therefore perturb the knowledge production landscape for this technology in Europe, leaving only 
9 organisations engaged in R&D and not collaborating together. Out of the 20 patents retrieved, 
10 are owned by Chinese entities. One patent from 1996 from Sweden has been retrieved and is 
therefore no in the public domain. 
 
If this technology is deemed of some importance, strong measures will be needed to accompany 
R&D actors in Europe during the Brexit-transition, to increase the number of R&D actors and 
reinforce collaborations, and to encourage the development of innovations to avoid future 
technological dependency. 
Wireless powered 
communication 
networks 
 
Top Countries (Publications) 
China (155), 
South Korea (63) 
EU (68/40)  
Singapore (41), US (35) 
 
Patents Cont. Europe/World 
2/60 
 
Fragmentation  
5,5 
 
China leads in this weak signal, both in terms of scientific publications (155) and patents (34 out 
of 60). After Brexit, Europe will rank 4th in number of publications behind Singapore but in front 
of the US. There is some knowledge about this technology in Europe, but the research ecosystem 
is very fragmented. 2 out of the 60 patents are owned by European organisations.  
 
Measures to reinforce R&D in Europe, to encourage collaboration between European organisations 
and to foster innovation and patenting should be considered. There is a risk of technology 
dependency should European organisations not transform their knowledge into patents. 
Hybrid modular 
multilevel converter 
 
 
Top Countries (Publications) 
China (79) 
 EU (37/13)  
US (19) 
 
Patents Cont. Europe/World 
0/22 
 
Fragmentation  
- 
China leads in this weak signal and EU occupies the second position. But out of the 37 
publications retrieved for EU, 24 are made by or in collaboration with UK organisations. Brexit will 
therefore perturb significantly the knowledge production landscape for this technology in Europe, 
leaving behind only 8 organisations engaged in R&D with no interaction through co-publications. 
Out of the 22 patents retrieved, 19 are owned by Chinese entities, 2 by General Electric (US), and 
1 by ABB (Switzerland).  
 
If this technology is deemed of some importance, strong measures will be needed to accompany 
R&D actors in Europe during the Brexit-transition, to increase the number of R&D actors and 
reinforce collaborations, and to encourage the development of innovations. 
4D printing 
 Top Countries (Publications) 
US (94) 
EU (64/48)  
China (59) 
 
Patents Cont. Europe/World 
0/34 
 
Fragmentation  
1,88 
US leads in terms of scientific publications and China leads in patenting. Europe occupies the 
second position in knowledge production with 64 publications. UK organisations are involved in a 
third of these publications. Brexit will slightly impact R&D in Europe, leaving behind 62 
organisations engaged in research in a fragmented collaborative landscape. China owns 22 of the 
34 patents retrieved (US: 5, South Korea: 5). No patents has been registered by a European 
organisation.  
 
If this technology is deemed of some importance, measures will be needed to strengthen R&D in 
Europe. As EU in lagging behind in patenting, strong measures should also be put in place to 
encourage the development of innovations and avoid technology dependency. 
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EU is weak in patenting 
Weak signal Actors in Europe (not UK) Indicators Analysis and recommendations 
3D Bioprinting 
 
 Top Countries (Publications) 
US (412) 
EU (277/203) 
 China (220) 
 
Patents Cont. Europe/World 
11/558 
 
Fragmentation 
0,94 
1043 publications and 558 patents were retrieved for this weak signal. Europe is strong in 
knowledge production and is second in terms of publications, behind the US but in front of China. A 
significant number of actors operate R&D in Europe, in a fairly well connected collaboration 
landscape. Europe is clearly lagging behind in patenting, with only 11 patents owned by 
organisations in Europe. China, the US, and South Korea own respectively 429 and 54, and 27 of 
the 558 patents.  
 
Europe is lagging behind in patenting and strong measures to encourage the transformation of 
European knowledge should be considered to ensure Europe can be competitive in this field. There 
is a likely risk of technology dependency. 
Quantum machine 
learning 
 
 Top Countries (Publications) 
US (53) 
EU (48/41)  
China (32) 
 
Patents Cont. Europe/World 
1/7 
 
Fragmentation  
1,24 
EU is second in knowledge production for this WS with 28% of the publications (48), close to the 
US (53). 40% of the scientific articles in EU involve an organisation form the UK, and Brexit will 
therefore have some impact on the research ecosystem for this technology. Europe is clearly 
lagging behind in patenting, with only 1 patents owned by a German organisation (Siemens). The 
other six patents retrieved are owned by US based entities.  
 
Europe is lagging behind in patenting and measures to encourage the transformation of European 
knowledge should be considered to ensure Europe can be competitive in this field. 
Robocasting 
 
 Top Countries (Publications) 
US (228) 
EU (174/143)  
China (79) 
 
Patents Cont. Europe/World 
0/15 
 
Fragmentation  
0,67 
 
EU is second in knowledge production for this WS with 35% of the publications (26% if UK 
organisations are not taken into account). The US lead in terms of scientific publications. 133 
organisations are engaged in R&D in Europe for this technology, in a well-connected collaboration 
landscape. None of the 15 patents retrieved belong to an EU based organisation (US: 7, China: 6).  
 
Europe is lagging behind in patenting and measures to encourage the transformation of European 
knowledge should be considered to ensure Europe can be competitive in this field. 
Wire arc additive 
printing 
 
 
Top Countries (Publications) 
EU (136/64)  
China (129) 
 Australia (43), US (39) 
 
Patents Cont. Europe/World 
1/27 
 
Fragmentation  
2,36 
Europe is first in knowledge production in this technology. But 72 of the publications retrieved for 
EU involve UK organisations. R&D actors in Europe do not exhibit a strong appetite for 
collaboration (high fragmentation) and are only involved in 64 of the publications. Brexit will 
therefore have a significant impact. In patenting, one patent comes from Germany. China leads 
with 24 patents out of the 27. 
 
Europe is lagging behind in patenting and measures to encourage the transformation of European 
knowledge should be considered to ensure Europe can be competitive in this field. Support should 
also be considered to accompany the research community in Europe during the Brexit transition. 
 80 
 
3D Concrete printing 
 
 
Top Countries (Publications) 
EU (53/53) 
Australia (26) 
Singapore (21)  
China (17),  US (10) 
 
Patents Cont. Europe/World 
0/36 
 
Fragmentation  
3,28 
 
Europe is first in knowledge production in this technology. Only 23 actors have been spotted in 
Europe, and they evolve in a fragmented collaboration landscape (high fragmentation) and are 
only involved in 64 of the publications. Brexit will therefore have a significant impact. None of the 
36 patents retrieved belong to an EU based organisation, most of them originate from China (27) 
and South Korea (8).  
 
Europe is lagging behind in patenting and measures to encourage the transformation of European 
knowledge should be considered to avoid future technology dependency.  
Levitated 
optomechanics 
 
 Top Countries (Publications) 
EU (87/63)  
US (53) 
China (25) 
 
Patents Cont. Europe/World 
1/6 
 
Fragmentation  
1,08 
 
Europe is first in knowledge production in this technology. 55 actors are engaged in R&D in Europe 
(UK excluded). They evolve in a fairly well collaborative environment (fragmentation~1). One of 
the six patents retrieved is owned by a European organisation (University of Vienna). 3 patents are 
from South Korea, 1 from Taiwan, and 1 from the US. 
 
Patenting activity is low for this technology, and Europe is not (yet) lagging behind. To avoid future 
technology dependency, measures should be put in place to ensure that the leading role in 
knowledge production translates into concrete innovations.  
3D printing of tablets 
 
Top Countries (Publications) 
EU (32/15)  
US (11) 
China (8) 
 
Patents Cont. Europe/World 
0/8 
 
Fragmentation  
1,46 
Europe is first in knowledge production in this technology. But out the 32 publications from EU, 17 
have been published solely by UK organisations. Brexit will therefore have a significant impact in 
this technology. 22 actors will remain in Europe, in a fragmented collaborative environment 
(fragmentation > 1). 5 of the 8 patents retrieved are owned by Chinese organisations, 2 by US 
organisations, 1 in Japan.  
 
Despite a leading role in knowledge production, Europe is lagging behind in patenting and 
measures to encourage the transformation of European knowledge should be considered to avoid 
future technology dependency. Transition measures should also be considered to allow 
organisations in Europe to absorb the Brexit chock. 
 
Weak signals with Brexit-risk 
Weak signal Actors in Europe (not UK) Indicators Analysis and recommendations 
Topological photonics 
 Top Countries (Publications) 
US (85) 
 China (75)  
EU (53/31) 
 
Patents Cont. Europe/World 
0/2 
 
Fragmentation  
1,02 
 
Europe is third in terms of scientific publications. 8 organisations from UK are involved in 23 of the 
53 EU publications and are connected to other organisations in Europe. Brexit will therefore impact 
this R&D environment.  
 
Brexit will have some impact on the R&D activities in this technology if measures to support the 
transition phase are not put in place. 
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Weak signals with Brexit-risk 
Weak signal Actors in Europe (not UK) Indicators Analysis and recommendations 
Algorithmic fairness 
 Top Countries (Publications) 
US (35) 
EU (27/16) 
China (17)  
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
2 
 
8 UK organisations are involved in more than 40 % of publications in this technology. Brexit will 
impact the research activities in Europe by reducing the available knowledge and weakening the 
collaborative landscape. 24 organisations in Europe are active but they do not collaborate much 
together.  
 
Brexit will have significant impact in this weak signal if measures to reinforce research activities 
and patenting are not put in place. 
Civic technologies 
 
Top Countries (Publications) 
EU (34/19) 
US (25) 
  
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
2,75 
 
16 UK organisations are involved in more than 40 % of publications in this technology. Brexit will 
impact the research activities in Europe by reducing the available knowledge (16 UK actors will 
leave Europe) and weakening the collaborative landscape (22 actors for a fragmentation~3).  
 
Brexit will have significant impact in this weak signal if measures to reinforce research activities 
and patenting are not put in place. 
Digital 
humanitarism 
 
Top Countries (Publications) 
EU (15/6) 
US (10) 
UK (9) 
Canada (6) 
  
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
1,5 
 
9 organisations from the UK are involved in 9 of the 15 publications produced in Europe. Brexit will 
impact the research activities in Europe by reducing the number of actors in Europe to a few. 
 
Should this WS be deemed of importance, measure to create R&D activities could be considered. 
Drug cryptomarkets 
 
Top Countries (Publications) 
UK (20) 
Australia (17), Canada (17) 
EU (34/14) 
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
1,88 
 
Half of the organisations active in this weak signal are from the UK and are involved in 20 of the 
34 publications from Europe. Brexit will impact the research activities in Europe by reducing the 
number of actors in Europe. 
 
Should this WS be deemed of importance, measure to support R&D activities in Europe could be 
considered. 
7.8 Social Sciences 
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EU is weak in knowledge production 
Weak signal Actors in Europe (not UK) Indicators Analysis and recommendations 
Coastal blue carbon 
 
 
Top Countries (Publications) 
US (17) 
 Australia (7) 
EU (6/3)  
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
1 
Only 29 publications have been retrieved for this weak signal. Organisations from the US lead in 
knowledge production; EU is second with 6 publications. If Brexit is taken into account, only 3 
publications have been produced so far in Europe, by 7 organisations. No patents has been 
retrieved. 
 
Should this WS be deemed important, significant efforts will have to be made to create R&D and 
push innovation in Europe. There is almost no knowledge in EU and the possibility of a future 
dependency should not be underestimated. 
Marine heatwave 
 
 
Top Countries (Publications) 
Australia (43) 
US (30) 
EU (22/16) 
 
Patents Cont. Europe/World 
0/0 
 
Fragmentation  
3,2 
43 out of the 74 publications retrieved originate from Australia, placing this country at the top 
position in terms of knowledge production. Research in Europe is rather weak, with 15 actors 
having produced 14 publications. No patents has been retrieved. 
 
Should this WS be deemed important, significant efforts will have to be made to create R&D and 
push innovation in Europe. There is almost no knowledge in EU and the possibility of a future 
dependency should not be underestimated. 
Black soldier fly 
larvae biodiesel 
 
 
Top Countries (Publications) 
China (11) 
Malaysia (7) 
US (5), EU (3/3)  
 
Patents Cont. Europe/World 
0/1 
 
Fragmentation  
2,5 
 
Only 33 publications have been retrieved for this technology. The level of research activity in 
Europe is quite low, with only 5 actors and 3 publications. The patent retrieved belongs to a 
Chinese University. 
 
Should this technology become essential, significant efforts will have to be made to create R&D 
and push innovation in Europe. There is almost no knowledge in EU and the possibility of a future 
technology dependency should not be underestimated. 
Peroxymonosulfate 
activation 
 
 
Top Countries (Publications) 
China (331) 
 Australia (42) 
US (40) 
EU (24/23)  
 
Patents Cont. Europe/World 
0/13 
 
Fragmentation  
17 
 
Chinese organisations have clearly take the lead in knowledge production. European organisations 
are only involved in 20 scientific publications (a mere 5% of the total number of publications). In 
addition to this low research activity, the landscape of R&D activities in Europe is fragmented. All 
of the 13 patents retrieved for this technology have been registered by Chinese organisations.  
 
Should this technology become important, significant efforts will have to be made to reinforce 
R&D activities and push innovation in Europe. There is little knowledge in EU and the possibility of 
a future technology dependency should not be underestimated. 
7.9 Environment 
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Functionalised 
Biochar 
 Top Countries (Publications) 
China (186) 
 US (70) 
EU (61/46)  
 
Patents Cont. Europe/World 
0/16 
 
Fragmentation  
1,45 
Chinese organisations are leading in knowledge production. Europe is third with 61 publications but 
if Brexit is taken into consideration, only 46 publications made by 56 actors originated in Europe. 
The landscape of collaboration is slightly fragmented. 14 of the patents retrieved are owned by 
Chinese organisations, 2 by an US company.  
 
Should this technology appear to be essential, significant efforts will have to be made to reinforce 
R&D activities and push innovation in Europe. There is little knowledge in EU to rely on and the 
possibility of a future technology dependency should not be underestimated. 
 
 
EU is weak in patenting 
Weak signal Actors in Europe (not UK) Indicators Analysis and recommendations 
Organophosphorus 
flame retardant 
 
 Top Countries (Publications) 
EU (43/41) 
 China (30) 
US (19) 
  
Patents Cont. Europe/World 
0/6 
 
Fragmentation 
2 
 
Even if Brexit is taken into account, Europe leads in publications in this technology. 42 research 
organisations are engage in R&D activities and the landscape of research is slightly fragmented. 
But in terms of patenting, China leads, owning all of the six patents retrieved.  
 
Patenting activity is still low for this technology but Europe is already lagging behind. To avoid 
future technology dependency, measures should be put in place to ensure that the leading role in 
knowledge production of organisations in Europe translates into concrete innovations. 
Cargo bikes  
Top Countries (Publications) 
EU (37/29) 
 US (3) 
  
Patents Cont. Europe/World 
4/15 
 
Fragmentation 
1,83 
 
37 publications have been made by European organisations, almost all from Europe. This puts 
Europe at the first position in knowledge production for this weak signal. 22 research 
organisations are engage in R&D activities and the landscape of research is slightly fragmented. 5 
of the patents are owned by European entities (US: 6).  
 
Despite its leading role in knowledge production, Europe is not leading in patenting. To avoid future 
technology dependency, measures should be put in place to ensure that the leading role in 
knowledge production of organisations in Europe translates into concrete innovations. 
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Weak signal Documents profile New application 
ReS2 
(Rhenium 
Disulfide) 
  
Rhenium disulphide is a material that is known since a long time. The weak signal corresponds to the discovery of its unique 
semiconducting properties that is of interest for electronic and optoelectronic devices, for energy storage, and photocatalytic and 
electro-catalytic applications. 
Circular RNA 
 
 
For many years, circular RNAs have been thought to be non-coding metabolites. 
It appears now that under some conditions they can code for proteins and also 
have a regulatory role in come cancers and diseases. The graphic to the left 
shows that the weak signal is most likely related to the study of circular RNA in 
the context of cancer detection and therapy (most frequent cancer-related 
keywords in documents retrieved for circular RNA). 
Platinium free 
catalyst 
 
 
Platinum is an expensive material that is used in the composition of many 
catalysts. The quest to reduce its amount or to find alternative materials is 
going on for many years. The weak signal relates to the need to find cheaper 
materials for catalyst inside fuel cells, which is key in the large scale 
commercialisation of this new technology. The graphic to the right shows the 
number of occurrence of the keyword “fuel cell” in the documents retrieved.   
Levitated 
optomechanics 
  
Levitated optomechanics is a technique used for more than 20 years to analyse the characteristics of micro sized molecule 
assemblies. Since a few years, it is used to explore nanosized particulates and explore phenomenon at the boundary between the 
classical and quantum worlds 
7.10 Persistent weak signals  
 
85 
Anti-PDGFR 
monoclonal 
antibodies 
Platelet-derived growth factor is known for many years. The weak signal is related 
to its potential use in the fight against cancers (as can be seen on the graphic to 
the right, showing that the use of the keywords related to cancer correspond to the 
peak of documents over the last four years. 
Cold sintering 
process 
Cold sintering is a well-known process to make solid masses more compact at low 
temperature. The weak signal is related to the use of this technique for the 
production of ceramic materials at low temperature (as can be seen in the graphic 
to the right showing the occurrence of keywords related to ceramic materials). 
SnSe (Tin 
selenide) 
Three articles in 2014 and 2015 reported unique thermoelectric properties for 
the polycristalline structure of Tin selenide. These articles triggered the 
increase of research on this new form and applications of this known material. 
The graphic to the right shows the publications citations landscape (the three 
founding articles have their title). 
Bacillus velenzis 
Bacillus velenzis is a known bacterium which has been recently the subject of 
increasing R&D for its application as suppressor of microbial pathogens and 
promoter of plant growth. The graphic to the right shows the increasing use of 
keyords related to biocontrol and plant growth. 
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Weak signal Documents profile Technological barrier 
Li-Metal 
batteries 
 
 
 
 
The sluggish progress of battery 
technologies has drastically hindered 
the rapid development of electric 
vehicles and next-generation portable 
electronics. One alternative to Li-ion 
batteries is to use Lithium metal 
anodes. Research on the Li-metal field 
has increased over recent years to 
break two technogical barriers 
preventing Li-Metal batteries to 
become commercially available : Li-
dendrite growth and low Coulombic 
efficiency. Unprecedent progresses have been made recently, explaining the renewed interested for research in that field. The two 
graphics below show the increase in keywrods related to Coulombic efficiency (left) and Lithium dendritic growth (right).  
Wearable 
electronics 
 
Wearable electonics have been on the 
radar for many years, but it is only 
recently that the conjonction of R&D in 
new powering mechanisms and of the 
development in printed flexible 
electronics has brought wearable 
electronics closer to becomling a reality. 
The graphics below illustrate the 
increase in research papers in flexible 
electronics (left) and on new powering 
means (right). 
 
 
 
Weak signal Documents profile Policy decision 
Ebola vaccine 
 
 
 
 
 
 
 
 
 
The increase in research and development for this weak signal is related to a policy decision made in 
2014 by the World Health Organisation, which declared that year a Public Health Emergency of 
International Concern (PHEIC) alerting the world that Ebola was out of control in West Africa. An 
international platform was mobilized to accelerate testing of existing experimental Ebola vaccines, 
resulting in a steep increase in the production of scientific publications and patents realted to Ebola 
vaccines. 
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